
<html lang="en"     class="pb-page"  data-request-id="20d15767-c589-4f5b-a078-d93b81cd0118"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b00059;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-10;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin" /></meta><meta name="dc.Creator" content="Yunqi  Li" /></meta><meta name="dc.Creator" content="Yuan  He" /></meta><meta name="dc.Creator" content="Ting  Shao" /></meta><meta name="dc.Creator" content="Haixiang  Pei" /></meta><meta name="dc.Creator" content="Weikai  Guo" /></meta><meta name="dc.Creator" content="Dazhao  Mi" /></meta><meta name="dc.Creator" content="Isabelle  Krimm" /></meta><meta name="dc.Creator" content="Yuanjin  Zhang" /></meta><meta name="dc.Creator" content="Peili  Wang" /></meta><meta name="dc.Creator" content="Xin  Wang" /></meta><meta name="dc.Creator" content="Mingyao  Liu" /></meta><meta name="dc.Creator" content="Zhengfang  Yi" /></meta><meta name="dc.Creator" content="Yihua  Chen" /></meta><meta name="dc.Description" content="Pancreatic cancer is one of the most common cancers with an extremely low survival rate. Metastasis, as one of the key reasons of cancer-related death, is found in more than 50% pancreatic cancer p..." /></meta><meta name="Description" content="Pancreatic cancer is one of the most common cancers with an extremely low survival rate. Metastasis, as one of the key reasons of cancer-related death, is found in more than 50% pancreatic cancer p..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 26, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00059" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00059" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00059" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00059" /></link>
        
    
    

<title>Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00059" /></meta><meta property="og:title" content="Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0014.jpeg" /></meta><meta property="og:description" content="Pancreatic cancer is one of the most common cancers with an extremely low survival rate. Metastasis, as one of the key reasons of cancer-related death, is found in more than 50% pancreatic cancer patients at diagnosis. Novel therapeutic targets and drugs blocking cancer metastasis are urgently needed. Herein, we report a series of 1,5-diaryl-1,2,4-triazole derivatives as potent antimetastatic agents. Lead compound 6y displayed effective antimetastatic activities in pancreatic cancer in vitro and in vivo. Concomitant studies indicated that 6y probably binds with myoferlin (MYOF), a novel potential antitumor metastasis target, which regulates vesicle trafficking and metastasis-related proteins. Subsequent biophysical and biochemical methods verified that 6y bound to MYOF. Mechanism studies revealed that 6y inhibited pancreatic cancer metastasis through reversing the epithelial mesenchymal transition, inhibiting the secretions of matrix metalloproteinase and blocking the receptor tyrosine kinases. Our findings suggest that targeting MYOF with 6y may be a promising therapeutic strategy to prevent pancreatic cancer metastasis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00059"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00059">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00059&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00059&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00059&amp;href=/doi/10.1021/acs.jmedchem.9b00059" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4949-4966</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b02014" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00068" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yunqi Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yunqi Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yunqi++Li">Yunqi Li</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2841-1253" title="Orcid link">http://orcid.org/0000-0002-2841-1253</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yuan He</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuan He</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div><div class="loa-info-affiliations-info">Joint Center for Translational Medicine, Fengxian District Central Hospital, 6600th Nanfeng Road, Fengxian District, Shanghai 201499, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuan++He">Yuan He</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8340-0875" title="Orcid link">http://orcid.org/0000-0001-8340-0875</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ting Shao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ting Shao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ting++Shao">Ting Shao</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5940-3777" title="Orcid link">http://orcid.org/0000-0001-5940-3777</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haixiang Pei</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haixiang Pei</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haixiang++Pei">Haixiang Pei</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5100-6950" title="Orcid link">http://orcid.org/0000-0002-5100-6950</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Weikai Guo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weikai Guo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weikai++Guo">Weikai Guo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9361-3903" title="Orcid link">http://orcid.org/0000-0001-9361-3903</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dazhao Mi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dazhao Mi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dazhao++Mi">Dazhao Mi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1385-8917" title="Orcid link">http://orcid.org/0000-0002-1385-8917</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Isabelle Krimm</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isabelle Krimm</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Université de Lyon, CNRS, Université Claude-Bernard Lyon 1, ENS de Lyon, Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, Villeurbanne 69100, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isabelle++Krimm">Isabelle Krimm</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5981-109X" title="Orcid link">http://orcid.org/0000-0002-5981-109X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yuanjin Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuanjin Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuanjin++Zhang">Yuanjin Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7103-2059" title="Orcid link">http://orcid.org/0000-0001-7103-2059</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peili Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peili Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peili++Wang">Peili Wang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3179-8364" title="Orcid link">http://orcid.org/0000-0002-3179-8364</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xin Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xin Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Wang">Xin Wang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8079-8638" title="Orcid link">http://orcid.org/0000-0001-8079-8638</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mingyao Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mingyao Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div><div class="loa-info-affiliations-info">Joint Center for Translational Medicine, Fengxian District Central Hospital, 6600th Nanfeng Road, Fengxian District, Shanghai 201499, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#315c485d58447153585e1f54525f441f5455441f525f"><span class="__cf_email__" data-cfemail="e18c988d8894a183888ecf84828f94cf848594cf828f">[email protected]</span></a>. Phone: +86-21-54345014. Fax: +86-21-54344922 (M.L.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mingyao++Liu">Mingyao Liu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7339-5048" title="Orcid link">http://orcid.org/0000-0001-7339-5048</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhengfang Yi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhengfang Yi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div><div class="loa-info-affiliations-info">Joint Center for Translational Medicine, Fengxian District Central Hospital, 6600th Nanfeng Road, Fengxian District, Shanghai 201499, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#5329352a3a13313a3c7d36303d267d3637267d303d"><span class="__cf_email__" data-cfemail="4c362a35250c2e252362292f223962292839622f22">[email protected]</span></a>. Phone: +86-21-54345016. Fax: +86-21-54344922 (Z.Y.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhengfang++Yi">Zhengfang Yi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3592-9912" title="Orcid link">http://orcid.org/0000-0003-3592-9912</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Yihua Chen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yihua Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China</div><div class="loa-info-affiliations-info">Joint Center for Translational Medicine, Fengxian District Central Hospital, 6600th Nanfeng Road, Fengxian District, Shanghai 201499, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#9fe6f7fcf7faf1dffdf6f0b1fafcf1eab1fafbeab1fcf1"><span class="__cf_email__" data-cfemail="265f4e454e434866444f49084345485308434253084548">[email protected]</span></a>. Phone: +86-21-24206647. Fax: +86-21-54344922 (Y.C.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yihua++Chen">Yihua Chen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1733-7980" title="Orcid link">http://orcid.org/0000-0003-1733-7980</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00059&amp;href=/doi/10.1021%2Facs.jmedchem.9b00059" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4949–4966</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 26, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 January 2019</li><li><span class="item_label"><b>Published</b> online</span>26 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00059" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00059</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4949%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYunqi%2BLi%252C%2BYuan%2BHe%252C%2BTing%2BShao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D10%26contentID%3Dacs.jmedchem.9b00059%26title%3DModification%2Band%2BBiological%2BEvaluation%2Bof%2Ba%2BSeries%2Bof%2B1%252C5-Diaryl-1%252C2%252C4-triazole%2BCompounds%2Bas%2BNovel%2BAgents%2Bagainst%2BPancreatic%2BCancer%2BMetastasis%2Bthrough%2BTargeting%2BMyoferlin%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4966%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00059"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1718</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00059" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yunqi&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yuan&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Ting&quot;,&quot;last_name&quot;:&quot;Shao&quot;},{&quot;first_name&quot;:&quot;Haixiang&quot;,&quot;last_name&quot;:&quot;Pei&quot;},{&quot;first_name&quot;:&quot;Weikai&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Dazhao&quot;,&quot;last_name&quot;:&quot;Mi&quot;},{&quot;first_name&quot;:&quot;Isabelle&quot;,&quot;last_name&quot;:&quot;Krimm&quot;},{&quot;first_name&quot;:&quot;Yuanjin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Peili&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Mingyao&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Zhengfang&quot;,&quot;last_name&quot;:&quot;Yi&quot;},{&quot;first_name&quot;:&quot;Yihua&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;4949-4966&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00059&quot;},&quot;abstract&quot;:&quot;Pancreatic cancer is one of the most common cancers with an extremely low survival rate. Metastasis, as one of the key reasons of cancer-related death, is found in more than 50% pancreatic cancer patients at diagnosis. Novel therapeutic targets and drugs blocking cancer metastasis are urgently needed. Herein, we report a series of 1,5-diaryl-1,2,4-triazole derivatives as potent antimetastatic agents. Lead compound 6y displayed effective antimetastatic activities in pancreatic cancer in vitro and in vivo. Concomitant studies indicated that 6y probably binds with myoferlin (MYOF), a novel potential antitumor metastasis target, which regulates vesicle trafficking and metastasis-related proteins. Subsequent biophysical and biochemical methods verified that 6y bound to MYOF. Mechanism studies revealed that 6y inhibited pancreatic cancer metastasis through reversing the epithelial mesenchymal transition, inhibiting the secretions of matrix metalloproteinase and blocking the receptor tyrosine kinases. Our findings s&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00059&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00059" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00059&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00059" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00059&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00059" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00059&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00059&amp;href=/doi/10.1021/acs.jmedchem.9b00059" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00059" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00059" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (10 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00059%26sid%3Dliteratum%253Aachs%26pmid%3D31026162%26genre%3Darticle%26aulast%3DLi%26date%3D2019%26atitle%3DModification%2Band%2BBiological%2BEvaluation%2Bof%2Ba%2BSeries%2Bof%2B1%252C5-Diaryl-1%252C2%252C4-triazole%2BCompounds%2Bas%2BNovel%2BAgents%2Bagainst%2BPancreatic%2BCancer%2BMetastasis%2Bthrough%2BTargeting%2BMyoferlin%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D10%26spage%3D4949%26epage%3D4966%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/jmcmar.2019.62.issue-10/20190523/jmcmar.2019.62.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pancreatic cancer is one of the most common cancers with an extremely low survival rate. Metastasis, as one of the key reasons of cancer-related death, is found in more than 50% pancreatic cancer patients at diagnosis. Novel therapeutic targets and drugs blocking cancer metastasis are urgently needed. Herein, we report a series of 1,5-diaryl-1,2,4-triazole derivatives as potent antimetastatic agents. Lead compound <b>6y</b> displayed effective antimetastatic activities in pancreatic cancer in vitro and in vivo. Concomitant studies indicated that <b>6y</b> probably binds with myoferlin (MYOF), a novel potential antitumor metastasis target, which regulates vesicle trafficking and metastasis-related proteins. Subsequent biophysical and biochemical methods verified that <b>6y</b> bound to MYOF. Mechanism studies revealed that <b>6y</b> inhibited pancreatic cancer metastasis through reversing the epithelial mesenchymal transition, inhibiting the secretions of matrix metalloproteinase and blocking the receptor tyrosine kinases. Our findings suggest that targeting MYOF with <b>6y</b> may be a promising therapeutic strategy to prevent pancreatic cancer metastasis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pancreatic cancer is projected to be the second leading cause of cancer-related death by 2030 in the U.S. based on its annual percentage increase in incidence and death rates.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> One of the major causes of death is tumor metastasis. Pancreatic cancer has already metastasized in 52% of patients at diagnosis, among whom the 5 year survival rate is only 3%.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Despite prominent improvement in cancer treatment, metastatic pancreatic cancer remains a major challenge. Systemic chemotherapy is still one of the most common and effective treatment strategies, especially for patients with metastatic pancreatic cancer. However, only eight drugs were listed on the National Comprehensive Cancer Network guidelines for treatment of pancreatic cancer (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Among them, gemcitabine-based therapy is the standard-first-line therapy for advanced pancreatic cancer. Nevertheless, the 1 year survival rate of patients under standard treatment was only 15–20%, and the median survival was 5–6 months.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Few options are available for patients who have failed gemcitabine-based therapy. Therefore, innovative and effective drug candidates are greatly needed, especially for those patients with metastatic pancreatic cancer.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Several representative on-market drugs for pancreatic cancer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Tumor metastasis is a process of interplay between cancer cells and the host distant site, which is also responsible for more than 90% cancer-related deaths.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Novel strategies and agents that could prevent or subdue tumor metastasis are urgently needed in drug development. Phenotypic assay has the advantage of identifying small molecules with a novel target, which are more likely to possess therapeutically relevant molecular mechanisms of action.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a></div><div class="NLM_p">Distribution and degradation of key membrane receptors play crucial roles in tumor cell invasion and metastasis.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Myoferlin (MYOF), an endocytosis and vesicle-transport-related membrane protein, has been reported to be prominently overexpressed in pancreatic cancer,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> breast cancer,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> B-cell lymphoma, and lung cancer<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> while being absent in most normal tissues.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> MYOF has been indicated to be involved in cancer cell migration and invasion by regulating the activities of metastasis-related proteins, such as epidermal growth factor receptor (EGFR),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> vascular endothelial growth factor receptor 2 (VEGFR2),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and matrix metalloproteinases (MMPs).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> It has been reported that MYOF induces epithelial to mesenchymal transition (EMT),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> promotes the secretions of MMPs,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and regulates activities of receptor tyrosine kinases (RTKs),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> which indicate that MYOF may act as one of the key regulators of cancer metastasis. Furthermore, the amplification of MYOF was revealed as a negative prognostic factor in pancreatic cancer.<a onclick="showRef(event, 'ref7 ref8 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref17 ref18 ref19 ref20">(7,8,17−20)</a> MYOF is essential for the maintenance of a branched mitochondrial structure as well as a high oxidative phosphorylation activity in pancreatic ductal adenocarcinoma, affecting the energy metabolism of pancreatic cancer cells.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Thus, prevention of the tumor-promoting function by novel MYOF modulators is a promising therapeutic approach for metastatic pancreatic cancer. Nevertheless, the crystal structure of MYOF is not available to date, which impedes the use of structure-based approaches for the design of MYOF inhibitors.</div><div class="NLM_p">Based on our previous structure–activity relationship (SAR) study on a series of 2,3-diaryl-4-thiazolidinone derivatives, compound <b>2a</b> was discovered to potently inhibit tumor growth and metastasis.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Here, we introduced the medicinally privileged structure of the triazole fragment to the core skeleton of hit compound <b>2a</b> to improve the antimigration activities and optimized the physicochemical properties by replacing the diphenyl rings with hydrophilic heteroaromatics. To evaluate the potential antimigration effects of designed compounds, the phenotypic assay was first applied for the initial evaluation of final compounds. More than thirty diaryl-substituted triazole derivatives were designed and synthesized to investigate the corresponding structure–activity relationship, including the following aspects: (1) further optimizing on the halogen-substituted phenethyl group tail (R<sup>1</sup>), (2) substituent position alteration or replacement of the methoxyl group and homologizing the diaryl substitution by other heterocycles (R<sup>2</sup>, ring A and ring B), and (3) replacement and modification of the 1,2,4-triazole with its isomers (R<sup>3</sup> and ring C) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of the hit compound <b>2a</b>, reported compound <b>2b</b>, and the optimization section that led to compound <b>6y</b> (rings A and B, as well as R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> are highlighted as cited in the text).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Concomitant with the study reported here, another part of structural optimization that focused on the tail of hit compound <b>2a</b> was also carried out, leading to the discovery of compound <b>2b</b>, which was identified with promising antitumor effects on breast cancer through targeting the MYOF C2D domain.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Based on previous results about the target identification of <b>2b</b>, three compounds with potent antimetastatic activities were then selected for evaluation of their potential binding affinities through the MYOF-C2D-based surface plasmon resonance (SPR) assay. Further, compound <b>6y</b>, as one of the potential leads against tumor metastasis, which possesses favorable binding affinity as well as physicochemical properties, was also studied with saturation transfer difference nuclear magnetic resonance (STD-NMR). Biological research subsequently showed that the anticancer activity of <b>6y</b> was positively correlated with the expression of MYOF in pancreatic cancer cells, and <b>6y</b> seemed to be insensitive to MYOF-knockout cells and restored its activity in MYOF-rescued cells. The animal model evidenced its ability to impede metastasis in vivo, presumably through its inhibition of MYOF. The specific antimetastasis molecular mechanisms of <b>6y</b> were also explored in pancreatic cancer.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The heterocyclization of 1,2,4-triazoles was carried out following the reported literature procedures.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Compounds <b>6a</b>–<b>z</b> were prepared as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. 2-(7-Aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyl-uronium hexafluorophosphate (HATU) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) were selected as coupling reagents to couple amidines and substituted-aryl carboxylic acids to form acylamidine intermediates <b>3</b>. Aryl hydrazine and acetic acid were added to the crude solutions of <b>3</b> and then heated to afford <b>4</b>. The 1,2,4-triazoles were generated in one pot with high tolerance for various functionalities and byproducts that could be easily removed. Compounds <b>7a</b>–<b>d</b> were prepared using a similar synthetic route with <b>6k</b> or <b>6p</b> by substituting <i>para</i>-anisic acid and methyl 3-hydrazinyl-benzoate with monomethyl isophthalate or pyridine-3,5-dicarboxylic acid monomethyl ester or 6-(methoxycarbonyl)picolinic acid and (4-methoxyphenyl)hydrazine, respectively. Demethylation of <b>6p</b> in the presence of BBr<sub>3</sub> in dichloromethane (DCM) led to <b>8</b>. Finally, compound <b>9</b> was synthesized similarly with 5-bromonicotic acid, followed by the Pd-catalyzed decarboxylative coupling reaction of potassium oxalate monoesters (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0018.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes of 1,2,3-Triazole Derivatives of Compounds <b>6a</b>–<b>z</b><sup>a</sup><sup>,</sup><sup>b</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>R<sup>1</sup> = aryl(CH<sub>2</sub>)<i><sub>n</sub></i>(O)<i><sub>x</sub></i>(CH<sub>2</sub>)<i><sub>m</sub></i> (<i>m</i>, <i>n</i>, <i>x</i> = 0–2); R<sup>2</sup> = MeO, EtO, CF<sub>3</sub>O, CHF<sub>2</sub>O; R<sup>3</sup> = Me, Et, <i>i</i>-Pr, cyclopropyl.</p><p class="last"><span class="fn-label"><sup>b</sup></span>Reagents and conditions: (a) HATU, DIPEA, dimethylformamide (DMF), room temperature (rt); (b) methyl 3-hydrazinylbenzoate, acetic acid, 80 °C; (c) LiOH·H<sub>2</sub>O, CH<sub>3</sub>OH/H<sub>2</sub>O; (d) amines, EDC·HCl, hydroxybenzotriazole (HOBt), DMF, 0 °C to rt; (e) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes of 1,2,3-Triazole Derivatives of Compounds <b>7a</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HATU, DIPEA, DMF, rt; (b) 4-methoxyphenylhydrazine hydrochloride, acetic acid, 80 °C; (c) LiOH·H<sub>2</sub>O, CH<sub>3</sub>OH/H<sub>2</sub>O; (d) 4-phenyl-1-butylamine, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl), HOBt, DMF, 0 °C to rt.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure–Activity Relationship (SAR) Exploration of Antimigration Activities against PANC1 Pancreatic Cancer Cells</h3><div class="NLM_p">The newly synthesized analogues were first evaluated through the transwell antimigration assay against pancreatic PANC1 cancer cells. Compound <b>1d</b> (gemcitabine), as the first-line drug for metastatic pancreatic cancer therapy, was selected as a positive control. The thiazolidinone fragment in compound <b>2a</b> was first replaced with five-member heterocycle groups. Hereby, we show the compounds containing the 1,2,4-triazole moiety based on our preliminary exploration (<b>6a</b> and <b>6b</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The substitution position of the methoxyl group on ring A was investigated (<b>6c</b> and <b>6d</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The results showed that the migration of the methoxyl group to p-position resulted in more than 2-fold increase in antimigration activities (<b>6c</b> vs <b>6a</b>, <b>6d</b> vs <b>6b</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Therefore, the substitution position of R<sup>2</sup> of phenyl ring A was kept in the p-position in the following structural modifications.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Antimigration Activities (Half-Maximal Inhibitory Concentration (IC<sub>50</sub>)) of Compounds <b>2a</b>, <b>6a</b>–<b>n</b>, and <b>1d</b> against the PANC1 Cell Line in the Transwell Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0011.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compds</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">antimigration activities IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.39 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">4-BrPh–</td><td class="colsep0 rowsep0" align="left">2-MeO–</td><td class="colsep0 rowsep0" align="left">7.92 ± 1.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">4-ClPh–</td><td class="colsep0 rowsep0" align="left">2-MeO–</td><td class="colsep0 rowsep0" align="left"> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">4-BrPh–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left">3.24 ± 0.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="left">4-ClPh–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left">4.36 ± 0.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6e</b></td><td class="colsep0 rowsep0" align="left">4-pyridinyl–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left"> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6f</b></td><td class="colsep0 rowsep0" align="left">2-pyridinyl–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left"> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6g</b></td><td class="colsep0 rowsep0" align="left">2-thiopheny-l</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left"> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6h</b></td><td class="colsep0 rowsep0" align="left">4-BrPhCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left"> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6i</b></td><td class="colsep0 rowsep0" align="left">4-ClPhCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left"> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6j</b></td><td class="colsep0 rowsep0" align="left">4-BrPh(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left">3.02 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6k</b></td><td class="colsep0 rowsep0" align="left">Ph(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left">0.63 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6l</b></td><td class="colsep0 rowsep0" align="left">PhOCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left">3.12 ± 0.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6m</b></td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub>O–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left">9.34 ± 1.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6n</b></td><td class="colsep0 rowsep0" align="left">Ph(CH<sub>2</sub>)<sub>3</sub>–</td><td class="colsep0 rowsep0" align="left">4-MeO–</td><td class="colsep0 rowsep0" align="left"> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1d</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.16 ± 0.04</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Structure of <b>2a</b> was shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</p></div></div></div><div class="NLM_p">Ten compounds were afterward synthesized with modifications on the halogen-substituted 2-phenylethyl tail, and their antimigration activities were examined (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <b>6e</b>–<b>n</b>). The replacements of the phenyl ring with other polar heteroaromatics such as pyridine (<b>6e</b> and <b>6f</b>) or thiophene (<b>6g</b>) unfortunately resulted in an almost complete loss of antimigration activities against cancer cells (IC<sub>50</sub> > 20 μM), which indicated that the existence of a phenyl ring in this position is necessary. The elongation of one methylene chain (<b>6h</b> and <b>6i</b>) conferred weaker activities, whereas two methylene groups’ elongation (<b>6j</b>) produced similar activities compared to <b>6c</b>. Intriguingly, the nonsubstituted counterpart (<b>6k</b>) showed about 5-fold antimigration activity of compound <b>6j</b> (bromo substitution on the p-position of the phenyl ring). To enrich the diversities of linkers between the amide group and the phenyl moiety and to optimize the physicochemical properties, the oxygen atom was incorporated into the carbon linker (<b>6l</b> and <b>6m</b>), which minimized perturbation of the overall compound structure, but the potencies of antimigration were markedly reduced compared to <b>6k</b>. Further linker expansion (<b>6n</b>) also led to diminished activity. The 4-phenylbutyl was thus retained in the following optimization.</div><div class="NLM_p">Subsequent replacements of 1,2,4-triazole with other N-heteroaromatics, such as pyrazole, imidazole, and 1,2,3-triazole, resulted in remarkable loss of antimigration activities in most cases (data not shown). Another 1,2,4-triazole analogue (<b>7a</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) showed about 2-fold less activity than <b>6k</b> as well. Meanwhile, 2-methyl substitution of the 1,2,4-triazole scaffold was modified as reported in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> (see R<sup>3</sup>). One methylene extension (<b>6p</b>) exhibited improved activities (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <b>6p</b> vs <b>6k</b>, <b>6o</b>, <b>6q</b>), about 4-fold more active than <b>6k</b>. The ethyl replacement on the isomer (<b>7b</b>) also showed a marked improvement (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <b>7b</b> vs <b>7a</b>). Introduction of the geminal methyl group and tethering gem-dimethyl into a cyclopropyl derivative showed little improvement in potency (<b>6r</b>, <b>6s</b> vs <b>6p</b>). These results suggested that ethyl substitution was preferred for R<sup>3</sup> among the groups investigated (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route of 1,2,3-Triazole Derivative of Compound <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(TFA)<sub>2</sub>, 1,3-bis(diphenylphosphino)-propane, ethyl potassium oxalate; (b) LiOH·H<sub>2</sub>O, CH<sub>3</sub>OH/H<sub>2</sub>O; (c) 4-phenyl-1-butylamine, EDC·HCl, HOBt, DMF, 0 °C to rt.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antimigration Activities (IC<sub>50</sub>) of Compounds <b>6o</b>–<b>z</b>, <b>8</b>, and <b>1d</b> against the PANC1 Cell Line in the Transwell Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0002.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0003.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Antimigration Activities (IC<sub>50</sub>) of Compounds <b>7a</b>–<b>d</b> and <b>9</b> against the PANC1 Cell Line in the Transwell Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0009.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0015.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Structure of <b>9</b> was shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</p></div></div><div></div></div><div class="NLM_p last">The subsequent modifications on the diaryl substitutions of 1,2,4-triazole were mainly focused on the aromatic ring A and its substitutions (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <b>6t</b>–<b>z</b>, <b>8</b>). The <i>para</i>-methoxyl group on ring A was replaced by ethoxyl (<b>6t</b>), difluoromethoxyl (<b>6u</b>), trifluoromethoxyl (<b>6v</b>), and hydroxyl (<b>8</b>). Among the four groups, only the analogue with hydroxyl (<b>8</b>) showed similar potency to <b>6p</b>. Meanwhile, the phenyl ring A was replaced by a more hydrophilic group like pyridyl (<b>6w</b>, <b>6x</b>) to curb the hydrophobic properties. The position of nitrogen in the pyridyl group greatly impacted the activities of compounds (<b>6w</b> vs <b>6x</b>), which suggested the possibility of improving the antimigration activity by introducing the 2-pyrimidinyl group (<b>6y</b>). Gratifyingly, compound <b>6y</b> (IC<sub>50</sub> = 0.11 μM) exhibited a comparable antimigration activity to positive control <b>1d</b> (IC<sub>50</sub> = 0.16 μM) and improved physicochemical properties according to the calculating model (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf" class="ext-link">Table S1</a>). Replacement of ring A with the pyrazinyl ring resulted in modest activities (<b>6z</b> vs <b>6w</b>, <b>6y</b>). The aromatic ring B was explored as reported in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> (<b>7c</b>, <b>7d</b>, and <b>9</b>), where the incorporation of the pyridyl group resulted in reduced activities (<b>7c</b>, <b>7d</b> vs <b>7b</b>, <b>9</b> vs <b>6p</b>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound <b>6y</b> Showed Potent Anti-invasion and Antimigration Activities against Different Pancreatic Cancer Cells</h3><div class="NLM_p">To further evaluate the anti-invasion activities of the 1,2,4-triazole compounds, several compounds with representative structures were selected for the investigation (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Compounds <b>6p</b>, <b>6x</b>, and <b>6y</b> displayed anti-invasion IC<sub>50</sub> values in the submicromolar range (0.18, 0.15, and 0.12 μM, respectively). Notably, among the investigated compounds, <b>6y</b> exhibited the greatest potency in suppressing cancer cells’ migration and invasion, showing comparable activity to that of <b>1d</b>. To further validate the antimigration activity of <b>6y</b>, two other pancreatic cancer cell lines MiaPaCa2 and Capan2 were selected in the transwell assay (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The results showed that treatment with <b>6y</b> concentration-dependently reduced migrated cell numbers of both MiaPaCa2 and Capan2 cells, indicating its strong inhibitory effect on motility of pancreatic cancer cells.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of compound <b>6y</b> on the migration of pancreatic cancer cells. Compound <b>6y</b> concentration-dependently inhibited the migration of PANC1, MiaPaCa2, and Capan2 cells in the transwell migration assay. Significance between groups was analyzed by one-way analysis of variance (ANOVA) using IBM SPSS software. **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Anti-invasion Activities of Representative Compounds against the PANC1 Cell Line in the Matrigel Invasion Assay</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compds</th><th class="colsep0 rowsep0" align="center" char="±">anti-invasion IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">compds</th><th class="colsep0 rowsep0" align="center" char="±">anti-invasion IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.54 ± 0.18</td><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="char" char="±">9.87 ± 2.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char="±">10.87 ± 2.81</td><td class="colsep0 rowsep0" align="left"><b>6l</b></td><td class="colsep0 rowsep0" align="char" char="±">3.56 ± 1.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="char" char="±">27.57 ± 3.54</td><td class="colsep0 rowsep0" align="left"><b>6p</b></td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="char" char="±">2.96 ± 0.86</td><td class="colsep0 rowsep0" align="left"><b>6x</b></td><td class="colsep0 rowsep0" align="char" char="±">0.15 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1d</b></td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.04</td><td class="colsep0 rowsep0" align="left"><b>6y</b></td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.05</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cellular Toxicity Assessment of Compound <b>6y</b> by the 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium (MTS) Assay</h3><div class="NLM_p">Since compound <b>6y</b> displayed promising antimigration and anti-invasion activities as well as physiochemical properties (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf" class="ext-link">Table S1</a>), its toxicity was initially assessed in the cellular model. Human pancreatic cancer cell lines (Capan2, MiaPaCa2, and PANC1) and normal human cell lines (HPED6-C7, human normal adult fibroblast (HAF), and MCF-10A) were used to determine the half-maximal inhibitory concentration (IC<sub>50</sub>) by the MTS assay (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). The results showed that compound <b>6y</b> displayed IC<sub>50</sub> values of 2.85–0.84 μM in three pancreatic cancer cell lines and 8.54–27.56 μM in three normal human cell lines. To rule out the possibility that the cellular toxicity of <b>6y</b> led to inhibition of cell migration, we performed an additional experiment by treating PANC1 with different concentrations of compound <b>6y</b> (0.1, 0.3, and 1.0 μM) for 18 h. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf" class="ext-link">Figure S1</a>, compound <b>6y</b> had very weak antiviability effects against PANC1 under these concentrations during the period. The results suggested that compound <b>6y</b> was tolerant to normal cell lines at effective concentrations against cancer migration, and the cellular toxicity of compound <b>6y</b> against PANC1 did not affect its antimigration result.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cellular Toxicity Assessment of Compound <b>6y</b> on Three Pancreatic Cancer Cell Lines and Three Normal Human Cell Lines by the MTS Assay</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cancer cell lines</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">normal cell lines</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Capan2</td><td class="colsep0 rowsep0" align="char" char="±">2.85 ± 0.34</td><td class="colsep0 rowsep0" align="left">HPDE6-C7</td><td class="colsep0 rowsep0" align="char" char="±">14.64 ± 1.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MiaPaCa2</td><td class="colsep0 rowsep0" align="char" char="±">1.54 ± 0.13</td><td class="colsep0 rowsep0" align="left">HAF</td><td class="colsep0 rowsep0" align="char" char="±">8.54 ± 2.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PANC1</td><td class="colsep0 rowsep0" align="char" char="±">0.84 ± 0.27</td><td class="colsep0 rowsep0" align="left">MCF-10A</td><td class="colsep0 rowsep0" align="char" char="±">27.56 ± 2.87</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Binding Affinity between Compounds and MYOF in SPR Experiments</h3><div class="NLM_p">To explore the possible targets of this series of compounds, the SPR-based biosensor assay of the MYOF-C2D domain interaction with three representative compounds was performed based on our previous results of the target identification of <b>2b</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Compound <b>6k</b>, as the first identified 1,2,4-triazole derivative with the IC<sub>50</sub> value below 1 μM against the migration assay of the PANC1 cell line, was included in SPR experiments. Since the substitution of ethyl in ring C resulted in an about 4-fold increase in biological activities (<b>6p</b> vs <b>6k</b>), compound <b>6p</b> was added to help us observe the corresponding binding affinity change. Compound <b>6y</b>, possessing the best antimigration and anti-invasion activities and the most favorable physicochemical properties, was also selected for evaluation. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, the modification from methyl to ethyl substitution on the 1,2,4-triazole resulted in over 10-fold improvement in the binding affinity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, <b>6p</b> vs <b>6k</b>), consistent with the increase in antimigration activities (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, <b>6p</b> vs <b>6k</b>). Compound <b>6y</b> also showed concentration-dependent and reversible binding with the MYOF-C2D protein, with a <i>K</i><sub>D</sub> value of 0.094 μM.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0016.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. SPR sensorgrams for the binding between the MYOF-C2D protein and each of the three representative compounds. The corresponding calculated <i>K</i><sub>D</sub> values (at the bottom of each sensorgram) are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> STD-NMR Spectroscopy Investigation of the Binding Interactions for the <b>6y</b>-MYOF Complex</h3><div class="NLM_p">STD is one of the most powerful and robust NMR techniques for the investigation of ligand–receptor interactions.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> STD-NMR was thus employed as an orthogonal technique to observe the direct binding between compound <b>6y</b> and MYOF. In agreement with the SPR experiment, the direct binding of <b>6y</b> to MYOF was observed in the STD spectrum. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, STD for the pyrimidine and methoxyl displayed weaker signals, indicating that the pyrimidine (ring A) and methoxyl moieties are more solvent-exposed compared to ring B. By contrast, proton 1 at the para-position of the phenyl ring tail and protons at the ethyl substitution on ring C displayed the strongest STD signals, suggesting that these protons are buried in the protein. In the absence of the protein three-dimensional structure, the STD data help rationalize SPR data. Substitution of methyl on ring C with ethyl increased the binding affinity by about 10-fold, in agreement with the STD-based observation that this moiety is buried in the protein. The results of STD-NMR indicated that the 4-phenylbutyl tail and the 3-ethyl substitute on the 1,2,4-triazole bind into the pocket of MYOF-C2D. Combined with SPR results of compounds <b>6k</b> and <b>6p</b>, we speculate that there may exist a narrow hydrophobic pocket wherein the ethyl group was buried.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0017.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. STD-NMR spectrum of <b>6y</b> bound to the MYOF-C2D protein. The STD-NMR spectrum (black) is superimposed with the one-dimensional (1D) spectrum (blue). MYOF-C2D and <b>6y</b> concentrations were set to 6 and 145 μM, respectively. The solvent accessibility of the <b>6y</b> protons, deduced from the STD signals, is indicated with spheres colored in red (buried) to yellow (solvent-exposed).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Activity of <b>6y</b> Is Positively Correlated with the Expression of MYOF</h3><div class="NLM_p">Compound <b>6y</b> was shown to bind to MYOF via both SPR and STD-NMR experiments and displayed favorable biological activity and physicochemical properties. Therefore, it was selected for further target validation by biological experiments. To determine whether the biological effect of <b>6y</b> is mainly due to binding with MYOF, sensitivity test of <b>6y</b> was performed in MYOF-knockout and MYOF-overexpressing cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The results showed that MYOF-knockout PANC1 cells reduced migration, demonstrating the critical role of MYOF in migration. Genetic ablation of MYOF in the PANC1 cell line caused cells to become less susceptible to <b>6y</b>. Nonetheless, genetically rescued expression of MYOF restored the antimigration activities of compound <b>6y</b>, suggesting that <b>6y</b> inhibited cancer cell migration through targeting MYOF (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,C). To rule out the possibility that MYOF abrogation could simply cause resistance to multiple types of anticancer agents, <b>1g</b> (docetaxel, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), an antimigration agent that inhibits microtubule depolymerization, was added to the MYOF-knockout cells (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf" class="ext-link">Figure S2A,B</a>). The results showed that <b>1g</b> significantly inhibited migration of MYOF-knockout cells.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0013.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antimigration effect of compound <b>6y</b> was positively correlated with the expression of MYOF in PANC1 cells. (a) MYOF expression in MYOF-knockout and MYOF-rescued cells. (b) MYOF knockout inhibited cell migration, whereas compound <b>6y</b> showed little effect on MYOF-knockout cells. Moreover, compound <b>6y</b> restored its antimigration activities in the MYOF-rescued cells. (c) Statistics of cell migration with or without <b>6y</b> in MYOF-knockout and MYOF-rescued cells. Significance between groups was analyzed by one-way ANOVA using IBM SPSS software. ***, <i>p</i> < 0.001; NS stands for nonsignificant (<i>p</i> > 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> CYPs Inhibitions of Compounds <b>2a</b>, <b>6k</b>, <b>6y</b>, and <b>7a</b></h3><div class="NLM_p">Drug-related adverse effect is a major challenge for drug development and may be attributable to the inhibition of cytochrome P450 enzymes.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Compounds <b>2a</b>, <b>6k</b>, <b>6y</b>, and <b>7a</b> with various concentrations ranging from 0.05 to 50 μM were used to determine the inhibition effects on human CYP enzymes. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf" class="ext-link">Figure S3</a>, compound <b>2a</b> had moderate inhibition effect on the CYP2C9 isozyme (IC<sub>50</sub> = 5.35 μM). However, compound <b>6y</b> had weak or little inhibition on tested human CYP activities (IC<sub>50</sub> values > 20 μM), with reduced inhibition on CYP2C9.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. IC<sub>50</sub> Values of CYP450 Isozyme Inhibition for Compounds <b>2a</b>, <b>6k</b>, <b>6y</b>, and <b>7a</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compds</th><th class="colsep0 rowsep0" align="center">CYP1A2</th><th class="colsep0 rowsep0" align="center">CYP2B6</th><th class="colsep0 rowsep0" align="center" char=".">CYP2C9</th><th class="colsep0 rowsep0" align="center" char=".">CYP2D6</th><th class="colsep0 rowsep0" align="center" char=".">CYP2E1</th><th class="colsep0 rowsep0" align="center">CYP3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">33.87</td><td class="colsep0 rowsep0" align="char" char=".">5.35</td><td class="colsep0 rowsep0" align="char" char=".">21.43</td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="left">19.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6k</b></td><td class="colsep0 rowsep0" align="left">39.73</td><td class="colsep0 rowsep0" align="left">29.38</td><td class="colsep0 rowsep0" align="char" char=".">3.93</td><td class="colsep0 rowsep0" align="char" char=".">24.07</td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="left">36.88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6y</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="char" char=".">20.48</td><td class="colsep0 rowsep0" align="char" char=".">49.60</td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">16.91</td><td class="colsep0 rowsep0" align="left">23.57</td><td class="colsep0 rowsep0" align="char" char=".">3.38</td><td class="colsep0 rowsep0" align="char" char=".">38.12</td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="left">37.69</td></tr></tbody></table></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Compound <b>6y</b> Blocked Pancreatic Cancer Metastasis and Prolonged Overall Survival in BALB/C Nude Mice</h3><div class="NLM_p">Since <b>6y</b> significantly inhibited the migration and invasion of pancreatic cancer cells and was shown to bind to MYOF, we then assessed its antimetastasis activity in vivo utilizing luciferase-based noninvasive animal bioluminescent imaging in a pancreatic cancer pulmonary metastasis model on BALB/C nude mice. PANC1-luciferuse (PANC1-luc) cells were injected into the tail veil of the BALB/C nude mice (<i>n</i> = 8). The mice were then averagely assigned into four groups according to the fluorescence value of mice: the negative control group (dimethyl sulfoxide (DMSO)), the positive control group (<b>1d</b>, 25 mg/(kg day)), and the <b>6y</b>-treated groups (25 and 50 mg/(kg day)). Lung metastasis was monitored every 10 days by bioluminescent imaging. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B, compound <b>6y</b> dose-dependently inhibited pancreatic cancer pulmonary metastasis with superior antitumor metastatic activity compared to the positive control at the same dosage. On day 20, the average luminescence was reduced by about 3-fold and 5-fold in treatment groups (25 and 50 mg/(kg day), respectively) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), indicating significant reduction in lung metastasis burden. After 3 weeks, the survivals were 25% (the negative control), 60% (the positive control), 75% (<b>6y</b>, 25 mg/(kg day)), and 87.5% (<b>6y</b>, 50 mg/(kg day)) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C), evidencing that compound <b>6y</b> significantly prolonged the overall survival. Moreover, the mice in the treated groups showed no significant loss in weight (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A) and displayed no signs of toxicity exhibited by pathological examination of various major organs such as the heart, lung, liver, spleen, and kidney (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B). Taken together, these results suggested that compound <b>6y</b> possesses potent antimetastatic activities in vivo and can improve overall survival without significant toxicity.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>6y</b> suppressed pancreatic cancer lung metastasis in vivo. (a) PANC1-luc cells were injected intravenously into female nude mice. DMSO, <b>6y</b>, or <b>1d</b> (gemcitabine) was injected intraperitoneally on day 0. Lung metastasis was monitored by bioluminescence in an in vivo imaging system. (b) Quantification of bioluminescence. (c) Overall survival rate of mice in different treatment groups. <i>n</i> = 8 mice/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>6y</b> exhibited no significant toxic effect in mice. (a) Body weights observed in mice treated with DMSO or compound <b>1d</b> or <b>6y</b> (25 or 50 mg/(kg day)). (b) Hematoxylin–eosin staining of the heart, lung, liver, spleen, and kidney from animals treated with DMSO, <b>1d</b>, or <b>6y</b> (25 or 50 mg/(kg day)).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Studies of the Possible Mechanism of Compound <b>6y</b> against Tumor Metastasis</h3><div class="NLM_p">EMT is the process of loss of cell polarity and generation of mesenchymal and migratory phenotype, which drives cancer cells toward the invasive phenotype in tumor metastasis.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Since it has been reported that genetic ablation of MYOF reverses EMT in breast cancer cells,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> whether <b>6y</b> impacts the EMT process of PANC1 cells was explored. Western blot results revealed that the expression of the epithelial cell marker E-cadherin was significantly upregulated. Conversely, fibronectin, a mesenchymal cell marker, was observed to be drastically reduced in a concentration-dependent manner with <b>6y</b> treatment (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). In summary, these results indicated that <b>6y</b> could reverse pancreatic cancer cells to the epithelial state. In the process of tumor metastasis, cancer cells secrete a variety of MMPs to degrade the extracellular matrix and basement membrane for efficient migration and invasion.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Research has revealed reduced secretions of MMPs in MYOF-depletion cancer cells.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Then, we collected and concentrated the cell culture medium of <b>6y</b>-treated PANC1 cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B, <b>6y</b> gradient-dependently inhibited the secretions of MMP1 and MMP2 in PANC1 cells.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Underlying mechanism of compound <b>6y</b> on pancreatic cancer cell metastasis. (a) <b>6y</b> increased expressions of the epithelial marker E-cadherin and downregulated the mesenchymal marker fibronectin. (b) <b>6y</b> suppressed the secretions of MMP1 and MMP2 in PANC1 cells. (c) <b>6y</b> depressed the phosphorylation of VEGFR induced by VEGF. (d) Time-dependent phospho-EGFR and EGFR expressions after EGF stimulation with or without <b>6y</b> exposure. (e) Compound <b>6y</b> inhibited the metastasis of cancer cells probably by selectively regulating multiple metastasis-related proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Moreover, MYOF acts as a key regulator of RTK recycling, whereas VEGFR and EGFR are two major RTK drug targets in pancreatic cancer clinical treatment.<a onclick="showRef(event, 'ref14 ref28'); return false;" href="javascript:void(0);" class="ref ref14 ref28">(14,28)</a> It is not surprising that ablation of MYOF in vascular endothelial cells led to instability and rapid degradation of the VEGFR2.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> MYOF deficiency also resulted in impaired degradation of phosphorylated EGFR, causing prolonged/aberrant signaling, notably resulting in the inhibition of EMT and migration in cancer cells.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> These studies revealed that MYOF served as a cancer-related protein likely via regulating tumor-associated endocytic processes. On the basis of this hypothesis, we examined the effect of <b>6y</b> on VEGFR and EGFR. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C,D, Western blot assay revealed that <b>6y</b> diminished the levels of phospho-VEGFR2 and VEGFR2 in PANC1 cells. <b>6y</b> treatment in PANC1 cells caused sustained EGFR phosphorylation upon 10 ng/mL EGF stimulation, switching off the EGFR signal pathway. These results indicated that <b>6y</b> suppresses tumor metastasis in a dose-dependent manner through both VEGF and EGFR signaling pathways.</div><div class="NLM_p">To prove that compound <b>6y</b> regulates these migration-related factors by targeting MYOF rather than directly affecting expressions, secretions, or phosphorylations of these factors, experiments on MYOF-knockout PANC1 cell were performed in comparison. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf" class="ext-link">Figure S4</a>, treatment of different concentrations of compound <b>6y</b> had almost no effect on expressions of E-cadherin and fibronectin, secretions of MMP1 and MMP2, expressions as well as phosphorylations of EGFR and VEGFR2 in MYOF-knockout PANC1 cells. These results suggest that compound <b>6y</b> regulates these migration-related factors by targeting MYOF rather than directly targeting these factors.</div><div class="NLM_p last">Moreover, two migration-associated proteins that are not under the control of MYOF were also examined (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf" class="ext-link">Figure S5</a>). The results showed that treatment of <b>6y</b> had no significant effect on the expression levels of Snail1 and Twist1. Besides, the expressions of two other proteins (myosin IIA and dynein) that regulate vesicle trafficking were detected after treatment with different concentrations of <b>6y</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf" class="ext-link">Figure S6</a>). The results showed that <b>6y</b> did not affect their expression. These data indicated that compound <b>6y</b> is more specific for MYOF inhibition.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">This study characterized a series of diaryl 1,2,4-triazole derivatives that inhibited migration and metastasis against pancreatic cancer in vitro and in vivo through targeting MYOF. Moreover, their antimigratory structure–activity relationship was explored. Among them, <b>6y</b> inhibited pancreatic cancer cell migration and invasion with IC<sub>50</sub> values in the nanomolar range. The SPR assay showed that <b>6y</b> can bind to MYOF-C2D with nanomolar affinity. STD-NMR experiments indicated that the phenyl tail is the most buried region of the inhibitor and that ring A appears the most solvent-exposed moiety of the compound. Also, compound <b>6y</b> showed little activity against the MYOF-knockout cell line and restored the activity in the MYOF-rescued cell. More importantly, compound <b>6y</b> potently blocked PANC1 metastasis in vivo without showing obvious toxicity. The MYOF inhibitor is likely to impart its effects by reversing EMT and inhibiting the secretions of MMP1 and MMP2 while affecting the phosphorylation of VEGFR2 and EGFR. Therefore, a novel therapeutic strategy to prevent pancreatic cancer metastasis can be developed based on our findings. In addition, the implication of MYOF overexpression in various types of cancer warrants further evaluation on the effect of these series of 1,2,4-triazole compounds against other types of cancers.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24570" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24570" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div class="NLM_p last">All reagents were purchased from Adamas-β Ltd., Aladdin-Reagents Inc., J&K Inc., or Sigma-Aldrich Inc. and used as received without purification unless otherwise stated. All reactions were carried out with standard operation procedures under an inert atmosphere (Ar or N<sub>2</sub>). <sup>1</sup>H and <sup>13</sup>C NMR spectra were measured on a Bruker 500 or 400 MHz instrument and obtained as CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> solutions (reported in ppm). CDCl<sub>3</sub> (7.26 and 77.00 ppm) or DMSO-<i>d</i><sub>6</sub> (2.50 and 39.51 ppm) was used as the internal reference. Coupling constants (<i>J</i>) are reported in hertz (Hz). High-resolution mass spectra were recorded on a Bruker MicroTOF-Q II liquid chromatography (LC)–mass spectrometry (MS) instrument operating in electrospray ionization (ESI). High-performance liquid chromatography (HPLC) (Agilent Technologies 1200 Series) was carried out for purity determination using the Eclipse XDB C18 column (5 μm, 4.6 mm × 150 mm) at 40 °C for column temperature by a mixture of solvent water/methanol at the flow rate of 1.5 mL/min. Purities of the prepared compounds were generally ≥95%, verified by HPLC.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Preparation Procedures of Key Intermediates 4 of 1,2,4-Triazole Compounds</h3><div class="NLM_p last">To a cooled mixture of substituted-aryl carboxylic acid (3 mmol), 2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyl-uronium hexafluorophosphate (HATU, 3.3 mmol), and amidine hydrochloride (4.5 mmol) in DMF (9 mL) was added <i>N,N</i>-diisopropylethylamine (DIPEA, 3.6 mmol) in a dropwise manner. The mixture was warmed to room temperature and stirred for 4 h. Methyl 3-hydrazinylbenzoate (4.5 mmol) and acetic acid (30 mmol) were subsequently added. Then, the reaction mixture was heated to 80 °C and stirred for 1–3 h until the end of reaction, which was monitored by thin-layer chromatography. After the completion of reaction, the reaction mixture was cooled to room temperature, diluted with ethyl acetate, and extracted (200 mL) once with saturated sodium bicarbonate solution (200 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude material was purified by silica gel chromatography (in heptane/ethyl acetate = 5:1) to afford pure compounds <b>4</b>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-(5-(2-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)<i>-N</i>-(4-bromophenethyl)benzamide (<b>6a</b>)</h3><div class="NLM_p last">The preparation of corresponding key intermediate <b>4</b>, specifically methyl 3-(5-(2-methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazol-1-yl)benzoate, was as described above, using 2-methoxybenzoic acid, methyl 3-hydrazinylbenzoate, and acetamidines hydrochloride. To a cooled mixture of methyl 3-(5-(2-methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazol-1-yl)benzoate (1.5 mmol) in methanol (20 mL) was added a solution of LiOH·H<sub>2</sub>O (6 mmol) in H<sub>2</sub>O (5 mL) in a dropwise manner at 0 °C. The mixture was warmed to room temperature and stirred overnight. After the completion of the reaction, the reaction mixture was concentrated under reduced pressure. Then, hydrochloric acid solution (6.8 mL, 1 M) was added into the reaction mixture. The corresponding intermediate <b>5</b>, specifically 3-(5-(2-methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazol-1-yl)benzoic acid, was precipitated in the form of a white or light-yellow solid, which was next filtered and dried in a reduced pressure oven without the need of chromatographic purification. To a cooled solution of 3-(5-(2-methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazol-1-yl)benzoic acid (1 mmol) in DMF (2.5 mL) were added EDC·HCl (1.3 mmol) and HOBt (1.3 mmol). After being stirred for 30 min at 0 °C, to the reaction mixture was added 2-(4-bromophenyl)-ethanamine in a dropwise manner. The mixture was then warmed to room temperature and stirred for 1 h. The reaction solution was quenched by cool water and extracted with ethyl acetate, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residues were purified by silica gel chromatography to afford the product <b>6a</b>, yield 51%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (t, <i>J</i> = 5.5 Hz, 1H), 7.81 (d, <i>J</i> = 1.7 Hz, 1H), 7.78 (d, <i>J</i> = 7.9 Hz, 1H), 7.57–7.45 (m, 4H), 7.42 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.26–7.21 (m, 1H), 7.18 (d, <i>J</i> = 8.3 Hz, 2H), 7.09 (dd, <i>J</i> = 7.4, 7.4 Hz, 1H), 6.99 (d, <i>J</i> = 8.3 Hz, 1H), 3.50–3.41 (m, 2H), 3.26 (s, 3H), 2.80 (t, <i>J</i> = 7.1 Hz, 2H), 2.39 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.31, 156.43, 138.90, 137.69, 135.46, 132.13, 131.76, 131.31, 130.50, 129.22, 126.49, 125.47, 121.08, 120.93, 120.49, 111.21, 54.91, 41.07, 35.04, 13.86. HPLC purity: 98.8%, <i>R</i><sub>t</sub> = 8.20 min. High-resolution mass spectrometry (HRMS) (ESI): calcd for [C<sub>25</sub>H<sub>23</sub>BrN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 491.1077, found 491.1081.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-(5-(2-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)<i>-N</i>-(4-chlorophenethyl)benzamide (<b>6b</b>)</h3><div class="NLM_p last">Compound <b>6b</b> was prepared according to the method described for the preparation of compound <b>6a</b>, except using 2-(4-chlorophenyl)ethanamine instead of 2-(4-bromophenyl)-ethanamine. White solid; yield 48%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (t, <i>J</i> = 5.5 Hz, 1H), 7.80 (s, 1H), 7.77 (d, <i>J</i> = 7.9 Hz, 1H), 7.53–7.45 (m, 2H), 7.41 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.33 (d, <i>J</i> = 8.3 Hz, 2H), 7.27–7.19 (m, 3H), 7.08 (dd, <i>J</i> = 7.5, 7.5 Hz, 1H), 6.99 (d, <i>J</i> = 8.3 Hz, 1H), 3.52–3.40 (m, 2H), 3.26 (s, 3H), 2.81 (t, <i>J</i> = 7.1 Hz, 2H), 2.39 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.32, 160.88, 156.41, 152.13, 138.87, 137.16, 135.47, 132.43, 132.11, 131.28, 130.08, 129.18, 128.78, 126.49, 125.45, 121.05, 120.98, 117.48, 111.20, 54.88, 41.12, 34.96, 13.83. HPLC purity: 99.9%, <i>R</i><sub>t</sub> = 7.93 min. HRMS (ESI): calcd for [C<sub>25</sub>H<sub>23</sub>ClN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 447.1582, found 447.1578.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-bromophenethyl)benzamide (<b>6c</b>)</h3><div class="NLM_p last">Compound <b>6c</b> was prepared according to the method described for the preparation of compound <b>6a</b>, except using 4-methoxybenzoic acid instead of 2-methoxybenzoic acid. White solid; yield 50%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (t, <i>J</i> = 5.5 Hz, 1H), 7.94–7.84 (m, 2H), 7.56 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.50–7.42 (m, 3H), 7.39–7.32 (m, 2H), 7.22–7.14 (m, 2H), 7.00–6.92 (m, 2H), 3.76 (s, 3H), 3.42–3.53 (m, 2H), 2.80 (t, <i>J</i> = 7.2 Hz, 2H), 2.37 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.77, 160.40, 159.75, 153.64, 138.90, 138.13, 135.73, 131.10, 130.95, 129.98, 129.53, 128.15, 127.52, 124.25, 119.70, 119.19, 114.09, 55.26, 40.62, 34.19, 13.54. HPLC purity: 98.6%, <i>R</i><sub>t</sub> = 8.53 min. HRMS (ESI): calcd for [C<sub>25</sub>H<sub>23</sub>BrN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 491.1077, found 491.1083.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-chlorophenethyl)benzamide (<b>6d</b>)</h3><div class="NLM_p last">Compound <b>6d</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 2-(4-chlorophenyl)ethanamine instead of 2-(4-bromophenyl)-ethanamine. White solid; yield 52%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.68 (t, <i>J</i> = 5.4 Hz, 1H), 7.94–7.85 (m, 2H), 7.56 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 7.46 (d, <i>J</i> = 7.9 Hz, 1H), 7.39–7.29 (m, 4H), 7.24 (d, <i>J</i> = 8.2 Hz, 2H), 6.95 (d, <i>J</i> = 8.6 Hz, 2H), 3.76 (s, 3H), 3.52–3.42 (m, 2H), 2.82 (t, <i>J</i> = 7.1 Hz, 2H), 2.37 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.77, 160.40, 159.75, 153.65, 138.48, 138.13, 135.74, 130.73, 130.54, 129.99, 129.54, 128.19, 128.15, 127.52, 124.26, 119.70, 114.10, 55.26, 40.68, 40.01, 39.84, 39.68, 39.51, 39.34, 39.18, 39.01, 34.13, 13.54. HPLC purity: 98.5%, <i>R</i><sub>t</sub> = 8.31 min. HRMS (ESI): calcd for [C<sub>25</sub>H<sub>23</sub>ClN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 447.1582, found 447.1588.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(2-(4-pyridinyl)ethyl)benzamide (<b>6e</b>)</h3><div class="NLM_p last">Compound <b>6e</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 2-(4-pyridinyl)ethanamine instead of 2-(4-bromophenyl)ethanamine. Yellow oil; yield 42%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.70 (t, <i>J</i> = 5.5 Hz, 1H), 8.44 (m, 2H), 7.96–7.84 (m, 2H), 7.56 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.50–7.43 (m, 1H), 7.40–7.32 (m, 2H), 7.28–7.18 (m, 2H), 7.02–6.90 (m, 2H), 3.76 (s, 3H), 3.57–3.48 (m, 2H), 2.86 (t, <i>J</i> = 7.1 Hz, 2H), 2.37 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.32, 160.98, 160.87, 154.21, 149.68, 149.59, 148.24, 138.51, 135.92, 130.27, 129.70, 128.01, 127.28, 124.21, 124.18, 123.36, 123.30, 119.75, 114.09, 55.32, 40.35, 35.03, 13.81. HPLC purity: 97.3%, <i>R</i><sub>t</sub> = 5.27 min. HRMS (ESI): calcd for [C<sub>24</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup> 419.1925, found 414.1927.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(2-(2-pyridinyl)ethyl)benzamide (<b>6f</b>)</h3><div class="NLM_p last">Compound <b>6f</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 2-(2-pyridinyl)ethanamine instead of 2-(4-bromophenyl)ethanamine. Yellow oil; yield 40%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.70 (t, <i>J</i> = 5.5 Hz, 1H), 8.48 (d, <i>J</i> = 4.0 Hz, 1H), 7.95–7.87 (m, 2H), 7.71–7.65 (m, 1H), 7.55 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.48–7.43 (m, 1H), 7.38–7.32 (m, 2H), 7.25 (d, <i>J</i> = 7.8 Hz, 1H), 7.23–7.17 (m, 1H), 6.99–6.92 (m, 2H), 3.76 (s, 3H), 3.64–3.58 (m, 2H), 3.02–2.95 (m, 2H), 2.37 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 165.83, 160.93, 160.69, 159.50, 154.19, 148.82, 138.48, 137.11, 136.34, 130.25, 129.53, 127.84, 127.28, 123.76, 123.68, 121.82, 119.74, 114.07, 55.28, 39.33, 36.25, 13.79. HPLC purity: 98.6%, <i>R</i><sub>t</sub> = 5.61 min. HRMS (ESI): calcd for [C<sub>24</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup> 419.1925, found 414.1929.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(2-(2-thiophenyl)ethyl)benzamide (<b>6g</b>)</h3><div class="NLM_p last">Compound <b>6g</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 2-(2-thiophenyl)ethanamine instead of 2-(4-bromophenyl)ethanamine. White solid; yield 45%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.75 (t, <i>J</i> = 5.5 Hz, 1H), 7.97–7.91 (m, 1H), 7.90–7.86 (m, 1H), 7.58 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.50–7.45 (m, 1H), 7.39–7.33 (m, 2H), 7.32–7.28 (m, 1H), 6.99–6.91 (m, 3H), 6.88 (m, 1H), 3.76 (s, 3H), 3.54–3.44 (m, 2H), 3.05 (t, <i>J</i> = 7.1 Hz, 2H), 2.37 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.31, 159.89, 159.26, 153.15, 140.93, 137.63, 135.20, 129.48, 129.05, 127.68, 127.03, 126.37, 124.66, 123.76, 123.55, 113.61, 54.75, 40.52, 28.49, 13.01. HPLC purity: 98.7%, <i>R</i><sub>t</sub> = 10.08 min. HRMS (ESI): calcd for [C<sub>23</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>S + H]<sup>+</sup> 419.1536, found 419.1543.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(3-(4-bromophenyl)propyl)benzamide (<b>6h</b>)</h3><div class="NLM_p last">Compound <b>6h</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 3-(4-bromophenyl)propan-1-amine instead of 2-(4-bromophenyl)-ethanamine. White solid; yield 54%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66–8.55 (m, 1H), 8.00–7.83 (m, 2H), 7.61–7.52 (m, 1H), 7.51–7.41 (m, 3H), 7.35 (d, <i>J</i> = 7.9 Hz, 2H), 7.18 (d, <i>J</i> = 7.5 Hz, 2H), 6.93 (d, <i>J</i> = 7.9 Hz, 2H), 3.74 (s, 3H), 3.28–3.19 (m, 2H), 2.59–2.57 (m, 2H), 2.37 (s, 3H), 1.81–1.78 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.79, 160.39, 159.75, 153.65, 141.13, 138.09, 135.83, 131.07, 130.62, 130.01, 129.48, 128.05, 127.56, 124.26, 119.71, 118.74, 114.08, 99.51, 55.24, 31.85, 30.41, 13.54. HPLC purity: 97.7%, <i>R</i><sub>t</sub> = 9.12 min. HRMS (ESI): calcd for [C<sub>26</sub>H<sub>25</sub>BrN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 505.1234, found 505.1228.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(3-(4-chlorophenyl)propyl)benzamide (<b>6i</b>)</h3><div class="NLM_p last">Compound <b>6i</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 3-(4-chlorophenyl)propan-1-amine instead of 2-(4-bromophenyl)-ethanamine. White solid; yield 53%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (t, <i>J</i> = 5.4 Hz, 1H), 7.95–7.89 (m, 2H), 7.59–7.52 (m, 1H), 7.47–7.43 (m, 1H), 7.39–7.29 (m, 4H), 7.24 (d, <i>J</i> = 8.3 Hz, 2H), 6.93 (d, <i>J</i> = 8.9 Hz, 2H), 3.74 (s, 3H), 3.27–3.21 (m, 2H), 2.60 (t, <i>J</i> = 7.6 Hz, 2H), 2.37 (s, 3H), 1.85–1.74 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.80, 160.40, 159.76, 153.66, 140.71, 138.11, 135.85, 130.19, 130.01, 129.48, 128.16, 128.05, 127.56, 124.27, 119.73, 114.09, 55.23, 31.80, 30.47, 13.53. HPLC purity: 96.1%, <i>R</i><sub>t</sub> = 8.92 min. HRMS (ESI): calcd for [C<sub>26</sub>H<sub>25</sub>ClN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 461.1739, found 461.1732.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-(4-bromophenyl)butyl)benzamide (<b>6j</b>)</h3><div class="NLM_p last">Compound <b>6j</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 4-(4-bromophenyl)butan-1-amine instead of 2-(4-bromophenyl)-ethanamine. White solid; yield 58%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (t, <i>J</i> = 5.5 Hz, 1H), 7.95–7.90 (m, 2H), 7.55 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 7.48–7.42 (m, 3H), 7.40–7.33 (m, 2H), 7.17 (d, <i>J</i> = 8.3 Hz, 2H), 6.93 (d, <i>J</i> = 8.9 Hz, 2H), 3.75 (s, 3H), 3.29–3.22 (m, 2H), 2.57 (t, <i>J</i> = 7.4 Hz, 2H), 2.37 (s, 3H), 1.60–1.47 (m, 4H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.66, 160.39, 159.74, 153.64, 141.53, 138.10, 135.87, 131.03, 130.59, 129.99, 129.46, 128.04, 127.53, 124.25, 119.71, 118.64, 114.07, 55.24, 34.01, 28.46, 28.12, 13.53. HPLC purity: 95.3%, <i>R</i><sub>t</sub> = 9.66 min. HRMS (ESI): calcd for [C<sub>27</sub>H<sub>27</sub>BrN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 519.1390, found 519.1389.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6k</b>)</h3><div class="NLM_p last">Compound <b>6k</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 4-phenylbutan-1-amine instead of 2-(4-bromophenyl)ethanamine. White solid; yield 60%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.82 (d, <i>J</i> = 7.8 Hz, 1H), 7.74 (d, <i>J</i> = 1.7 Hz, 1H), 7.45 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.41–7.35 (m, 3H), 7.30–7.26 (m, 2H), 7.21–7.14 (m, 3H), 6.86–6.81 (m, 2H), 6.07 (s, 1H), 3.80 (s, 3H), 3.48–3.41 (m, 2H), 2.49 (s, 3H), 2.66 (t, <i>J</i> = 7.4 Hz, 2H), 1.73–1.67 (m, 2H), 1.65–1.59 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.13, 160.99, 160.82, 154.24, 141.92, 138.45, 136.40, 130.32, 129.67, 128.39, 128.36, 127.82, 127.40, 125.87, 123.17, 114.09, 77.00, 55.31, 40.02, 35.43, 29.10, 28.65, 13.84. HPLC purity: 98.9%, <i>R</i><sub>t</sub> = 10.97 min. HRMS (ESI): calcd for [C<sub>27</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 441.2285, found 441.2279.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(3-phenoxypropyl)benzamide (<b>6l</b>)</h3><div class="NLM_p last">Compound <b>6l</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 3-phenoxypropan-1-amine instead of 2-(4-bromophenyl)ethanamine. Yellow oil; yield 48%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66–8.58 (m, 1H), 8.00–7.89 (m, 2H), 7.60–7.50 (m, 1H), 7.44 (d, <i>J</i> = 7.7 Hz, 1H), 7.36 (d, <i>J</i> = 8.6 Hz, 2H), 7.30–7.21 (m, 2H), 6.97–6.88 (m, 5H), 4.06–4.00 (m, 2H), 3.76 (s, 3H), 3.49–3.38 (m, 2H), 2.37 (s, 3H), 1.98–1.93 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.03, 161.00, 160.66, 158.35, 154.19, 138.44, 136.30, 129.61, 129.56, 127.89, 127.39, 123.42, 121.10, 119.59, 114.30, 114.09, 77.00, 66.67, 55.29, 38.60, 28.66, 13.76. HPLC purity: 95.2%, <i>R</i><sub>t</sub> = 7.84 min. HRMS (ESI): calcd for [C<sub>26</sub>H<sub>26</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 443.2078, found 443.2074.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(2-(benzyloxy)ethyl)benzamide (<b>6m</b>)</h3><div class="NLM_p last">Compound <b>6m</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 2-(benzyloxy)ethanamine instead of 2-(4-bromophenyl)ethanamine. Yellow oil; yield 44%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.71–8.60 (m, 1H), 7.94 (d, <i>J</i> = 9.3 Hz, 2H), 7.55 (d, <i>J</i> = 7.6 Hz, 1H), 7.44 (d, <i>J</i> = 6.8 Hz, 1H), 7.39–7.19 (m, 7H), 6.93 (d, <i>J</i> = 8.7 Hz, 2H), 4.50 (s, 2H), 3.76 (s, 3H), 3.62–3.52 (m, 2H), 3.47 (d, <i>J</i> = 5.2 Hz, 2H), 2.37 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.92, 160.40, 159.75, 153.66, 138.38, 138.14, 135.68, 129.99, 129.52, 128.21, 128.19, 127.59, 127.51, 127.39, 124.38, 119.70, 114.10, 71.77, 68.07, 55.26, 13.54. HPLC purity: 96.1%, <i>R</i><sub>t</sub> = 7.36 min. HRMS (ESI): calcd for [C<sub>26</sub>H<sub>26</sub>N<sub>4</sub>O<sub>3</sub> + H]<sup>+</sup> 443.2078, found 443.2074.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3-(5-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(5-phenylpentyl)benzamide (<b>6n</b>)</h3><div class="NLM_p last">Compound <b>6n</b> was prepared according to the method described for the preparation of compound <b>6c</b>, except using 5-phenylpentan-1-amine instead of 2-(4-bromophenyl)ethanamine. White solid; yield 62%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.90 (d, <i>J</i> = 7.6 Hz, 1H), 7.86–7.80 (m, 1H), 7.53 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 7.50–7.42 (m, 3H), 7.39–7.31 (m, 3H), 7.25–7.20 (m, 2H), 6.93 (d, <i>J</i> = 8.6 Hz, 2H), 6.96–6.88 (m, 1H), 3.89 (s, 3H), 3.54–3.46 (m, 2H), 2.71 (t, <i>J</i> = 7.6 Hz, 2H), 2.58 (s, 3H), 1.79–1.67 (m, 4H), 1.52–1.45 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.16, 160.98, 160.79, 154.23, 142.29, 138.38, 136.45, 130.31, 129.64, 128.35, 128.26, 127.77, 127.44, 125.69, 123.18, 119.77, 114.07, 55.29, 40.09, 35.68, 30.96, 29.34, 26.43, 13.81. HPLC purity: 99.8%, <i>R</i><sub>t</sub> = 9.31 min. HRMS (ESI): calcd for [C<sub>28</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 455.2442, found 455.2441.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 3-(5-(4-Methoxyphenyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6o</b>)</h3><div class="NLM_p last">Compound <b>6o</b> was prepared according to the method described for the preparation of compound <b>6k</b>, except using formamidine hydrochloride instead of acetamidines hydrochloride. White solid; yield 51%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (t, <i>J</i> = 5.6 Hz, 1H), 8.23 (s, 1H), 8.00–7.95 (m, 1H), 7.94–7.89 (m, 1H), 7.58 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.52–7.46 (m, 1H), 7.40–7.35 (m, 2H), 7.29–7.23 (m, 2H), 7.21–7.11 (m, 3H), 6.97–6.94 (m, 2H), 3.76 (s, 3H), 3.30–3.24 (m, 2H), 2.59 (t, <i>J</i> = 7.5 Hz, 2H), 1.64–1.56 (m, 2H), 1.55–1.47 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.60, 160.48, 153.43, 151.46, 142.07, 138.07, 135.93, 130.07, 129.56, 128.27, 128.20, 128.19, 127.78, 125.62, 124.39, 119.55, 114.13, 55.26, 34.77, 28.59, 28.41. HPLC purity: 99.2%, <i>R</i><sub>t</sub> = 8.28 min. HRMS (ESI): calcd for [C<sub>26</sub>H<sub>26</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 427.2129, found 427.2123.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3-(3-Ethyl-5-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6p</b>)</h3><div class="NLM_p last">Compound <b>6p</b> was prepared according to the method described for the preparation of compound <b>6k</b>, except using propionamidine hydrochloride instead of acetamidines hydrochloride. White solid; yield 63%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (t, <i>J</i> = 5.6 Hz, 1H), 7.97–7.89 (m, 2H), 7.55 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.46–7.42 (m, 1H), 7.38–7.33 (m, 2H), 7.30–7.23 (m, 2H), 7.22–7.12 (m, 3H), 6.95–6.92 (m, 2H), 3.75 (s, 3H), 3.30–3.24 (m, 2H), 2.74 (q, <i>J</i> = 7.6 Hz, 2H), 2.59 (t, <i>J</i> = 7.5 Hz, 2H), 1.64–1.56 (m, 2H), 1.55–1.49 (m, 2H), 1.30 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.66, 164.41, 160.37, 153.62, 142.08, 138.17, 135.87, 130.02, 129.45, 128.27, 128.20, 128.09, 127.52, 125.62, 124.29, 119.79, 114.07, 55.24, 34.76, 28.59, 28.41, 21.10, 12.36. HPLC purity: 95.0%, <i>R</i><sub>t</sub> =11.21 min. HRMS (ESI): calcd for [C<sub>28</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 455.2442, found 455.2439.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3-(5-(4-Methoxyphenyl)-3-propyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6q</b>)</h3><div class="NLM_p last">Compound <b>6q</b> was prepared according to the method described for the preparation of compound <b>6k</b>, except using butyramidine hydrochloride instead of acetamidines hydrochloride. White solid; yield 49%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (t, <i>J</i> = 5.6 Hz, 1H), 7.97–7.87 (m, 2H), 7.55 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.48–7.42 (m, 1H), 7.40–7.32 (m, 2H), 7.30–7.23 (m, 2H), 7.19–7.14 (m, 3H), 6.99–6.89 (m, 2H), 3.75 (s, 3H), 3.30–3.22 (m, 2H), 2.68 (t, <i>J</i> = 7.5 Hz, 2H), 2.60 (t, <i>J</i> = 7.4 Hz, 2H), 1.82–1.71 (m, 2H), 1.64–1.56 (m, 2H), 1.55–1.49 (m, 2H), 0.99 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.67, 163.33, 160.37, 153.56, 142.08, 138.16, 135.88, 130.02, 129.46, 128.27, 128.20, 128.06, 127.50, 125.62, 124.25, 119.80, 55.24, 34.77, 29.60, 28.60, 28.41, 21.01, 13.82. HPLC purity: 98.2%, <i>R</i><sub>t</sub> = 9.82 min. HRMS (ESI): calcd for [C<sub>29</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 469.2598, found 469.2607.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3-(3-Isopropyl-5-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6r</b>)</h3><div class="NLM_p last">Compound <b>6r</b> was prepared according to the method described for the preparation of compound <b>6k</b>, except using 2-methylpropanimidamide instead of acetamidines hydrochloride. White solid; yield 30%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (t, <i>J</i> = 5.2 Hz, 1H), 8.01–7.85 (m, 2H), 7.54 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.45 (d, <i>J</i> = 7.6 Hz, 1H), 7.35 (d, <i>J</i> = 8.7 Hz, 2H), 7.29–7.23 (m, 2H), 7.21–7.13 (m, 3H), 6.93 (d, <i>J</i> = 8.7 Hz, 2H), 3.75 (s, 3H), 3.29–3.19 (m, 2H), 3.08–3.02 (m, 1H), 2.59 (t, <i>J</i> = 7.4 Hz, 2H), 1.68–1.46 (m, 4H), 1.33 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.03, 164.67, 160.36, 153.56, 142.08, 138.20, 135.86, 130.05, 129.46, 128.27, 128.20, 128.14, 127.51, 125.62, 124.30, 119.85, 114.06, 55.24, 34.76, 28.59, 28.41, 27.60, 21.48. HPLC purity: 96.7%, <i>R</i><sub>t</sub> = 11.34 min. HRMS (ESI): calcd for [C<sub>29</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 469.2598, found 469.2608.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-(3-Cyclopropyl-5-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6s</b>)</h3><div class="NLM_p last">Compound <b>6s</b> was prepared according to the method described for the preparation of compound <b>6k</b>, except using cyclopropane carboxamidine instead of acetamidines hydrochloride. White solid; yield 35%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.56 (br s, 1H), 7.94–7.85 (m, 2H), 7.59–7.49 (m, 1H), 7.43 (d, <i>J</i> = 8.1 Hz, 1H), 7.37–7.21 (m, 4H), 7.21–7.08 (m, 3H), 6.98–6.87 (m, 2H), 3.75 (s, 3H), 3.29–3.20 (m, 2H), 2.63–2.56 (m, 2H), 2.12–2.01 (m, 1H), 1.65–1.44 (m, 4H), 1.04–0.94 (m, 2H), 0.94–0.87 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.70, 164.66, 160.38, 153.54, 142.08, 138.10, 135.85, 130.03, 129.42, 128.27, 128.20, 128.03, 127.48, 125.62, 124.27, 119.73, 114.04, 55.24, 34.77, 28.60, 28.41, 8.59, 7.52. HPLC purity: 99.2%, <i>R</i><sub>t</sub> = 9.55 min. HRMS (ESI): calcd for [C<sub>29</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 467.2442, found 467.2449.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-(5-(4-Ethoxyphenyl)-3-ethyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6t</b>)</h3><div class="NLM_p last">Compound <b>6t</b> was prepared according to the method described for the preparation of compound <b>6p</b>, except using 4-ethoxybenzoic acid instead of 4-methoxybenzoic acid. White solid; yield 60%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (t, <i>J</i> = 5.5 Hz, 1H), 7.97–7.88 (m, 2H), 7.55 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.44 (d, <i>J</i> = 8.0 Hz, 1H), 7.34 (d, <i>J</i> = 8.8 Hz, 2H), 7.29–7.22 (m, 2H), 7.21–7.12 (m, 3H), 6.91 (d, <i>J</i> = 8.8 Hz, 2H), 4.01 (q, <i>J</i> = 6.9 Hz, 2H), 3.29–3.20 (m, 2H), 2.73 (q, <i>J</i> = 7.6 Hz, 2H), 2.59 (t, <i>J</i> = 7.3 Hz, 2H), 1.70–1.44 (m, 4H), 1.34–1.26 (m, 6H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.66, 164.40, 159.67, 153.64, 142.08, 138.17, 135.86, 130.01, 129.45, 128.27, 128.20, 128.07, 127.50, 125.62, 124.26, 119.63, 114.44, 63.21, 34.76, 28.59, 28.41, 21.10, 14.50, 12.35. HPLC purity: 95.7%, <i>R</i><sub>t</sub> = 11.48 min. HRMS (ESI): calcd for [C<sub>29</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 469.2598, found 469.2611.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-(5-(4-(Difluoromethoxy)phenyl)-3-ethyl-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6u</b>)</h3><div class="NLM_p last">Compound <b>6u</b> was prepared according to the method described for the preparation of compound <b>6p</b>, except using 4-(difluoromethoxy)benzoic acid instead of 4-methoxybenzoic acid. White solid; yield 48%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (t, <i>J</i> = 5.5 Hz, 1H), 7.94 (d, <i>J</i> = 8.1 Hz, 2H), 7.55 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 7.50–7.42 (m, 3H), 7.34–7.23 (m, 2H), 7.22–7.10 (m, 5H), 3.29–3.23 (m, 2H), 2.76 (q, <i>J</i> = 7.6 Hz, 2H), 2.59 (t, <i>J</i> = 7.3 Hz, 2H), 1.67–1.45 (m, 4H), 1.31 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.61, 152.91, 152.00, 142.08, 137.86, 135.93, 130.47, 129.51, 128.27, 128.20, 128.09, 127.69, 125.62, 124.32, 118.35, 115.98 (t, <i>J</i> = 259 Hz), 34.77, 28.60, 28.41, 21.08, 12.32. HPLC purity: 95.9 %, <i>R</i><sub>t</sub> = 11.21 min. HRMS (ESI): calcd for [C<sub>28</sub>H<sub>29</sub>F<sub>2</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 491.2253, found 491.2261.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-(3-Ethyl-5-(4-(trifluoromethoxy)phenyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6v</b>)</h3><div class="NLM_p last">Compound <b>6v</b> was prepared according to the method described for the preparation of compound <b>6p</b>, except using 4-(trifluoromethoxy)benzoic acid instead of 4-methoxybenzoic acid. White solid; yield 44%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (t, <i>J</i> = 5.5 Hz, 1H), 7.99–7.89 (m, 2H), 7.62–7.51 (m, 3H), 7.47 (d, <i>J</i> = 8.5 Hz, 1H), 7.40 (d, <i>J</i> = 8.3 Hz, 2H), 7.31–7.22 (m, 2H), 7.21–7.11 (m, 3H), 3.30–3.22 (m, 2H), 2.77 (q, <i>J</i> = 7.6 Hz, 2H), 2.59 (t, <i>J</i> = 7.3 Hz, 2H), 1.68–1.45 (m, 4H), 1.32 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.70, 164.59, 152.52, 149.21, 142.07, 137.69, 135.94, 130.73, 129.55, 128.26, 128.19, 128.05, 127.76, 126.80, 125.62, 124.29, 121.02, 120.93, 118.89, 34.77, 28.61, 28.41, 21.08, 12.30. HPLC purity: 96.6%, <i>R</i><sub>t</sub> = 11.62 min. HRMS (ESI): calcd for [C<sub>28</sub>H<sub>27</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 509.2159, found 509.2165.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3-(3-Ethyl-5-(6-methoxy-3-pyridinyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6w</b>)</h3><div class="NLM_p last">Compound <b>6w</b> was prepared according to the method described for the preparation of compound <b>6p</b>, except using 6-methoxynicotinic acid instead of 4-methoxybenzoic acid. White solid; yield 41%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (t, <i>J</i> = 5.5 Hz, 1H), 8.26–8.18 (m, 1H), 8.01–7.89 (m, 2H), 7.70 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.57 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 7.53–7.46 (m, 1H), 7.29–7.23 (m, 2H), 7.21–7.10 (m, 3H), 6.84 (dd, <i>J</i> = 8.7, 0.5 Hz, 1H), 3.85 (s, 3H), 3.29–3.22 (m, 2H), 2.76 (q, <i>J</i> = 7.6 Hz, 2H), 2.59 (t, <i>J</i> = 7.4 Hz, 2H), 1.75–1.45 (m, 4H), 1.31 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.01, 166.94, 164.81, 152.01, 147.40, 141.92, 138.66, 138.23, 136.62, 129.85, 128.39, 128.36, 127.91, 127.50, 127.49, 125.86, 123.67, 117.24, 111.01, , 53.81, 40.05, 35.43, 29.10, 28.65, 21.73, 12.58. HPLC purity: 99.6%, <i>R</i><sub>t</sub> = 11.10 min. HRMS (ESI): calcd for [C<sub>27</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup> 456.2394, found 456.2403.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3-(3-Ethyl-5-(5-methoxy-2-pyridinyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6x</b>)</h3><div class="NLM_p last">Compound <b>6x</b> was prepared according to the method described for the preparation of compound <b>6p</b>, except using 5-methoxypicolinic acid instead of 4-methoxybenzoic acid. White solid; yield 40%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.55 (t, <i>J</i> = 5.6 Hz, 1H), 8.07 (d, <i>J</i> = 2.6 Hz, 1H), 7.97 (d, <i>J</i> = 8.7 Hz, 1H), 7.93–7.82 (m, 2H), 7.57–7.47 (m, 2H), 7.46–7.40 (m, 1H), 7.30–7.23 (m, 2H), 7.22–7.13 (m, 3H), 3.83 (s, 3H), 3.30–3.23 (m, 2H), 2.82–2.71 (m, 2H), 2.58 (t, <i>J</i> = 7.4 Hz, 2H), 1.63–1.48 (m, 4H), 1.31 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.90, 164.37, 156.06, 152.33, 142.17, 139.12, 138.96, 136.90, 135.23, 128.78, 128.35, 128.28, 128.07, 127.01, 125.69, 125.13, 124.01, 121.19, 99.57, 55.81, 34.84, 28.71, 28.53, 21.15, 12.47. HPLC purity: 96.1%, <i>R</i><sub>t</sub> = 10.91 min. HRMS (ESI): calcd for [C<sub>27</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup> 456.2394, found 456.2401.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3-(3-Ethyl-5-(5-methoxy-2-pyrimidinyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6y</b>)</h3><div class="NLM_p last">Compound <b>6y</b> was prepared according to the method described for the preparation of compound <b>6p</b>, except using 5-methoxypyrimidine-2-carboxylic acid instead of 4-methoxybenzoic acid. White solid; yield 42%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (br s, 2H), 8.55 (dd, <i>J</i> = 5.7, 5.7 Hz, 1H), 7.89–7.87 (m, 1H), 7.84 (dd, <i>J</i> = 1.8, 1.8 Hz, 1H), 7.49 (dd, <i>J</i> = 7.9, 7.9 Hz, 1H), 7.41–7.39 (m, 1H), 7.28–7.25 (m, 2H), 7.19–7.16 (m, 3H), 3.92 (s, 3H), 3.28–3.24 (m, 2H), 2.79 (q, <i>J</i> = 7.6 Hz, 2H), 2.59 (t, <i>J</i> = 7.5 Hz, 2H), 1.58–1.49 (m, 4H), 1.32 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.27, 165.91, 152.95, 151.40, 148.81, 143.37, 141.93, 139.11, 135.70, 129.02, 128.49, 128.37, 128.33, 127.35, 125.83, 123.99, 56.08, 39.98, 35.42, 29.11, 28.65, 21.73, 12.58. HPLC purity: 98.7%, <i>R</i><sub>t</sub> = 8.23 min. HRMS (ESI): calcd for [C<sub>26</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub> + H]<sup>+</sup> 457.2347, found 457.2343.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3-(3-Ethyl-5-(5-methoxy-2-pyrazinyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>6z</b>)</h3><div class="NLM_p last">Compound <b>6z</b> was prepared according to the method described for the preparation of compound <b>6p</b>, except using 5-methoxypyrazine-2-carboxylic acid instead of 4-methoxybenzoic acid. White solid; yield 41%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (d, <i>J</i> = 1.4 Hz, 1H), 8.55 (t, <i>J</i> = 5.6 Hz, 1H), 8.14 (d, <i>J</i> = 1.4 Hz, 1H), 7.91–7.87 (m, 2H), 7.53–7.46 (m, 2H), 7.29–7.23 (m, 2H), 7.22–7.13 (m, 3H), 3.96 (s, 3H), 3.29–3.24 (m, 2H), 2.79 (q, <i>J</i> = 7.6 Hz, 2H), 2.59 (t, <i>J</i> = 7.5 Hz, 2H), 1.59–1.47 (m, 4H), 1.32 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.17, 165.82, 160.46, 150.83, 141.93, 141.68, 138.81, 135.82, 135.15, 134.52, 129.15, 128.38, 128.35, 128.32, 127.20, 125.84, 123.91, 54.10, 40.00, 35.43, 29.13, 28.66, 21.73, 12.61. HPLC purity: 95.3%, <i>R</i><sub>t</sub> = 9.28 min. HRMS (ESI): calcd for [C<sub>26</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub> + H]<sup>+</sup> 457.2347, found 457.2350.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 3-(1-(4-Methoxyphenyl)-3-methyl-1<i>H</i>-1,2,4-triazol-5-yl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>7a</b>)</h3><div class="NLM_p last">Compound <b>7a</b> was prepared using the similar synthesis pathway of <b>6k</b> by substituting 4-methoxybenzoic acid and methyl 3-hydrazinylbenzoate with monomethyl isophthalate and (4-methoxyphenyl)hydrazine, respectively. White solid; yield 62%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.97 (s, 1H), 7.88 (d, <i>J</i> = 7.7 Hz, 1H), 7.41 (d, <i>J</i> = 7.8 Hz, 1H), 7.36–7.32 (m, 1H), 7.31–7.26 (m, 2H), 7.24 (d, <i>J</i> = 8.8 Hz, 2H), 7.21–7.14 (m, 3H), 6.91 (d, <i>J</i> = 8.8 Hz, 2H), 6.52–6.40 (m, 1H), 3.83 (s, 3H), 3.55–3.39 (m, 2H), 2.66 (t, <i>J</i> = 7.4 Hz, 2H), 2.49 (s, 3H), 1.73–1.61 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.54, 160.56, 159.90, 153.18, 142.00, 135.42, 131.13, 130.92, 129.07, 128.94, 128.42, 128.37, 128.04, 126.83, 126.46, 125.87, 114.62, 99.98, 55.56, 39.96, 35.47, 29.16, 28.70, 13.85. HPLC purity: 95.3%, <i>R</i><sub>t</sub> = 8.69 min. HRMS (ESI): calcd for [C<sub>27</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 441.2285, found 441.2274.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 3-(3-Ethyl-1-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-yl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>7b</b>)</h3><div class="NLM_p last"><b>7b</b> was prepared according to the method described for the preparation of compound <b>7a</b> except using propanimidamide hydrochloride instead of acetamide hydrochloride. White solid, yield 65%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.53 (t, <i>J</i> = 5.5 Hz, 1H), 8.06 (d, <i>J</i> = 1.4 Hz, 1H), 7.90–7.83 (m, 1H), 7.45–7.36 (m, 2H), 7.34–7.23 (m, 4H), 7.23–7.12 (m, 3H), 7.01–6.99 (m, 2H), 3.78 (s, 3H), 3.30–3.22 (m, 2H), 2.77–2.72 (m, 2H), 2.60 (t, <i>J</i> = 7.5 Hz, 2H), 1.66–1.46 (m, 4H), 1.31 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.56, 159.86, 153.07, 141.99, 135.40, 131.19, 130.95, 129.04, 128.90, 128.41, 128.35, 126.86, 126.57, 125.85, 114.60, 55.55, 39.95, 35.46, 29.14, 28.69, 21.75, 12.68. HPLC purity: 99.2%, <i>R</i><sub>t</sub> = 11.72 min. HRMS (ESI): calcd for [C<sub>28</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 455.2442, found 455.2438.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 5-(3-Ethyl-1-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-yl)-<i>N</i>-(4-phenylbutyl)nicotinamide (<b>7c</b>)</h3><div class="NLM_p last">Compound <b>7c</b> was prepared according to the method described for the preparation of compound <b>7b</b>, except using 5-(methoxycarbonyl)nicotinic acid instead of 3-(methoxycarbonyl)-benzoic acid. White solid; yield 40%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.99 (d, <i>J</i> = 2.0 Hz, 1H), 8.75 (t, <i>J</i> = 5.4 Hz, 1H), 8.56 (d, <i>J</i> = 2.0 Hz, 1H), 8.38–8.28 (m, 1H), 7.37 (d, <i>J</i> = 8.9 Hz, 2H), 7.31–7.24 (m, 2H), 7.23–7.12 (m, 3H), 7.03 (d, <i>J</i> = 8.9 Hz, 2H), 3.80 (s, 3H), 3.30–3.25 (m, 2H), 2.77 (q, <i>J</i> = 7.6 Hz, 2H), 2.60 (t, <i>J</i> = 7.4 Hz, 2H), 1.65–1.57 (m, 2H), 1.55–1.48 (m, 2H), 1.32 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.10, 164.92, 160.50, 151.27, 150.89, 149.40, 142.10, 134.54, 130.62, 130.43, 128.63, 128.62, 127.11, 126.14, 124.37, 115.19, 55.83, 40.30, 35.66, 29.29, 28.88, 21.96, 12.83. HPLC purity: 97.6%, <i>R</i><sub>t</sub> = 8.92 min. HRMS (ESI): calcd for [C<sub>27</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup> 456.2394, found 456.2392.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 6-(3-Ethyl-1-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-yl)-<i>N</i>-(4-phenylbutyl)picolinamide (<b>7d</b>)</h3><div class="NLM_p last">Compound <b>7d</b> was prepared according to the method described for the preparation of compound <b>7b</b>, except using 6-(methoxycarbonyl)picolinic acid instead of 3-(methoxycarbonyl)-benzoic acid. White solid; yield 38%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.28 (d, <i>J</i> = 7.9 Hz, 1H), 8.14 (t, <i>J</i> = 9.8 Hz, 1H), 7.00 (d, <i>J</i> = 7.8 Hz, 1H), 7.41 (d, <i>J</i> = 8.8 Hz, 2H), 7.27 (d, <i>J</i> = 7.3 Hz, 2H), 7.19 (d, <i>J</i> = 7.7 Hz, 3H), 7.03 (d, <i>J</i> = 8.8 Hz, 2H), 6.76 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 3.79 (s, 3H), 3.17–3.03 (m, 2H), 2.77 (q, <i>J</i> = 7.6 Hz, 2H), 2.58 (t, <i>J</i> = 7.6 Hz, 2H), 1.56–1.42 (m, 3H), 1.35–1.30 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 163.31, 159.60, 151.27, 148.95, 142.13, 138.51, 132.97, 128.42, 128.32, 127.46, 125.82, 125.68, 122.56, 114.07, 55.49, 39.05, 35.50, 29.25, 28.72, 21.75, 12.62. HPLC purity: 95.1%, <i>R</i><sub>t</sub> = 11.69 min. HRMS (ESI): calcd for [C<sub>27</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup> 456.2394, found 456.2398.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 3-(3-Ethyl-5-(4-hydroxyphenyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)benzamide (<b>8</b>)</h3><div class="NLM_p last">To a cooled solution of <b>6q</b> (1 mmol) in dried DCM (10 mL) was added BBr<sub>3</sub> (3 mmol) dropwise. The reaction mixture was stirred for 3 h at 0 °C. After the completion of reaction, methanol (3 mL) was added to quench the reaction. After concentration in vacuo, the residue was purified in silica gel column chromatography to give the pure product as a white solid. White solid; yield 34%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.95 (s, 1H), 8.58 (t, <i>J</i> = 5.6 Hz, 1H), 7.91 (dd, <i>J</i> = 7.3, 5.2 Hz, 2H), 7.54 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 7.42 (d, <i>J</i> = 7.9 Hz, 1H), 7.31–7.11 (m, 7H), 6.74 (d, <i>J</i> = 8.7 Hz, 2H), 3.31–3.21 (m, 2H), 2.72 (q, <i>J</i> = 7.6 Hz, 2H), 2.59 (t, <i>J</i> = 7.4 Hz, 2H), 1.67–1.46 (m, 4H), 1.29 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.70, 164.33, 158.93, 153.94, 142.09, 138.25, 135.84, 130.08, 129.38, 128.28, 128.21, 127.99, 127.37, 125.62, 124.19, 118.16, 115.40, 34.78, 28.61, 28.44, 21.12, 12.38. HPLC purity: 95.8%, <i>R</i><sub>t</sub> = 10.72 min. HRMS (ESI): calcd for [C<sub>27</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 441.2285, found 441.2288.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 5-(3-Ethyl-5-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazolyl)-<i>N</i>-(4-phenylbutyl)nicotinamide (<b>9</b>)</h3><div class="NLM_p last">The intermediate 3-bromo-5-(3-ethyl-5-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazolyl)pyridine was prepared according to the method described for the preparation of intermediate <b>4</b>, except using 3-bromo-5-hydrazinylpyridine instead of methyl 3-hydrazinylbenzoate. Palladium(II) trifluoroacetate (0.01 mmol), 1,3-bis(diphenylphosphino)-propane (0.015 mmol), ethyl potassium oxalate (1.5 mmol), 3-bromo-5-(3-ethyl-5-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazolyl)pyridine (1.00 mmol), and <i>N</i>-methyl-2-pyrrolidone (2 mL) were added and stirred under strictly Ar protection condition. Then, the mixture was heated to 150 ± 5 °C and reacted for 24 h. Upon completion of the reaction, the mixture was cooled to room temperature and diluted with diethyl ether (20 mL) and then filtered through a short silica column to remove the deposition. The organic layers were washed with water (20 mL × 3) and then with brine, dried over MgSO<sub>4</sub>, and filtered. The concentration of the filtrate and purification by column chromatography yielded ethyl 5-(3-ethyl-5-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazolyl)nicotinate. After hydrolysis and amidation, the final product was produced. White solid; yield 24%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.93 (s, 1H), 8.60 (d, <i>J</i> = 1.4 Hz, 1H), 8.15 (s, 1H), 7.38 (d, <i>J</i> = 8.7 Hz, 2H), 7.31–7.26 (m, 2H), 7.22–7.16 (m, 3H), 6.87 (d, <i>J</i> = 8.7 Hz, 2H), 6.22 (br, s, 1H), 3.81 (s, 3H), 3.52–3.42 (m, 2H), 2.85 (q, <i>J</i> = 7.6 Hz, 2H), 2.79–2.78 (m, 1H), 2.66 (t, <i>J</i> = 7.3 Hz, 2H), 1.40 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 166.45, 164.27, 161.29, 154.74, 147.84, 147.29, 141.81, 134.94, 130.96, 130.68, 130.33, 128.38, 128.37, 125.92, 119.30, 114.44, 55.35, 40.14, 35.39, 29.01, 28.61, 21.76, 12.48. HPLC purity: 99.7%, <i>R</i><sub>t</sub> = 8.99 min. HRMS (ESI): calcd for [C<sub>27</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup> 456.2394, found 456.2390.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Biological Evaluation</h3><div id="sec4_35_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Cell Lines and Reagents</h4><div class="NLM_p last">Human pancreatic cancer cell line PANC1, MiaPaCa2, Capan2, human normal breast epithelial cell line MCF-10A, human normal pancreatic ductal cell line HPDE6-C7, and human normal adult fibroblast (HAF) were obtained from American Type Culture Collection (Manassas, VA) and cultured in Dulbecco’s modified Eagle’s medium media (Gibco) in a 37 °C and 5% CO<sub>2</sub> incubator. Mitomycin C was purchased from Sigma. Matrigel was purchased from BD Biosciences (San Jose, CA). The pcDNA3.1-myoferlin HA vector was obtained from Addgene. Primary antibodies: MYOF (ab76746, Abcam), fibronectin (ab137720, Abcam), β-actin (A5441, Sigma), MMP1 (ab137332, Abcam), MMP2 (ab37150, Abcam), E-cadherin (3195, CST), VEGFR2 (9698, CST), phospho-VEGFR2 (2478, CST), EGFR (4267, CST) and phospho-EGFR antibodies (3777, CST), Snail1 (3879, CST), Twist1 (46702, CST), myosin IIA (3403, CST), dynein (ab23905, Abcam). The AQueous One Solution Cell Proliferation Kit was purchased from Promega (MTS reagent, Madison, WI). BugBuster 10× protein extraction reagent was purchased from Merck.</div></div><div id="sec4_35_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> In Vitro Transwell Migration Assays and Invasion Assay</h4><div class="NLM_p last">Transwell migration assays were performed in 24-well plates following the manufacturer’s instruction. Briefly, PANC1, MiaPaCa2, and Capan2 cells were pretreated with 20 ng/mL mitomycin C for 2 h to exclude the effect of cell proliferation. Then, cells were trypsinized and seeded in upper chambers of a 24-well transwell chamber with 300 μL of basic medium containing different concentrations of compounds (0, 0.16, 0.8, 4, 20 μM or 0, 0.05, 0.1, 0.2, 0.4 μM). The lower chambers were filled with 600 mL of total medium containing the corresponding compounds. After incubation at 37 °C (18 h for PANC1, 24 h for MiaPaCa2, and 36 h for Capan2), noninvasive cells were scraped with a cotton swab, and invaded cells were fixed with 4% paraformaldehyde and then stained with 0.1% crystal violet. Images were photographed using a digital camera attached to an OLYMPUS inverted microscope, and migrated cells were quantified by manual counting. Invasion assay was performed as the transwell migration assay except that the upper surface of the transwell membrane was coated with 20 μL of Matrigel (1.5 mg/mL) and incubated for 15 min before the cell seeding. Three independent experiments were performed.</div></div><div id="sec4_35_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Cell Viability Assay</h4><div class="NLM_p last">In brief, cells were seeded in 96-well plates with an appropriate cell density. After 12 h of incubation, various concentrations of drugs were added for 48 h incubation. Then, 20 μL of MTS reagent per well was added and incubated for 45 min at 37 °C. Spectrophotometric absorbance at 490 nm was measured with a microplate reader (SpectraMax 190; Molecular Devices). The IC<sub>50</sub> was calculated using GraphPad software. Three independent experiments were conducted in triplicate.</div></div><div id="sec4_35_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Knockout of MYOF by sgRNA</h4><div class="NLM_p last">sgRNA directed against human MYOF was inserted into the lentiCRISPR v2 vector (oligo 1: 5′-CACCGGGCTTGCCAAATTTCGTTTT-3′ and oligo 2: 5′-AAACAAAACGAAATTTGGCAAGCCC-3′). HEK293T cells were cotransfected with the lentiviral expression plasmid, plus packaging plasmid psPAX2 and envelope plasmid pMD2.G. After 48 h of transfection, the supernatant was harvested for MYOF-knockout cells.</div></div><div id="sec4_35_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Overexpression of MYOF</h4><div class="NLM_p last">In a six-well cell culture plate, 3 μg of pcDNA3.1-myoferlin HA vector or equivalent empty vector was transfected into MYOF-Knockout PANC1 cells using 6 μL of Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer’s instructions. After 48 h of transfection, the migration abilities of cells were tested.</div></div><div id="sec4_35_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Cloning, Expression, and Purification of MYOF-C2D Protein</h4><div class="NLM_p last">Human MYOF-C2D gene sequence composed of bases 3445–3912 of MYOF CDS was ligated into the <i>Bam</i>HI and <i>Xho</i>I sites of the pGEX4T-1 vector (forward primer: 5′-CGGGATCCCGAGTGCCACCACT-GTGTTCGGAG-3′; reversed primer: 5′-CCGCTCGAGCCTCAGAATCAGCTCTGCAGTT-3′). Recombinant plasmid was transformed into BL21 (DE3) chemically competent cells (TransGen Biotech) for protein expression. Then, 0.5 mM isopropyl β-thiogalactopyranoside (IPTG) (Sigma) was added to induce protein expression when the optical density value of 100 mL of culture medium reached 0.7. After an additional 4 h post induction, cells were centrifugated and resuspended in 5 mL of lysis buffer (50 mM Tris–HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid (EDTA), 150 mM NaCl, 10% glycerol, 1% NP40) and followed by ultrasonic cell lysis (300 W, twice for 10 min). Inclusion bodies (IB) were collected and thoroughly resuspend in 5 mL 1× IB wash buffer (20 mM Tris–HCl, pH 7.5, 10 mM EDTA, 1% Triton X-100). IB solubilization buffer (10 mL, 50 mM <i>N</i>-cyclohexyl-3-aminopropane sulfonic acid, pH 11.0) with 0.3% <i>N</i>-lauroylsarcosine was added into inclusion bodies and incubated for 15 min. The solution was centrifugated, and the supernatant containing the solubilized protein was transferred into a clean tube. Solubilized protein was dialyzed in dialysis buffer (20 mM Tris–HCl, 0.1 mM dithiothreitol (DTT), pH 8.5) for 6 h at 4 °C. The dialysis continued through two additional changes (3 h each) with the dialysis buffer lacking DTT. Reduced glutathione (1 mM) and oxidized glutathione (0.2 mM) in the dialysis buffer were used to dialyze the refolded protein overnight at 4 °C. Then, glutathione agarose gel beads were incubated with protein overnight at 4 °C to purify the refolding glutathione S-transferase (GST)-tagged MYOF-C2D protein. The unbound protein and impurities were washed off with phosphate-buffered saline (PBS). The GST-tagged MYOF-C2D protein was eluted with an elution buffer (20 mL, 10 mM reduced glutathione, 50 mM Tris, pH 8.0) and concentrated with an ultrafiltration column at 5000<i>g</i>, and the eluent buffer was replaced with PBS simultaneously. The purified protein was quantified and detected by coomassie blue staining and Western blot.</div></div><div id="sec4_35_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Surface Plasmon Resonance Assay</h4><div class="NLM_p">Experiments were performed at 25 °C with a Biacore T200 instrument (GE Healthcare) as previously described.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> GST-tagged MYOF-C2D protein in sodium acetate buffer (pH 4.5) was immobilized on the sensor chip (CM5) for 7 min using the standard amine coupling kit (GE Healthcare). To deactivate the unreacted esters and remove the unbound protein, the surface of the flow cell was then blocked with ethanolamine for 7 min. A blank flow cell was activated and deactivated in the same manner with GST-tagged peptide immobilization.</div><div class="NLM_p last">Gradient concentrations of compounds that were dissolved in degassed and filter-sterilized PBS buffer were injected into the channel and analyzed at 25 °C. The bulk effects were corrected with solvent correction, and the reference and blank were subtracted from the binding response curves. Data processing and affinity analysis were performed using BIA evaluation software in a 1:1 Langmuir binding model.</div></div><div id="sec4_35_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Saturation Transfer Difference NMR Spectroscopy</h4><div class="NLM_p last">D<sub>2</sub>O 99.9% and DMSO-<i>d</i><sub>6</sub> were purchased from Sigma. PBS buffer (50 mL) was prepared with NaCl (400 mg), KCl (10 mg), Na<sub>2</sub>HPO<sub>4</sub> (72 mg), and KH<sub>2</sub>PO<sub>4</sub> (12 mg), and the pH was adjusted to 7.5 by hydrochloric acid. The NMR sample contained 6 μM MYOF-C2D protein, 145 μM <b>6y</b> in 10% D<sub>2</sub>O, 1% DMSO-<i>d</i><sub>6</sub>, and PBS buffer. NMR spectra were acquired in a Bruker spectrometer operating at a proton frequency of 600 MHz equipped with a <i>z</i>-gradient cryoprobe. The NMR experiments were performed at 293 K. Water suppression was achieved using excitation sculpting for both the 1D and STD experiments. 1D and STD experiments were performed using identical experimental conditions (spin lock, interscan delays). For the STD experiment, selective saturation of the protein was achieved at 0 ppm, whereas off-saturation was achieved at −15 ppm. Saturation time was set to 2 s.</div></div><div id="sec4_35_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Microsomal Incubation</h4><div class="NLM_p last">Microsomal incubation was carried out at 37 °C in a mixture of 200 μL in 0.05 M Tris–HCl buffer (pH 7.4) consisting of pooled HLMs (0.5 mg/mL) and an NADPH-regenerating system including MgCl<sub>2</sub> (5 mM), G6P (10 mM), G6PDH (0.4 U/mL), and NADP (1 mM). Substrates were added into the incubation system, and the final concentrations were obtained (10 μM phenacetin for CYP1A2, 20 μM bupropion for CYP2B6, 20 μM tolbutamide for CYP2C9, 5 μM dextromethorphan for CYP2D6, 20 μM chlorzoxazone for CYP2E1, and 10 μM midazolam for CYP3A4). The ratio of the organic solvent was not higher than 1% (v/v) in the incubation system.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The reaction was initiated by addition of NADP after preincubation for 5 min. The incubation process was performed for 20 min and stopped by adding 200 μL of ice-cold acetonitrile. Then, 20 μL of internal standard solution was added (3-acetamidophenol 2 μg/mL, chlorpropamide 2 μg/mL, and mebendazole 2 μg/mL). The solution was mixed thoroughly and centrifuged for 15 min at 16 000<i>g</i> at 4 °C. The supernatant (80 μL) was transferred to a cell plate, and 2 μL was injected into the LC–tandem mass spectrometry (MS/MS) system. The inhibition IC<sub>50</sub> values were fitted by nonlinear regression analysis using GraphPad Prism 6.0 (GraphPad Software Inc., CA).</div></div><div id="sec4_35_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Pancreatic Cancer Lung Metastasis Animal Model</h4><div class="NLM_p last">Eight-week-old BALB/c nude mice were purchased from National Rodent Laboratory Animal Resources (Shanghai, China). Animals were housed in a specific pathogen-free room within the animal facilities, and studies were performed according to the guidelines approved by the Institute of Biomedical Sciences, East China Normal University. Next, 1 × 10<sup>6</sup> PANC1-luc cancer cells were intravenously introduced into the mice. On the next day (day 0), the mice were divided into four groups according to the fluorescence value of mice. All mice in drug treatment groups were intraperitoneally injected with 50 μL of <b>6y</b> (25 and 50 mg/kg) or <b>1d</b> (25 mg/kg) every day, with an equivalent volume of DMSO serving as the control group (<i>n</i> = 8). The bioluminescence of cancer cells in lungs was monitored every 10 days by an IVIS Imaging System (Xenogen Corporation, Alameda, CA). When the mice showed near-death indicators such as loss of mobility and temperature drop, they were euthanized immediately in consideration of animal ethics. The Kaplan–Meier survival curve was used to estimate the survival curve during the treatment.</div></div><div id="sec4_35_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Histological Analysis</h4><div class="NLM_p last">The tissues of hearts, livers, spleens, lungs, and kidneys were harvested and fixed with 4% formaldehyde for 12 h, processed with tissue dehydration, and embedded in paraffin blocks. Paraffin-embedded tissues were cut into 4 μm sections and mounted on glass slides. The tissue sections were hydrated through decreasing concentration of alcohol baths and stained with hematoxylin and eosin. After tissue dehydration, the slides were mounted with xylene-based mounting media and covered with coverslips. Histopathological changes were observed and captured with a Leica DM 4000B photomicroscope.</div></div><div id="sec4_35_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Western Blot Assay</h4><div class="NLM_p last">Pancreatic cells were lysed with a radioimmunoprecipitation assay buffer supplemented with phenylmethylsulfonyl fluoride and a proteinase inhibitor cocktail and a phosphatase inhibitor cocktail (Sigma). Protein concentrations were determined using a Bicinchoninic Acid Protein Assay Kit (Thermo Scientific) and equalized before loading. Total cellular protein samples were applied to 8–12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels and transferred onto nitrocellulose membranes. Then, membranes were blocked with 5% bovine serum albumin in PBS and probed with specific primary antibodies overnight at 4 °C. Membranes were incubated with florescence conjugated secondary antibodies and detected by the infrared dichroic laser scanning imaging system (Li-Cor, Odyssey).</div></div><div id="sec4_35_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> MMP Detection Assay</h4><div class="NLM_p last">In the test for the secretions of MMP1 and MMP2, wild-type or MYOF-knockout PANC1 cells were serum starved in basal media with different concentrations of <b>6y</b> for 24 h. Then, the conditioned media were concentrated 50-fold with Amicon Ultra-4 10 kDa centrifugal filters (Millipore, Billerica, MA), and equal volumes of concentrated media were reconstituted in the sample buffer and resolved by SDS-PAGE.</div></div><div id="sec4_35_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Statistical Analysis</h4><div class="NLM_p last">Grouped data are expressed as mean ± standard deviation. In the transwell migration assay, the invasion assay, and the cell viability assay, significance between groups was analyzed by one-way ANOVA, and lung metastasis animal experiment was measured by repeated measurement ANOVA using IBM SPSS Statistics software. All experiments were performed at least three times except animal experiments. <i>p</i> values less than 0.05 were considered statistically significant.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00059" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52062" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52062" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00059" class="ext-link">10.1021/acs.jmedchem.9b00059</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Physicochemical properties of representative compounds (Table S1); antiviability effects of compound <b>6y</b> against PANC1 cell lines in different concentration for 18 h (Figure S1); <b>1g</b> inhibited the migration of MYOF-knockout cells (Figure S2); inhibitory effects against CYP450 isozymes in pooled human liver microsomes for compounds <b>2a</b>, <b>6k</b>, <b>6y</b>, and <b>7a</b> (Figure S3); effects of different concentrations of compound <b>6y</b> on the expressions of E-cadherin and fibronectin, secretions of MMP1 and MMP2, expressions as well as phosphorylations of EGFR and VEGFR2 in MYOF-knockout PANC1 cells (Figure S4); compound <b>6y</b> exhibited selectivity for MYOF over other metastasis-associated proteins (Figure S5); compound <b>6y</b> did not affect the expressions of myosin IIA and dynein (Figure S6); <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS (ESI), and HPLC spectra of target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf">jm9b00059_si_001.pdf (13.63 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_002.csv">jm9b00059_si_002.csv (3.34 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00059" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingyao Liu</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="hlFld-Affiliation affiliation">Joint
Center for Translational Medicine, Fengxian
District Central Hospital, 6600th Nanfeng Road, Fengxian District, Shanghai 201499, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7339-5048" title="Orcid link">http://orcid.org/0000-0001-7339-5048</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b8d5c1d4d1cdf8dad1d796dddbd6cd96dddccd96dbd6"><span class="__cf_email__" data-cfemail="3b564257524e7b595254155e58554e155e5f4e155855">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhengfang Yi</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="hlFld-Affiliation affiliation">Joint
Center for Translational Medicine, Fengxian
District Central Hospital, 6600th Nanfeng Road, Fengxian District, Shanghai 201499, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3592-9912" title="Orcid link">http://orcid.org/0000-0003-3592-9912</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#84fee2fdedc4e6edebaae1e7eaf1aae1e0f1aae7ea"><span class="__cf_email__" data-cfemail="a6dcc0dfcfe6c4cfc988c3c5c8d388c3c2d388c5c8">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yihua Chen</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="hlFld-Affiliation affiliation">Joint
Center for Translational Medicine, Fengxian
District Central Hospital, 6600th Nanfeng Road, Fengxian District, Shanghai 201499, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1733-7980" title="Orcid link">http://orcid.org/0000-0003-1733-7980</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a7decfc4cfc2c9e7c5cec889c2c4c9d289c2c3d289c4c9"><span class="__cf_email__" data-cfemail="fe87969d969b90be9c9791d09b9d908bd09b9a8bd09d90">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunqi Li</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2841-1253" title="Orcid link">http://orcid.org/0000-0002-2841-1253</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuan He</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="hlFld-Affiliation affiliation">Joint
Center for Translational Medicine, Fengxian
District Central Hospital, 6600th Nanfeng Road, Fengxian District, Shanghai 201499, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8340-0875" title="Orcid link">http://orcid.org/0000-0001-8340-0875</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ting Shao</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5940-3777" title="Orcid link">http://orcid.org/0000-0001-5940-3777</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haixiang Pei</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5100-6950" title="Orcid link">http://orcid.org/0000-0002-5100-6950</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weikai Guo</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9361-3903" title="Orcid link">http://orcid.org/0000-0001-9361-3903</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dazhao Mi</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1385-8917" title="Orcid link">http://orcid.org/0000-0002-1385-8917</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabelle Krimm</span> - <span class="hlFld-Affiliation affiliation">Université
de Lyon, CNRS, Université Claude-Bernard Lyon 1, ENS de Lyon,
Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, Villeurbanne 69100, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5981-109X" title="Orcid link">http://orcid.org/0000-0002-5981-109X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuanjin Zhang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7103-2059" title="Orcid link">http://orcid.org/0000-0001-7103-2059</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peili Wang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3179-8364" title="Orcid link">http://orcid.org/0000-0002-3179-8364</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Wang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Regulatory Biology, The Institute of Biomedical
Sciences and School of Life Sciences, East
China Normal University, Shanghai 200241, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8079-8638" title="Orcid link">http://orcid.org/0000-0001-8079-8638</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.L., Y.H., and T.S. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5036-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the grants from National Key R&D Program of China (2018YFA0507001), National Natural Science Foundation of China (81673304, 81830083, 81472788, and 81773204), Innovation program of Shanghai municipal education commission (2017-01-07-00-05-E00011), Major State Basic Research Development Program of China (2015CB910400), and Chinese Scholarship Council (CSC).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">MYOF</td><td class="NLM_def"><p class="first last">myoferlin</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">STD-NMR</td><td class="NLM_def"><p class="first last">saturation transfer difference nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial mesenchymal transition</p></td></tr><tr><td class="NLM_term">RTKs</td><td class="NLM_def"><p class="first last">receptor tyrosine kinases</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahib, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleshman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matrisian, L. M.</span></span> <span> </span><span class="NLM_article-title">Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2913</span>– <span class="NLM_lpage">2921</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-0155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1158%2F0008-5472.CAN-14-0155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=24840647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=2913-2921&author=L.+Rahibauthor=B.+D.+Smithauthor=R.+Aizenbergauthor=A.+B.+Rosenzweigauthor=J.+M.+Fleshmanauthor=L.+M.+Matrisian&title=Projecting+cancer+incidence+and+deaths+to+2030%3A+the+unexpected+burden+of+thyroid%2C+liver%2C+and+pancreas+cancers+in+the+United+States&doi=10.1158%2F0008-5472.CAN-14-0155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States</span></div><div class="casAuthors">Rahib, Lola; Smith, Benjamin D.; Aizenberg, Rhonda; Rosenzweig, Allison B.; Fleshman, Julie M.; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2913-2921</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the av. annual percentage changes in incidence and death rates.  Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, resp.  Lung cancer is projected to remain the top cancer killer throughout this time period.  However, pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, resp.  Advances in screening, prevention, and treatment can change cancer incidence and/or death rates, but it will require a concerted effort by the research and healthcare communities now to effect a substantial change for the future.  Cancer Res; 74(11); 2913-21. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHGt66quENkbVg90H21EOLACvtfcHk0lic_hXznTy6SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D&md5=893d688f1ccba88ee094b743f7e4f152</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0155%26sid%3Dliteratum%253Aachs%26aulast%3DRahib%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DAizenberg%26aufirst%3DR.%26aulast%3DRosenzweig%26aufirst%3DA.%2BB.%26aulast%3DFleshman%26aufirst%3DJ.%2BM.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DProjecting%2520cancer%2520incidence%2520and%2520deaths%2520to%25202030%253A%2520the%2520unexpected%2520burden%2520of%2520thyroid%252C%2520liver%252C%2520and%2520pancreas%2520cancers%2520in%2520the%2520United%2520States%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D2913%26epage%3D2921%26doi%3D10.1158%2F0008-5472.CAN-14-0155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2018</span>. <i>CA—Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.3322/caac.21442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.3322%2Fcaac.21442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=29313949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A280%3ADC%252BC1MzoslGisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2018&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2018&doi=10.3322%2Fcaac.21442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2018</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data, available through 2014, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries.  Mortality data, available through 2015, were collected by the National Center for Health Statistics.  In 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the United States.  Over the past decade of data, the cancer incidence rate (2005-2014) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2006-2015) declined by about 1.5% annually in both men and women.  The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak.  Of the 10 leading causes of death, only cancer declined from 2014 to 2015.  In 2015, the cancer death rate was 14% higher in non-Hispanic blacks (NHBs) than non-Hispanic whites (NHWs) overall (death rate ratio [DRR], 1.14; 95% confidence interval [95% CI], 1.13-1.15), but the racial disparity was much larger for individuals aged <65 years (DRR, 1.31; 95% CI, 1.29-1.32) compared with those aged ≥65 years (DRR, 1.07; 95% CI, 1.06-1.09) and varied substantially by state.  For example, the cancer death rate was lower in NHBs than NHWs in Massachusetts for all ages and in New York for individuals aged ≥65 years, whereas for those aged <65 years, it was 3 times higher in NHBs in the District of Columbia (DRR, 2.89; 95% CI, 2.16-3.91) and about 50% higher in Wisconsin (DRR, 1.78; 95% CI, 1.56-2.02), Kansas (DRR, 1.51; 95% CI, 1.25-1.81), Louisiana (DRR, 1.49; 95% CI, 1.38-1.60), Illinois (DRR, 1.48; 95% CI, 1.39-1.57), and California (DRR, 1.45; 95% CI, 1.38-1.54).  Larger racial inequalities in young and middle-aged adults probably partly reflect less access to high-quality health care.  CA Cancer J Clin 2018;68:7-30. © 2018 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8-MQOcW2xELJzI8owOhpDfW6udTcc2eZ6JZsNw7Hdxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzoslGisQ%253D%253D&md5=0a85e5c9a2bffba9aa3950a140939b14</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21442%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202018%26jtitle%3DCA%25E2%2580%2594Cancer%2520J.%2520Clin.%26date%3D2018%26volume%3D68%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciliberto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correale, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caraglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tassone, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliaferri, P.</span></span> <span> </span><span class="NLM_article-title">Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">603</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2012.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.ejca.2012.08.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=593-603&author=D.+Cilibertoauthor=C.+Bottaauthor=P.+Correaleauthor=M.+Rossiauthor=M.+Caragliaauthor=P.+Tassoneauthor=P.+Tagliaferri&title=Role+of+gemcitabine-based+combination+therapy+in+the+management+of+advanced+pancreatic+cancer%3A+a+meta-analysis+of+randomised+trials&doi=10.1016%2Fj.ejca.2012.08.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2012.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2012.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DCiliberto%26aufirst%3DD.%26aulast%3DBotta%26aufirst%3DC.%26aulast%3DCorreale%26aufirst%3DP.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DCaraglia%26aufirst%3DM.%26aulast%3DTassone%26aufirst%3DP.%26aulast%3DTagliaferri%26aufirst%3DP.%26atitle%3DRole%2520of%2520gemcitabine-based%2520combination%2520therapy%2520in%2520the%2520management%2520of%2520advanced%2520pancreatic%2520cancer%253A%2520a%2520meta-analysis%2520of%2520randomised%2520trials%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D593%26epage%3D603%26doi%3D10.1016%2Fj.ejca.2012.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qian, B. Z.</span></span> <span> </span><span class="NLM_article-title">Inflammation fires up cancer metastasis</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2017.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.semcancer.2017.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=28838845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=170-176&author=B.+Z.+Qian&title=Inflammation+fires+up+cancer+metastasis&doi=10.1016%2Fj.semcancer.2017.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation fires up cancer metastasis</span></div><div class="casAuthors">Qian, Bin-Zhi</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">170-176</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Metastatic disease is the major challenge of cancer that accounts for over 90% of total cancer lethality.  Mounting clin. and preclin. data now indicate that inflammation, a potent immune and repair response, is indispensable for metastasis.  In this review we describe our current understanding of how major inflammatory cells contribute to metastatic cascade with a focus on the primary tumor.  We also discuss exciting new directions for future research and novel therapeutic approaches to tackle metastatic disease through targeting inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwDh7cWa-HSbVg90H21EOLACvtfcHk0lhJzJeQ5qwCBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeisL7E&md5=3e25238fa825b25d60941cce27ad0fac</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2017.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2017.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DB.%2BZ.%26atitle%3DInflammation%2520fires%2520up%2520cancer%2520metastasis%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D47%26spage%3D170%26epage%3D176%26doi%3D10.1016%2Fj.semcancer.2017.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swinney, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, J.</span></span> <span> </span><span class="NLM_article-title">How were new medicines discovered?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1038/nrd3480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fnrd3480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=21701501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F&doi=10.1038%2Fnrd3480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">How were new medicines discovered?</span></div><div class="casAuthors">Swinney, David C.; Anthony, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">507-519</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Preclin. strategies that are used to identify potential drug candidates include target-based screening, phenotypic screening, modification of natural substances and biol.-based approaches.  To investigate whether some strategies have been more successful than others in the discovery of new drugs, we analyzed the discovery strategies and the mol. mechanism of action (MMOA) for new mol. entities and new biologics that were approved by the US Food and Drug Administration between 1999 and 2008.  Out of the 259 agents that were approved, 75 were first-in-class drugs with new MMOAs, and out of these, 50 (67%) were small mols. and 25 (33%) were biologics.  The results also show that the contribution of phenotypic screening to the discovery of first-in-class small-mol. drugs exceeded that of target-based approaches - with 28 and 17 of these drugs coming from the two approaches, resp. - in an era in which the major focus was on target-based approaches.  We postulate that a target-centric approach for first-in-class drugs, without consideration of an optimal MMOA, may contribute to the current high attrition rates and low productivity in pharmaceutical research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE8Ah1iNz76bVg90H21EOLACvtfcHk0lhJzJeQ5qwCBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D&md5=7503620f8fbadb0a829f6ea2029936a2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3480%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519%26doi%3D10.1038%2Fnrd3480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, D.</span></span> <span> </span><span class="NLM_article-title">Phenotypic screening in cancer drug discovery - past, present and future</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1038/nrd4366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fnrd4366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=25033736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFygsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=588-602&author=J.+G.+Moffatauthor=J.+Rudolphauthor=D.+Bailey&title=Phenotypic+screening+in+cancer+drug+discovery+-+past%2C+present+and+future&doi=10.1038%2Fnrd4366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Phenotypic screening in cancer drug discovery - past, present and future</span></div><div class="casAuthors">Moffat, John G.; Rudolph, Joachim; Bailey, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">588-602</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There has been a resurgence of interest in the use of phenotypic screens in drug discovery as an alternative to target-focused approaches.  Given that oncol. is currently the most active therapeutic area, and also one in which target-focused approaches have been particularly prominent in the past two decades, we investigated the contribution of phenotypic assays to oncol. drug discovery by analyzing the origins of all new small-mol. cancer drugs approved by the US Food and Drug Administration (FDA) over the past 15 years and those currently in clin. development.  Although the majority of these drugs originated from target-based discovery, we identified a significant no. whose discovery depended on phenotypic screening approaches.  We postulate that the contribution of phenotypic screening to cancer drug discovery has been hampered by a reliance on 'classical' nonspecific drug effects such as cytotoxicity and mitotic arrest, exacerbated by a paucity of mechanistically defined cellular models for therapeutically translatable cancer phenotypes.  However, tech. and biol. advances that enable such mechanistically informed phenotypic models have the potential to empower phenotypic drug discovery in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTWtoTIgWqvbVg90H21EOLACvtfcHk0lhJzJeQ5qwCBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFygsr7L&md5=0e8efed90e5bc4b47f959b83a6ab5b96</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd4366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4366%26sid%3Dliteratum%253Aachs%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DRudolph%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DD.%26atitle%3DPhenotypic%2520screening%2520in%2520cancer%2520drug%2520discovery%2520-%2520past%252C%2520present%2520and%2520future%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D588%26epage%3D602%26doi%3D10.1038%2Fnrd4366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blomme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanza, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Tullio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Simaeys, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doumont, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Valentin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokobori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gofflot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peulen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellahcene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Goff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouithys-Mickalad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouret, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifrange, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pauw, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronovo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turtoi, A.</span></span> <span> </span><span class="NLM_article-title">Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2116</span>– <span class="NLM_lpage">2130</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fonc.2016.369" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=2116-2130&author=A.+Blommeauthor=B.+Costanzaauthor=P.+de+Tullioauthor=M.+Thiryauthor=G.+Van+Simaeysauthor=S.+Boutryauthor=G.+Doumontauthor=E.+Di+Valentinauthor=T.+Hiranoauthor=T.+Yokoboriauthor=S.+Gofflotauthor=O.+Peulenauthor=A.+Bellahceneauthor=F.+Shererauthor=C.+Le+Goffauthor=E.+Cavalierauthor=A.+Mouithys-Mickaladauthor=F.+Jouretauthor=P.+G.+Cusumanoauthor=E.+Lifrangeauthor=R.+N.+Mullerauthor=S.+Goldmanauthor=P.+Delvenneauthor=E.+De+Pauwauthor=M.+Nishiyamaauthor=V.+Castronovoauthor=A.+Turtoi&title=Myoferlin+regulates+cellular+lipid+metabolism+and+promotes+metastases+in+triple-negative+breast+cancer&doi=10.1038%2Fonc.2016.369"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.369%26sid%3Dliteratum%253Aachs%26aulast%3DBlomme%26aufirst%3DA.%26aulast%3DCostanza%26aufirst%3DB.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DThiry%26aufirst%3DM.%26aulast%3DVan%2BSimaeys%26aufirst%3DG.%26aulast%3DBoutry%26aufirst%3DS.%26aulast%3DDoumont%26aufirst%3DG.%26aulast%3DDi%2BValentin%26aufirst%3DE.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DYokobori%26aufirst%3DT.%26aulast%3DGofflot%26aufirst%3DS.%26aulast%3DPeulen%26aufirst%3DO.%26aulast%3DBellahcene%26aufirst%3DA.%26aulast%3DSherer%26aufirst%3DF.%26aulast%3DLe%2BGoff%26aufirst%3DC.%26aulast%3DCavalier%26aufirst%3DE.%26aulast%3DMouithys-Mickalad%26aufirst%3DA.%26aulast%3DJouret%26aufirst%3DF.%26aulast%3DCusumano%26aufirst%3DP.%2BG.%26aulast%3DLifrange%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DR.%2BN.%26aulast%3DGoldman%26aufirst%3DS.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DDe%2BPauw%26aufirst%3DE.%26aulast%3DNishiyama%26aufirst%3DM.%26aulast%3DCastronovo%26aufirst%3DV.%26aulast%3DTurtoi%26aufirst%3DA.%26atitle%3DMyoferlin%2520regulates%2520cellular%2520lipid%2520metabolism%2520and%2520promotes%2520metastases%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D2116%26epage%3D2130%26doi%3D10.1038%2Fonc.2016.369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rademaker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequiere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brohee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nokin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovinfosse, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gofflot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanza, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herfs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiffer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettendorff, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deroanne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hustinx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellahcene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronovo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peulen, O.</span></span> <span> </span><span class="NLM_article-title">Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">4398</span>– <span class="NLM_lpage">4412</span>, <span class="refDoi"> DOI: 10.1038/s41388-018-0287-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fs41388-018-0287-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=4398-4412&author=G.+Rademakerauthor=V.+Hennequiereauthor=L.+Broheeauthor=M.+J.+Nokinauthor=P.+Lovinfosseauthor=F.+Durieuxauthor=S.+Gofflotauthor=J.+Bellierauthor=B.+Costanzaauthor=M.+Herfsauthor=R.+Peifferauthor=L.+Bettendorffauthor=C.+Deroanneauthor=M.+Thiryauthor=P.+Delvenneauthor=R.+Hustinxauthor=A.+Bellahceneauthor=V.+Castronovoauthor=O.+Peulen&title=Myoferlin+controls+mitochondrial+structure+and+activity+in+pancreatic+ductal+adenocarcinoma%2C+and+affects+tumor+aggressiveness&doi=10.1038%2Fs41388-018-0287-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fs41388-018-0287-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-018-0287-z%26sid%3Dliteratum%253Aachs%26aulast%3DRademaker%26aufirst%3DG.%26aulast%3DHennequiere%26aufirst%3DV.%26aulast%3DBrohee%26aufirst%3DL.%26aulast%3DNokin%26aufirst%3DM.%2BJ.%26aulast%3DLovinfosse%26aufirst%3DP.%26aulast%3DDurieux%26aufirst%3DF.%26aulast%3DGofflot%26aufirst%3DS.%26aulast%3DBellier%26aufirst%3DJ.%26aulast%3DCostanza%26aufirst%3DB.%26aulast%3DHerfs%26aufirst%3DM.%26aulast%3DPeiffer%26aufirst%3DR.%26aulast%3DBettendorff%26aufirst%3DL.%26aulast%3DDeroanne%26aufirst%3DC.%26aulast%3DThiry%26aufirst%3DM.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DHustinx%26aufirst%3DR.%26aulast%3DBellahcene%26aufirst%3DA.%26aulast%3DCastronovo%26aufirst%3DV.%26aulast%3DPeulen%26aufirst%3DO.%26atitle%3DMyoferlin%2520controls%2520mitochondrial%2520structure%2520and%2520activity%2520in%2520pancreatic%2520ductal%2520adenocarcinoma%252C%2520and%2520affects%2520tumor%2520aggressiveness%26jtitle%3DOncogene%26date%3D2018%26volume%3D37%26spage%3D4398%26epage%3D4412%26doi%3D10.1038%2Fs41388-018-0287-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turtoi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musmeci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somja, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevilacqua, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pauw, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronovo, V.</span></span> <span> </span><span class="NLM_article-title">Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4302</span>– <span class="NLM_lpage">4313</span>, <span class="refDoi"> DOI: 10.1021/pr200527z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr200527z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=4302-4313&author=A.+Turtoiauthor=D.+Musmeciauthor=Y.+Wangauthor=B.+Dumontauthor=J.+Somjaauthor=G.+Bevilacquaauthor=E.+De+Pauwauthor=P.+Delvenneauthor=V.+Castronovo&title=Identification+of+novel+accessible+proteins+bearing+diagnostic+and+therapeutic+potential+in+human+pancreatic+ductal+adenocarcinoma&doi=10.1021%2Fpr200527z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Accessible Proteins Bearing Diagnostic and Therapeutic Potential in Human Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Turtoi, Andrei; Musmeci, Davide; Wang, Ying-Hong; Dumont, Bruno; Somja, Joan; Bevilacqua, Generoso; De Pauw, Edwin; Delvenne, Philippe; Castronovo, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4302-4313</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pancreas ductal adenocarcinoma (PDAC) remains a deadly malignancy with poor early diagnostic and no effective therapy.  Although several proteomic studies have performed comparative anal. between normal and malignant tissues, there is a lack of clear characterization of proteins that could be of clin. value.  Systemically reachable ("potentially accessible") proteins, suitable for imaging technologies and targeted therapies represent a major group of interest.  The current study explores potentially accessible proteins overexpressed in PDAC, employing innovative proteomics technologies.  In the discovery phase, potentially accessible proteins from fresh human normal and PDAC tissues were ex vivo biotinylated, isolated and identified using 2D-nano-HPLC-MS/MS method.  The anal. revealed 422 up-regulated proteins in the tumor, of which 83 (including protein isoforms) were evaluated as potentially accessible.  Eleven selected candidates were further confirmed as up-regulated using Western blot and multiple reaction monitoring protein quantification.  Of these, transforming growth factor beta-induced (TGFBI), latent transforming growth factor beta binding 2 (LTBP2), and asporin (ASPN) were further investigated by employing large scale immunohistochem.-based validations.  They were significantly expressed in a large group of clin. PDAC samples compared to corresponding normal and inflammatory tissues.  In conclusion, TGFBI, LTBP2, and ASPN are novel, overexpressed, and potentially accessible proteins in human PDAC.  They bear the potential to be of clin. value for diagnostic and therapeutic applications and merit further studies using in vivo models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbexSrePaqALVg90H21EOLACvtfcHk0likEy8m-BIzKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSrs7g%253D&md5=f5144c8d407f0e9bb04a545bd0407855</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fpr200527z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr200527z%26sid%3Dliteratum%253Aachs%26aulast%3DTurtoi%26aufirst%3DA.%26aulast%3DMusmeci%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDumont%26aufirst%3DB.%26aulast%3DSomja%26aufirst%3DJ.%26aulast%3DBevilacqua%26aufirst%3DG.%26aulast%3DDe%2BPauw%26aufirst%3DE.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DCastronovo%26aufirst%3DV.%26atitle%3DIdentification%2520of%2520novel%2520accessible%2520proteins%2520bearing%2520diagnostic%2520and%2520therapeutic%2520potential%2520in%2520human%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2011%26volume%3D10%26spage%3D4302%26epage%3D4313%26doi%3D10.1021%2Fpr200527z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tognon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernatchez, P.</span></span> <span> </span><span class="NLM_article-title">Expression of myoferlin in human and murine carcinoma tumors: role in membrane repair, cell proliferation, and tumorigenesis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">1900</span>– <span class="NLM_lpage">1909</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2013.01.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.ajpath.2013.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=23499551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlGgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2013&pages=1900-1909&author=C.+Leungauthor=C.+Yuauthor=M.+I.+Linauthor=C.+Tognonauthor=P.+Bernatchez&title=Expression+of+myoferlin+in+human+and+murine+carcinoma+tumors%3A+role+in+membrane+repair%2C+cell+proliferation%2C+and+tumorigenesis&doi=10.1016%2Fj.ajpath.2013.01.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Myoferlin in Human and Murine Carcinoma Tumors</span></div><div class="casAuthors">Leung, Cleo; Yu, Carol; Lin, Michelle I.; Tognon, Cristina; Bernatchez, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1900-1909</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer cells are often characterized by high proliferation rates, a consequence of increased mitotic signaling coupled with unchecked cellular growth.  We recently demonstrated that vascular endothelial cells unexpectedly express ferlins, a family of muscle-specific proteins capable of regulating the fusion of lipid patches to the plasma membrane, and that these highly regulated membrane fusion events are essential to endothelial cell proliferation and homeostasis.  Here, we show that human and mouse breast cancer cell lines also express myoferlin at various levels, and that the processes of transformation, epithelial-mesenchymal transition, and metastasis do not appear to have any effect on myoferlin expression in vitro.  In vivo, we obsd. that solid mouse and human carcinoma tissues also express high levels of myoferlin protein.  Loss-of-function studies performed in mice revealed that myoferlin gene knockdown can attenuate cancer cell proliferation in vitro and decrease tumor burden, and that accelerated tumor cell growth appears to rely on intact myoferlin-dependent membrane repair and signaling under exponential growth conditions.  To our knowledge, these data provide the first evidence of myoferlin expression in solid human and mouse tumors.  We have thus identified a novel membrane repair process that likely helps sustain the high growth rates characteristic of tumors, and we suggest that interfering with normal myoferlin expression and/or membrane repair and remodeling may provide therapeutically relevant antiproliferative effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3kCV3cIdhPrVg90H21EOLACvtfcHk0likEy8m-BIzKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlGgsrk%253D&md5=4201cee24dadd49ee15d2cc52e684aa8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2013.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2013.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DM.%2BI.%26aulast%3DTognon%26aufirst%3DC.%26aulast%3DBernatchez%26aufirst%3DP.%26atitle%3DExpression%2520of%2520myoferlin%2520in%2520human%2520and%2520murine%2520carcinoma%2520tumors%253A%2520role%2520in%2520membrane%2520repair%252C%2520cell%2520proliferation%252C%2520and%2520tumorigenesis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2013%26volume%3D182%26spage%3D1900%26epage%3D1909%26doi%3D10.1016%2Fj.ajpath.2013.01.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sachen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singletary, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alizadeh, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kattah, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lossos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellins, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, R.</span></span> <span> </span><span class="NLM_article-title">Self-antigen recognition by follicular lymphoma B-cell receptors</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">4182</span>– <span class="NLM_lpage">4190</span>, <span class="refDoi"> DOI: 10.1182/blood-2012-05-427534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1182%2Fblood-2012-05-427534" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=4182-4190&author=K.+L.+Sachenauthor=M.+J.+Strohmanauthor=J.+Singletaryauthor=A.+A.+Alizadehauthor=N.+H.+Kattahauthor=C.+Lossosauthor=E.+D.+Mellinsauthor=S.+Levyauthor=R.+Levy&title=Self-antigen+recognition+by+follicular+lymphoma+B-cell+receptors&doi=10.1182%2Fblood-2012-05-427534"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-05-427534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-05-427534%26sid%3Dliteratum%253Aachs%26aulast%3DSachen%26aufirst%3DK.%2BL.%26aulast%3DStrohman%26aufirst%3DM.%2BJ.%26aulast%3DSingletary%26aufirst%3DJ.%26aulast%3DAlizadeh%26aufirst%3DA.%2BA.%26aulast%3DKattah%26aufirst%3DN.%2BH.%26aulast%3DLossos%26aufirst%3DC.%26aulast%3DMellins%26aufirst%3DE.%2BD.%26aulast%3DLevy%26aufirst%3DS.%26aulast%3DLevy%26aufirst%3DR.%26atitle%3DSelf-antigen%2520recognition%2520by%2520follicular%2520lymphoma%2520B-cell%2520receptors%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D4182%26epage%3D4190%26doi%3D10.1182%2Fblood-2012-05-427534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turtoi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellahcene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilles, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequiere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pauw, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifrange, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronovo, V.</span></span> <span> </span><span class="NLM_article-title">Myoferlin is a key regulator of EGFR activity in breast cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">5438</span>– <span class="NLM_lpage">5448</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-1142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1158%2F0008-5472.CAN-13-1142" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=5438-5448&author=A.+Turtoiauthor=A.+Blommeauthor=A.+Bellahceneauthor=C.+Gillesauthor=V.+Hennequiereauthor=P.+Peixotoauthor=E.+Bianchiauthor=A.+Noelauthor=E.+De+Pauwauthor=E.+Lifrangeauthor=P.+Delvenneauthor=V.+Castronovo&title=Myoferlin+is+a+key+regulator+of+EGFR+activity+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-13-1142"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-1142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-1142%26sid%3Dliteratum%253Aachs%26aulast%3DTurtoi%26aufirst%3DA.%26aulast%3DBlomme%26aufirst%3DA.%26aulast%3DBellahcene%26aufirst%3DA.%26aulast%3DGilles%26aufirst%3DC.%26aulast%3DHennequiere%26aufirst%3DV.%26aulast%3DPeixoto%26aufirst%3DP.%26aulast%3DBianchi%26aufirst%3DE.%26aulast%3DNoel%26aufirst%3DA.%26aulast%3DDe%2BPauw%26aufirst%3DE.%26aulast%3DLifrange%26aufirst%3DE.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DCastronovo%26aufirst%3DV.%26atitle%3DMyoferlin%2520is%2520a%2520key%2520regulator%2520of%2520EGFR%2520activity%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D5438%26epage%3D5448%26doi%3D10.1158%2F0008-5472.CAN-13-1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernatchez, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acevedo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Hernando, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalouni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdjument-Bromage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sessa, W. C.</span></span> <span> </span><span class="NLM_article-title">Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">30745</span>– <span class="NLM_lpage">30753</span>, <span class="refDoi"> DOI: 10.1074/jbc.M704798200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1074%2Fjbc.M704798200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=30745-30753&author=P.+N.+Bernatchezauthor=L.+Acevedoauthor=C.+Fernandez-Hernandoauthor=T.+Murataauthor=C.+Chalouniauthor=J.+Kimauthor=H.+Erdjument-Bromageauthor=V.+Shahauthor=J.+P.+Grattonauthor=E.+M.+McNallyauthor=P.+Tempstauthor=W.+C.+Sessa&title=Myoferlin+regulates+vascular+endothelial+growth+factor+receptor-2+stability+and+function&doi=10.1074%2Fjbc.M704798200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M704798200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M704798200%26sid%3Dliteratum%253Aachs%26aulast%3DBernatchez%26aufirst%3DP.%2BN.%26aulast%3DAcevedo%26aufirst%3DL.%26aulast%3DFernandez-Hernando%26aufirst%3DC.%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DChalouni%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DShah%26aufirst%3DV.%26aulast%3DGratton%26aufirst%3DJ.%2BP.%26aulast%3DMcNally%26aufirst%3DE.%2BM.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DSessa%26aufirst%3DW.%2BC.%26atitle%3DMyoferlin%2520regulates%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520stability%2520and%2520function%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D30745%26epage%3D30753%26doi%3D10.1074%2Fjbc.M704798200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kniss, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, A.</span></span> <span> </span><span class="NLM_article-title">Mechanistic modeling of the effects of myoferlin on tumor cell invasion</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">20078</span>– <span class="NLM_lpage">20083</span>, <span class="refDoi"> DOI: 10.1073/pnas.1116327108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1073%2Fpnas.1116327108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=20078-20083&author=M.+C.+Eisenbergauthor=Y.+Kimauthor=R.+Liauthor=W.+E.+Ackermanauthor=D.+A.+Knissauthor=A.+Friedman&title=Mechanistic+modeling+of+the+effects+of+myoferlin+on+tumor+cell+invasion&doi=10.1073%2Fpnas.1116327108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1116327108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1116327108%26sid%3Dliteratum%253Aachs%26aulast%3DEisenberg%26aufirst%3DM.%2BC.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DAckerman%26aufirst%3DW.%2BE.%26aulast%3DKniss%26aufirst%3DD.%2BA.%26aulast%3DFriedman%26aufirst%3DA.%26atitle%3DMechanistic%2520modeling%2520of%2520the%2520effects%2520of%2520myoferlin%2520on%2520tumor%2520cell%2520invasion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D20078%26epage%3D20083%26doi%3D10.1073%2Fpnas.1116327108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span> <span> </span><span class="NLM_article-title">A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">3726</span> <span class="refDoi"> DOI: 10.1038/s41467-018-06179-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fs41467-018-06179-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=30213946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A280%3ADC%252BB3c3os1OrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&author=T.+Zhangauthor=J.+Liauthor=Y.+Heauthor=F.+Yangauthor=Y.+Haoauthor=W.+Jinauthor=J.+Wuauthor=Z.+Sunauthor=Y.+Liauthor=Y.+Chenauthor=Z.+Yiauthor=M.+Liu&title=A+small+molecule+targeting+myoferlin+exerts+promising+anti-tumor+effects+on+breast+cancer&doi=10.1038%2Fs41467-018-06179-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer</span></div><div class="casAuthors">Zhang Tao; Li Jingjie; He Yuan; Yang Feifei; Hao Yun; Jin Wangrui; Wu Jing; Li Yunqi; Chen Yihua; Yi Zhengfang; Liu Mingyao; Zhang Tao; Li Jingjie; Sun Zhenliang; Yi Zhengfang; Liu Mingyao</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3726</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Breast cancer is one of the most lethal cancers in women when it reaches the metastatic stage.  Here, we screen a library of small molecules for inhibitors of breast cancer cell invasion, and use structure/activity relationship studies to develop a series of small molecules with improved activity.  We find WJ460 as one of the lead compounds exerting anti-metastatic activity in the nanomolar range in breast cancer cells.  Proteomic and biochemical studies identify myoferlin (MYOF) as the direct target of WJ460.  In parallel, loss of MYOF or pharmacological inhibition of MYOF by WJ460 reduces breast cancer extravasation into the lung parenchyma in an experimental metastasis mouse model, which reveals an essential role of MYOF in breast cancer progression.  Our findings suggest that MYOF can be explored as a molecular target in breast cancer metastasis and that targeting MYOF by WJ460 may be a promising therapeutic strategy in MYOF-driven cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWjR92U2Rfrae0F5ixvZgXfW6udTcc2ebr32rSSX9SeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3os1OrtQ%253D%253D&md5=11d72646d0e09ec8c11826ec126e4766</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06179-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06179-0%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DHao%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DM.%26atitle%3DA%2520small%2520molecule%2520targeting%2520myoferlin%2520exerts%2520promising%2520anti-tumor%2520effects%2520on%2520breast%2520cancer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26doi%3D10.1038%2Fs41467-018-06179-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volakis, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghadiali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kniss, D. A.</span></span> <span> </span><span class="NLM_article-title">Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion</span>. <i>PloS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e39766</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0039766</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1371%2Fjournal.pone.0039766" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=R.+Liauthor=W.+E.+Ackermanauthor=C.+Mihaiauthor=L.+I.+Volakisauthor=S.+Ghadialiauthor=D.+A.+Kniss&title=Myoferlin+depletion+in+breast+cancer+cells+promotes+mesenchymal+to+epithelial+shape+change+and+stalls+invasion&doi=10.1371%2Fjournal.pone.0039766"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0039766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0039766%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DAckerman%26aufirst%3DW.%2BE.%26aulast%3DMihai%26aufirst%3DC.%26aulast%3DVolakis%26aufirst%3DL.%2BI.%26aulast%3DGhadiali%26aufirst%3DS.%26aulast%3DKniss%26aufirst%3DD.%2BA.%26atitle%3DMyoferlin%2520depletion%2520in%2520breast%2520cancer%2520cells%2520promotes%2520mesenchymal%2520to%2520epithelial%2520shape%2520change%2520and%2520stalls%2520invasion%26jtitle%3DPloS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0039766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fahmy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arafa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellahcene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turtoi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronovo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peulen, O.</span></span> <span> </span><span class="NLM_article-title">Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">652</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1002/ijc.29820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1002%2Fijc.29820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=26311411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVGms77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=652-663&author=K.+Fahmyauthor=A.+Gonzalezauthor=M.+Arafaauthor=P.+Peixotoauthor=A.+Bellahceneauthor=A.+Turtoiauthor=P.+Delvenneauthor=M.+Thiryauthor=V.+Castronovoauthor=O.+Peulen&title=Myoferlin+plays+a+key+role+in+VEGFA+secretion+and+impacts+tumor-associated+angiogenesis+in+human+pancreas+cancer&doi=10.1002%2Fijc.29820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer</span></div><div class="casAuthors">Fahmy, Karim; Gonzalez, Arnaud; Arafa, Mohammad; Peixoto, Paul; Bellahcene, Akeila; Turtoi, Andrei; Delvenne, Philippe; Thiry, Marc; Castronovo, Vincent; Peulen, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">652-663</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma is one of the most deadly forms of cancers with no satisfactory treatment to date.  Recent studies have identified myoferlin, a ferlin family member, in human pancreas adenocarcinoma where its expression was assocd. to a bad prognosis.  However, the function of myoferlin in pancreas adenocarcinoma has not been reported.  In other cell types, myoferlin is involved in several key plasma membrane processes such as fusion, repair, endocytosis and tyrosine kinase receptor activity.  In this study, we showed that myoferlin silencing in BxPC-3 human pancreatic cancer cells resulted in the inhibition of cell proliferation in vitro and in a significant redn. of the tumor vol. in chick chorioallantoic membrane assay.  In addn. to be smaller, the tumors formed by the myoferlin-silenced cells showed a marked absence of functional blood vessels.  We further demonstrated that this effect was due, at least in part, to an inhibition of VEGFA secretion by BxPC-3 myoferlin-silenced cells.  Using immunofluorescence and electron microscopy, we linked the decreased VEGFA secretion to an impairment of VEGFA exocytosis.  The clin. relevance of our results was further strengthened by a significant correlation between myoferlin expression in a series of human pancreatic malignant lesions and their angiogenic status evaluated by the detn. of the blood vessel d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq30594mcCpQ7Vg90H21EOLACvtfcHk0lhvZCq6_euVPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVGms77L&md5=b8aa0ed2bb02b753e64e219d97713540</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fijc.29820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29820%26sid%3Dliteratum%253Aachs%26aulast%3DFahmy%26aufirst%3DK.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DArafa%26aufirst%3DM.%26aulast%3DPeixoto%26aufirst%3DP.%26aulast%3DBellahcene%26aufirst%3DA.%26aulast%3DTurtoi%26aufirst%3DA.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DThiry%26aufirst%3DM.%26aulast%3DCastronovo%26aufirst%3DV.%26aulast%3DPeulen%26aufirst%3DO.%26atitle%3DMyoferlin%2520plays%2520a%2520key%2520role%2520in%2520VEGFA%2520secretion%2520and%2520impacts%2520tumor-associated%2520angiogenesis%2520in%2520human%2520pancreas%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2016%26volume%3D138%26spage%3D652%26epage%3D663%26doi%3D10.1002%2Fijc.29820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. C.</span></span> <span> </span><span class="NLM_article-title">Prognostic role of myoferlin expression in patients with clear cell renal cell carcinoma</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">89033</span>– <span class="NLM_lpage">89039</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.21645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.18632%2Foncotarget.21645" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=89033-89039&author=D.+H.+Songauthor=G.+H.+Koauthor=J.+H.+Leeauthor=J.+S.+Leeauthor=J.+W.+Yangauthor=M.+H.+Kimauthor=H.+J.+Anauthor=M.+H.+Kangauthor=K.+N.+Jeonauthor=D.+C.+Kim&title=Prognostic+role+of+myoferlin+expression+in+patients+with+clear+cell+renal+cell+carcinoma&doi=10.18632%2Foncotarget.21645"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.21645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.21645%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DD.%2BH.%26aulast%3DKo%26aufirst%3DG.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DYang%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DM.%2BH.%26aulast%3DAn%26aufirst%3DH.%2BJ.%26aulast%3DKang%26aufirst%3DM.%2BH.%26aulast%3DJeon%26aufirst%3DK.%2BN.%26aulast%3DKim%26aufirst%3DD.%2BC.%26atitle%3DPrognostic%2520role%2520of%2520myoferlin%2520expression%2520in%2520patients%2520with%2520clear%2520cell%2520renal%2520cell%2520carcinoma%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D89033%26epage%3D89039%26doi%3D10.18632%2Foncotarget.21645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span> <span> </span><span class="NLM_article-title">Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1743</span>– <span class="NLM_lpage">1754</span>, <span class="refDoi"> DOI: 10.1111/jcmm.13455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1111%2Fjcmm.13455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=29164766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsVykt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=1743-1754&author=W.+Zhangauthor=P.+Zhouauthor=A.+Mengauthor=R.+Zhangauthor=Y.+Zhou&title=Down-regulating+Myoferlin+inhibits+the+vasculogenic+mimicry+of+melanoma+via+decreasing+MMP-2+and+inducing+mesenchymal-to-epithelial+transition&doi=10.1111%2Fjcmm.13455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition</span></div><div class="casAuthors">Zhang, Wenxue; Zhou, Ping; Meng, Ai; Zhang, Rongxin; Zhou, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1743-1754</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Vasculogenic mimicry (VM) constitutes a novel approach for tumor blood supply and contributes to tumor metastasis and poor prognosis in patients with melanoma.  Myoferlin (MYOF), a type II membrane protein involved in membrane regeneration and repair, is elevated in several malignant tumors, esp. in advanced melanomas.  This study aims to investigate the role and mechanism of MYOF in the regulation of VM.  VM structures were found in 14 of 52 tested melanoma samples, and high MYOF expression correlated with VM structures.  According to Kaplan-Meier survival curves, VM channels and elevated MYOF expression both correlated with poor prognosis in melanoma patients.  Down-regulation of MYOF by siRNA severely impaired the capability of A375 cells to form VM structures in vitro.  Further studies demonstrated MYOF knockdown inhibited cell migration and invasion, which is required for VM formation, via decreasing MMP-2 expression as evidenced by Western blotting, RT-RCP and ELISA results.  SB-3CT, a specific inhibitor of MMP-2, showed similar inhibiting effects with siMYOF, further supporting that MYOF down-regulation inhibits MMP-2 expression to affect VM formation.  Moreover, MYOF knockdown suppress VM formation by A375 cells by inducing mesenchymal-to-epithelial transition (MET).  After down-regulating MYOF, focal adhesions were enlarged and A375 cells developed into a clear epithelial morphol.  Such cells acquired the expression of E-cadherin at adherens junctions along with a loss of mesenchymal markers, such as Vimentin and Twist1.  In conclusion, MYOF plays an important role in VM and knockdown of MYOF suppresses VM formation via decreasing MMP-2 and inducing MET in A375 melanoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkXnMfe0o0M7Vg90H21EOLACvtfcHk0lhvZCq6_euVPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsVykt7Y%253D&md5=604bcb98525fdf101cc5e945c6f93883</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.13455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.13455%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DMeng%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DDown-regulating%2520Myoferlin%2520inhibits%2520the%2520vasculogenic%2520mimicry%2520of%2520melanoma%2520via%2520decreasing%2520MMP-2%2520and%2520inducing%2520mesenchymal-to-epithelial%2520transition%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2018%26volume%3D22%26spage%3D1743%26epage%3D1754%26doi%3D10.1111%2Fjcmm.13455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Z.</span></span> <span> </span><span class="NLM_article-title">A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling</span>. <i>Sci. China: Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1007/s11427-016-0369-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1007%2Fs11427-016-0369-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=28194552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVaru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=202-214&author=Y.+Liuauthor=Y.+Heauthor=F.+Yangauthor=X.+Congauthor=J.+Wangauthor=S.+Pengauthor=D.+Gaoauthor=W.+Wangauthor=L.+Lanauthor=X.+Yingauthor=M.+Liuauthor=Y.+Chenauthor=Z.+Yi&title=A+novel+synthetic+small+molecule+YF-452+inhibits+tumor+growth+through+antiangiogenesis+by+suppressing+VEGF+receptor+2+signaling&doi=10.1007%2Fs11427-016-0369-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling</span></div><div class="casAuthors">Liu, Yongrui; He, Yuan; Yang, Feifei; Cong, Xiaonan; Wang, Jinhua; Peng, Shihong; Gao, Dan; Wang, Weifang; Lan, Liping; Ying, Xuexiang; Liu, Mingyao; Chen, Yihua; Yi, Zhengfang</div><div class="citationInfo"><span class="NLM_cas:title">Science China: Life Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-214</span>CODEN:
                <span class="NLM_cas:coden">SCLSCJ</span>;
        ISSN:<span class="NLM_cas:issn">1674-7305</span>.
    
            (<span class="NLM_cas:orgname">Science China Press</span>)
        </div><div class="casAbstract">Tumor angiogenesis is characterized by abnormal vessel morphol., endowing tumor with highly hypoxia and unresponsive toward treatment.  To date, mounting angiogenic factors have been discovered as therapeutic targets in antiangiogenic drug development.  Among them, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors exerts potent antiangiogenic activity in tumor therapy.  Therefore, it may provide a valid strategy for cancer treatment through targeting the tumor angiogenesis via VEGFR2 pathway.  In this study, we established a high-profile compds. library and certificated a novel compd. named N-(N-pyrrolidylacetyl)-9-(4-bromobenzyl)-1,3,4,9-tetrahydro-β-carboline (YF-452), which remarkably inhibited the migration, invasion and tube-like structure formation of human umbilical vein endothelial cells (HUVECs) with little toxicity invitro.  Rat thoracic aorta ring assay indicated that YF-452 significantly blocked the formation of microvascular exvivo.  In addn., YF-452 inhibited angiogenesis in chick chorioallantoic membrane (CAM) and mouse corneal micropocket assays.  Moreover, YF-452 remarkably suppressed tumor growth in xenografts mice model.  Furthermore, investigation of mol. mechanism revealed that YF-452 inhibited VEGF-induced phosphorylation of VEGFR2 kinase and the downstream protein kinases including extracellular signal regulated kinase (ERK), focal adhesion kinase (FAK) and Src.  These results indicate that YF-452 inhibits angiogenesis and may be a potential antiangiogenic drug candidate for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrny_aLxFOISrVg90H21EOLACvtfcHk0ljsjXwDiUSm_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVaru74%253D&md5=298f917f77ced4f69f7efdb47a9d257c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs11427-016-0369-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11427-016-0369-6%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DCong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DYing%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYi%26aufirst%3DZ.%26atitle%3DA%2520novel%2520synthetic%2520small%2520molecule%2520YF-452%2520inhibits%2520tumor%2520growth%2520through%2520antiangiogenesis%2520by%2520suppressing%2520VEGF%2520receptor%25202%2520signaling%26jtitle%3DSci.%2520China%253A%2520Life%2520Sci.%26date%3D2017%26volume%3D60%26spage%3D202%26epage%3D214%26doi%3D10.1007%2Fs11427-016-0369-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Optimization of 2-(3-(arylalkyl amino carbonyl)phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.ejmech.2014.04.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2014&pages=340-351&author=J.+Wuauthor=L.+Yuauthor=F.+Yangauthor=J.+Liauthor=P.+Wangauthor=W.+Zhouauthor=L.+Qinauthor=Y.+Liauthor=J.+Luoauthor=Z.+Yiauthor=M.+Liuauthor=Y.+Chen&title=Optimization+of+2-%283-%28arylalkyl+amino+carbonyl%29phenyl%29-3-%282-methoxyphenyl%29-4-thiazolidinone+derivatives+as+potent+antitumor+growth+and+metastasis+agents&doi=10.1016%2Fj.ejmech.2014.04.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DYi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DOptimization%2520of%25202-%25283-%2528arylalkyl%2520amino%2520carbonyl%2529phenyl%2529-3-%25282-methoxyphenyl%2529-4-thiazolidinone%2520derivatives%2520as%2520potent%2520antitumor%2520growth%2520and%2520metastasis%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D80%26spage%3D340%26epage%3D351%26doi%3D10.1016%2Fj.ejmech.2014.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seng, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span> <span> </span><span class="NLM_article-title">Rapid synthesis of 1,3,5-substituted 1,2,4-triazoles from carboxylic acids, amidines, and hydrazines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1177</span>– <span class="NLM_lpage">1179</span>, <span class="refDoi"> DOI: 10.1021/jo1023393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo1023393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=1177-1179&author=G.+M.+Castanedoauthor=P.+S.+Sengauthor=N.+Blaquiereauthor=S.+Trappauthor=S.+T.+Staben&title=Rapid+synthesis+of+1%2C3%2C5-substituted+1%2C2%2C4-triazoles+from+carboxylic+acids%2C+amidines%2C+and+hydrazines&doi=10.1021%2Fjo1023393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Synthesis of 1,3,5-Substituted 1,2,4-Triazoles from Carboxylic Acids, Amidines, and Hydrazines</span></div><div class="casAuthors">Castanedo, Georgette M.; Seng, Pamela S.; Blaquiere, Nicole; Trapp, Sean; Staben, Steven T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1177-1179</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general method for the synthesis of 1,3,5-trisubstituted 1,2,4-triazoles has been developed from reaction of carboxylic acids, primary amidines, and monosubstituted hydrazines.  This highly regioselective and one-pot process provides rapid access to highly diverse triazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxnKwy9kVqdrVg90H21EOLACvtfcHk0lgSMO_O4da2Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVehtw%253D%253D&md5=4ed7e87d6f25f096287e41185367da7d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo1023393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo1023393%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DSeng%26aufirst%3DP.%2BS.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DTrapp%26aufirst%3DS.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26atitle%3DRapid%2520synthesis%2520of%25201%252C3%252C5-substituted%25201%252C2%252C4-triazoles%2520from%2520carboxylic%2520acids%252C%2520amidines%252C%2520and%2520hydrazines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2011%26volume%3D76%26spage%3D1177%26epage%3D1179%26doi%3D10.1021%2Fjo1023393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Synthesis of aromatic esters via Pd-catalyzed decarboxylative coupling of potassium oxalate monoesters with aryl bromides and chlorides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">5738</span>– <span class="NLM_lpage">5739</span>, <span class="refDoi"> DOI: 10.1021/ja900984x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja900984x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFKktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=5738-5739&author=R.+Shangauthor=Y.+Fuauthor=J.+B.+Liauthor=S.+L.+Zhangauthor=Q.+X.+Guoauthor=L.+Liu&title=Synthesis+of+aromatic+esters+via+Pd-catalyzed+decarboxylative+coupling+of+potassium+oxalate+monoesters+with+aryl+bromides+and+chlorides&doi=10.1021%2Fja900984x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Aromatic Esters via Pd-Catalyzed Decarboxylative Coupling of Potassium Oxalate Monoesters with Aryl Bromides and Chlorides</span></div><div class="casAuthors">Shang, Rui; Fu, Yao; Li, Jia-Bin; Zhang, Song-Lin; Guo, Qing-Xiang; Liu, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5738-5739</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pd-catalyzed decarboxylative cross-coupling of aryl iodides, bromides, and chlorides with potassium oxalate monoesters has been discovered.  This reaction is potentially useful for lab.-scale synthesis of aryl and alkenyl esters.  Bulky, electron-rich bidentate phosphine ligands are preferred in the reaction, whereas Cu is not needed for decarboxylation.  Theor. calcns. suggest a five-coordinate Pd(II) transition state for decarboxylation with an energy barrier of ∼30 kcal/mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolyycA3l3rPbVg90H21EOLACvtfcHk0lgSMO_O4da2Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFKktb4%253D&md5=055f5268f66859ba37718ff4b83ff991</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fja900984x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja900984x%26sid%3Dliteratum%253Aachs%26aulast%3DShang%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%2BB.%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DGuo%26aufirst%3DQ.%2BX.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DSynthesis%2520of%2520aromatic%2520esters%2520via%2520Pd-catalyzed%2520decarboxylative%2520coupling%2520of%2520potassium%2520oxalate%2520monoesters%2520with%2520aryl%2520bromides%2520and%2520chlorides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D5738%26epage%3D5739%26doi%3D10.1021%2Fja900984x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angulo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, P. M.</span></span> <span> </span><span class="NLM_article-title">STD-NMR: application to transient interactions between biomolecules-a quantitative approach</span>. <i>Eur. Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1357</span>– <span class="NLM_lpage">1369</span>, <span class="refDoi"> DOI: 10.1007/s00249-011-0749-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1007%2Fs00249-011-0749-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=21947507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeisbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=1357-1369&author=J.+Anguloauthor=P.+M.+Nieto&title=STD-NMR%3A+application+to+transient+interactions+between+biomolecules-a+quantitative+approach&doi=10.1007%2Fs00249-011-0749-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">STD-NMR: application to transient interactions between biomolecules-a quantitative approach</span></div><div class="casAuthors">Angulo, Jesus; Nieto, Pedro M.</div><div class="citationInfo"><span class="NLM_cas:title">European Biophysics Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1357-1369</span>CODEN:
                <span class="NLM_cas:coden">EBJOE8</span>;
        ISSN:<span class="NLM_cas:issn">0175-7571</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Satn. transfer difference NMR (STD NMR) spectroscopy is one of the most powerful NMR techniques for detection and characterization of transient (fast) receptor-ligand interactions in soln.  By observing the signals of a small mol. (ligand) with spectroscopic properties suitable for high-resoln. studies, irresp. of receptor size, STD NMR enables quant. structural and affinity information to be obtained about the mol. recognition process under study.  Approx. one decade after its introduction, the technique has reached maturity, and is highly robust and useful.  The objective of this article is to review the current status of this powerful technique, with particular emphasis on quant. applications, within the framework of the (bio-)chem. of mol. recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpviA2KOCTF8bVg90H21EOLACvtfcHk0lgSMO_O4da2Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeisbjI&md5=e1a08ce79d780175dd5d6b96e661f68e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs00249-011-0749-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00249-011-0749-5%26sid%3Dliteratum%253Aachs%26aulast%3DAngulo%26aufirst%3DJ.%26aulast%3DNieto%26aufirst%3DP.%2BM.%26atitle%3DSTD-NMR%253A%2520application%2520to%2520transient%2520interactions%2520between%2520biomolecules-a%2520quantitative%2520approach%26jtitle%3DEur.%2520Biophys.%2520J.%26date%3D2011%26volume%3D40%26spage%3D1357%26epage%3D1369%26doi%3D10.1007%2Fs00249-011-0749-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, A.</span></span> <span> </span><span class="NLM_article-title">The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects</span>. <i>Am. Fam. Physician</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=17708140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A280%3ADC%252BD2svovFGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=391-396&author=T.+Lynchauthor=A.+Price&title=The+effect+of+cytochrome+P450+metabolism+on+drug+response%2C+interactions%2C+and+adverse+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects</span></div><div class="casAuthors">Lynch Tom; Price Amy</div><div class="citationInfo"><span class="NLM_cas:title">American family physician</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">391-6</span>
        ISSN:<span class="NLM_cas:issn">0002-838X</span>.
    </div><div class="casAbstract">Cytochrome P450 enzymes are essential for the metabolism of many medications.  Although this class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most significant enzymes being CYP3A4 and CYP2D6.  Genetic variability (polymorphism) in these enzymes may influence a patient's response to commonly prescribed drug classes, including beta blockers and antidepressants.  Cytochrome P450 enzymes can be inhibited or induced by drugs, resulting in clinically significant drug-drug interactions that can cause unanticipated adverse reactions or therapeutic failures.  Interactions with warfarin, antidepressants, antiepileptic drugs, and statins often involve the cytochrome P450 enzymes.  Knowledge of the most important drugs metabolized by cytochrome P450 enzymes, as well as the most potent inhibiting and inducing drugs, can help minimize the possibility of adverse drug reactions and interactions.  Although genotype tests can determine if a patient has a specific enzyme polymorphism, it has not been determined if routine use of these tests will improve outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQE6VB-Pf2cThe4jJGKT5N0fW6udTcc2eZCPLSVBt9nj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svovFGhtQ%253D%253D&md5=68832276c56c8fb5f2818fc25bcc637f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DPrice%26aufirst%3DA.%26atitle%3DThe%2520effect%2520of%2520cytochrome%2520P450%2520metabolism%2520on%2520drug%2520response%252C%2520interactions%252C%2520and%2520adverse%2520effects%26jtitle%3DAm.%2520Fam.%2520Physician%26date%3D2007%26volume%3D76%26spage%3D391%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jolly, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somarelli, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biddle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanash, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bapat, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangarajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, H.</span></span> <span> </span><span class="NLM_article-title">Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2018.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.pharmthera.2018.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=30268772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGisLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2019&pages=161-184&author=M.+K.+Jollyauthor=J.+A.+Somarelliauthor=M.+Shethauthor=A.+Biddleauthor=S.+C.+Tripathiauthor=A.+J.+Armstrongauthor=S.+M.+Hanashauthor=S.+A.+Bapatauthor=A.+Rangarajanauthor=H.+Levine&title=Hybrid+epithelial%2Fmesenchymal+phenotypes+promote+metastasis+and+therapy+resistance+across+carcinomas&doi=10.1016%2Fj.pharmthera.2018.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas</span></div><div class="casAuthors">Jolly, Mohit Kumar; Somarelli, Jason A.; Sheth, Maya; Biddle, Adrian; Tripathi, Satyendra C.; Armstrong, Andrew J.; Hanash, Samir M.; Bapat, Sharmila A.; Rangarajan, Annapoorni; Levine, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">161-184</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Cancer metastasis and therapy resistance are the major unsolved clin. challenges, and account for nearly all cancer-related deaths.  Both metastasis and therapy resistance are fueled by epithelial plasticity, the reversible phenotypic transitions between epithelial and mesenchymal phenotypes, including epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET).  EMT and MET have been largely considered as binary processes, where cells detach from the primary tumor as individual units with many, if not all, traits of a mesenchymal cell (EMT) and then convert back to being epithelial (MET).  However, recent studies have demonstrated that cells can metastasize in ways alternative to traditional EMT paradigm; for example, they can detach as clusters, and/or occupy one or more stable hybrid epithelial/mesenchymal (E/M) phenotypes that can be the end point of a transition.  Such hybrid E/M cells can integrate various epithelial and mesenchymal traits and markers, facilitating collective cell migration.  Furthermore, these hybrid E/M cells may possess higher tumor-initiation and metastatic potential as compared to cells on either end of the EMT spectrum.  Here, we review in silico, in vitro, in vivo and clin. evidence for the existence of one or more hybrid E/M phenotype(s) in multiple carcinomas, and discuss their implications in tumor-initiation, tumor relapse, therapy resistance, and metastasis.  Together, these studies drive the emerging notion that cells in a hybrid E/M phenotype may occupy 'metastatic sweet spot' in multiple subtypes of carcinomas, and pathways linked to this (these) hybrid E/M state(s) may be relevant as prognostic biomarkers as well as a promising therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocsdQxD5n7iLVg90H21EOLACvtfcHk0lg5R8IGz4lqjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGisLbJ&md5=4837c77f0c3eb157f352490d8641e592</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2018.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2018.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DJolly%26aufirst%3DM.%2BK.%26aulast%3DSomarelli%26aufirst%3DJ.%2BA.%26aulast%3DSheth%26aufirst%3DM.%26aulast%3DBiddle%26aufirst%3DA.%26aulast%3DTripathi%26aufirst%3DS.%2BC.%26aulast%3DArmstrong%26aufirst%3DA.%2BJ.%26aulast%3DHanash%26aufirst%3DS.%2BM.%26aulast%3DBapat%26aufirst%3DS.%2BA.%26aulast%3DRangarajan%26aufirst%3DA.%26aulast%3DLevine%26aufirst%3DH.%26atitle%3DHybrid%2520epithelial%252Fmesenchymal%2520phenotypes%2520promote%2520metastasis%2520and%2520therapy%2520resistance%2520across%2520carcinomas%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D194%26spage%3D161%26epage%3D184%26doi%3D10.1016%2Fj.pharmthera.2018.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, K.</span></span> <span> </span><span class="NLM_article-title">Proteolytic interstitial cell migration: a five-step process</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1007/s10555-008-9174-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1007%2Fs10555-008-9174-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=19153672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A280%3ADC%252BD1M3hslSnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=129-135&author=P.+Friedlauthor=K.+Wolf&title=Proteolytic+interstitial+cell+migration%3A+a+five-step+process&doi=10.1007%2Fs10555-008-9174-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic interstitial cell migration: a five-step process</span></div><div class="casAuthors">Friedl Peter; Wolf Katarina</div><div class="citationInfo"><span class="NLM_cas:title">Cancer metastasis reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">129-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cell migration is a multi-step process that leads to the actin-driven translocation of cells on or through tissue substrate.  Basic steps involved in cell migration have been defined for two-dimensional haptokinetic migration which, however, does not provide physical constraints imposed by three-dimensional interstitial tissues.  We here describe the process of pericellular proteolysis that leads to extracellular matrix (ECM) degradation and realignment during cell movement and integrate it into established steps of cell migration.  After actin-driven leading edge protrusion (step I) and anterior formation of integrin-mediated focal interactions to the substrate (step II), ECM breakdown is focalized towards physical ECM barriers several micrometer rearward of the leading edge (step III).  Actomyosin-mediated cell contraction (step IV) then leads to rear-end retraction and forward sliding of cell body and nucleus so that a small tube-like matrix defect bordered by realigned ECM fibers becomes apparent (step V).  Pericellular proteolysis is thus integral to the migration cycle and serves to widen ECM gaps and thereby lowers physical stress upon the cell body, which ultimately leads to aligned higher-oder ECM patterns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgWNHWmc0hKL7NkxioyDXTfW6udTcc2eYyhsL-7X0mVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3hslSnsQ%253D%253D&md5=27340e9b034a83d270057d54201c996c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9174-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9174-3%26sid%3Dliteratum%253Aachs%26aulast%3DFriedl%26aufirst%3DP.%26aulast%3DWolf%26aufirst%3DK.%26atitle%3DProteolytic%2520interstitial%2520cell%2520migration%253A%2520a%2520five-step%2520process%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2009%26volume%3D28%26spage%3D129%26epage%3D135%26doi%3D10.1007%2Fs10555-008-9174-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, F.</span></span> <span> </span><span class="NLM_article-title">Emerging protein kinase inhibitors for treating pancreatic cancer</span>. <i>Expert Opin. Emerging Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1080/14728214.2017.1293648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1080%2F14728214.2017.1293648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=28253828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFWntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=77-86&author=J.+Furuseauthor=F.+Nagashima&title=Emerging+protein+kinase+inhibitors+for+treating+pancreatic+cancer&doi=10.1080%2F14728214.2017.1293648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging protein kinase inhibitors for treating pancreatic cancer</span></div><div class="casAuthors">Furuse, Junji; Nagashima, Fumio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-86</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Pancreatic cancer, the incidence and mortality of which are increasing around the world, has the most dismal prognosis among the commonly encountered cancers.  Systemic chemotherapy plays an important role in the treatment of patients with pancreatic cancer, and development of more effective chemotherapies is being sought.: This review article provides a summary about protein kinase inhibitors that have been investigated for the treatment of pancreatic cancer, not only existing agents targeting RAS, EGFR, VEGFR, MEK, etc., but also various compds. targeting, including the MAPK, PI3 K/Akt/mTOR, and JAK/STAT signaling pathways, trials of which are currently ongoing.  To date, none has shown sufficient efficacy as to merit becoming established as a std. treatment agent for pancreatic cancer.: As the toxicities of protein kinase inhibitors usually differ from those of cytotoxic agents, it could be of value to use these agents in combination with gemcitabine plus nab-paclitaxel.  It may be reasonable to identify a suitable disease and/or predictive markers for new compds. in proof of concept trials.  It is an urgent need to conduct phase III trials, on the basis of the results obtained, in subpopulations with biomarkers to predict the efficacy of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8KLcqtCPuhbVg90H21EOLACvtfcHk0lg5R8IGz4lqjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFWntL0%253D&md5=e421eee1b9489287ee1fd63f177e619c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F14728214.2017.1293648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728214.2017.1293648%26sid%3Dliteratum%253Aachs%26aulast%3DFuruse%26aufirst%3DJ.%26aulast%3DNagashima%26aufirst%3DF.%26atitle%3DEmerging%2520protein%2520kinase%2520inhibitors%2520for%2520treating%2520pancreatic%2520cancer%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2017%26volume%3D22%26spage%3D77%26epage%3D86%26doi%3D10.1080%2F14728214.2017.1293648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Y.</span></span> <span> </span><span class="NLM_article-title">Drug target identification using network analysis: Taking active components in Sini decoction as an example</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">24245</span> <span class="refDoi"> DOI: 10.1038/srep24245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fsrep24245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=27095146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A280%3ADC%252BC28bhslWqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=S.+Chenauthor=H.+Jiangauthor=Y.+Caoauthor=Y.+Wangauthor=Z.+Huauthor=Z.+Zhuauthor=Y.+Chai&title=Drug+target+identification+using+network+analysis%3A+Taking+active+components+in+Sini+decoction+as+an+example&doi=10.1038%2Fsrep24245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Drug target identification using network analysis: Taking active components in Sini decoction as an example</span></div><div class="casAuthors">Chen Si; Jiang Hailong; Cao Yan; Wang Yun; Zhu Zhenyu; Chai Yifeng; Hu Ziheng</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24245</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Identifying the molecular targets for the beneficial effects of active small-molecule compounds simultaneously is an important and currently unmet challenge.  In this study, we firstly proposed network analysis by integrating data from network pharmacology and metabolomics to identify targets of active components in sini decoction (SND) simultaneously against heart failure.  To begin with, 48 potential active components in SND against heart failure were predicted by serum pharmacochemistry, text mining and similarity match.  Then, we employed network pharmacology including text mining and molecular docking to identify the potential targets of these components.  The key enriched processes, pathways and related diseases of these target proteins were analyzed by STRING database.  At last, network analysis was conducted to identify most possible targets of components in SND.  Among the 25 targets predicted by network analysis, tumor necrosis factor α (TNF-α) was firstly experimentally validated in molecular and cellular level.  Results indicated that hypaconitine, mesaconitine, higenamine and quercetin in SND can directly bind to TNF-α, reduce the TNF-α-mediated cytotoxicity on L929 cells and exert anti-myocardial cell apoptosis effects.  We envisage that network analysis will also be useful in target identification of a bioactive compound.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyH-6lz7TqEaNc3HjJRoFAfW6udTcc2ebHRJXeU3O_kLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bhslWqsA%253D%253D&md5=804323e4a9c8e68ae8f2c9fa804fd926</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep24245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep24245%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DChai%26aufirst%3DY.%26atitle%3DDrug%2520target%2520identification%2520using%2520network%2520analysis%253A%2520Taking%2520active%2520components%2520in%2520Sini%2520decoction%2520as%2520an%2520example%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fsrep24245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2017.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.toxlet.2017.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=28941798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKit7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2017&pages=74-83&author=S.+Tangauthor=A.+Chenauthor=X.+Zhouauthor=L.+Zengauthor=M.+Liuauthor=X.+Wang&title=Assessment+of+the+inhibition+risk+of+shikonin+on+cytochrome+P450+via+cocktail+inhibition+assay&doi=10.1016%2Fj.toxlet.2017.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay</span></div><div class="casAuthors">Tang, Shuowen; Chen, Ang; Zhou, Xiaojing; Zeng, Li; Liu, Mingyao; Wang, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-83</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Shikonin is a naphthoquinone pigment extd. from roots of Lithospermum erythrorhizon Sieb. et Zucc. (Boraginaceae), and possesses various pharmaceutical activities, such as anti-inflammation and anti-cancer effects.  In addn., shikonin as a natural red colorant for food garnishment and cosmetics ingredient is widely used in the world.  However, the inhibition risk of shikonin on cytochrome P 450 (CYP) remains unclear.  The aim of this study was to investigate the potential inhibition of shikonin against CYP1A2, CYP2B1/6, CYP2C9/11, CYP2D1/6, CYP2E1 and CYP3A2/4 activities in human and rat liver microsomes through cocktail approach in vitro.  The results demonstrated that shikonin exhibited no time-dependent inhibition of CYP activities.  In human liver microsomes, shikonin was not only a mixed inhibitor of CYP1A2, CYP2B6, CYP2C9, CYP2D6 and CYP3A4, but also a competitive inhibitor of CYP2E1, with Ki values no more than 7.72 μM.  In rat liver microsomes, shikonin also exhibited the mixed inhibition on CYP1A2, CYP2B1, CYP2C11, CYP2D1, and the competitive inhibition on CYP2E1.  Interestingly, shikonin presented an atypical kinetic inhibition of CYP3A2-mediated midazolam 1-hydroxylation in rats.  In conclusion, the relatively low Ki values of shikonin would have a high risk potential to cause the possible toxicity, esp. drug-drug or food-drug interactions based on the potent inhibition of CYP enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_H8DW4pWptLVg90H21EOLACvtfcHk0lgz-JXBvvR82A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKit7zI&md5=4a91fcb7abfccbb9030ea01c62a8d8cd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2017.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2017.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DAssessment%2520of%2520the%2520inhibition%2520risk%2520of%2520shikonin%2520on%2520cytochrome%2520P450%2520via%2520cocktail%2520inhibition%2520assay%26jtitle%3DToxicol.%2520Lett.%26date%3D2017%26volume%3D281%26spage%3D74%26epage%3D83%26doi%3D10.1016%2Fj.toxlet.2017.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lu-Nan Zhou, Fang-Fang Feng, Chi Wai Cheung, <span class="NLM_string-name hlFld-ContribAuthor">Jun-An Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Cu-Enabled [3 + 2] Annulation of In Situ Formed Nitrile Ylides with Aryldiazonium Salts: Access to 5-Cyano-1,2,4-Triazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     , 739-744. <a href="https://doi.org/10.1021/acs.orglett.0c03960" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03960%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCu-Enabled%252B%25255B3%252B%25252B%252B2%25255D%252BAnnulation%252Bof%252BIn%252BSitu%252BFormed%252BNitrile%252BYlides%252Bwith%252BAryldiazonium%252BSalts%25253A%252BAccess%252Bto%252B5-Cyano-1%25252C2%25252C4-Triazoles%26aulast%3DZhou%26aufirst%3DLu-Nan%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30112020%26date%3D11012021%26volume%3D23%26issue%3D3%26spage%3D739%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lori Gonnet, Christiane André-Barrès, Brigitte Guidetti, Alain Chamayou, Christophe Menendez, Michel Baron, Rachel Calvet, <span class="NLM_string-name hlFld-ContribAuthor">Michel Baltas</span>. </span><span class="cited-content_cbyCitation_article-title">Study of the Two Steps and One-Pot Two-Step Mechanochemical Synthesis of Annulated 1,2,4-Triazoles. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2020,</strong> <em>8 </em>
                                    (8)
                                     , 3114-3125. <a href="https://doi.org/10.1021/acssuschemeng.9b05886" title="DOI URL">https://doi.org/10.1021/acssuschemeng.9b05886</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.9b05886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.9b05886%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DStudy%252Bof%252Bthe%252BTwo%252BSteps%252Band%252BOne-Pot%252BTwo-Step%252BMechanochemical%252BSynthesis%252Bof%252BAnnulated%252B1%25252C2%25252C4-Triazoles%26aulast%3DGonnet%26aufirst%3DLori%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D2020%26date%3D02102019%26date%3D17012020%26date%3D18022020%26date%3D05022020%26volume%3D8%26issue%3D8%26spage%3D3114%26epage%3D3125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weifeng  Ma</span>, <span class="hlFld-ContribAuthor ">Peng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiansen  Huo</span>, <span class="hlFld-ContribAuthor ">Yufeng  Ma</span>, <span class="hlFld-ContribAuthor ">Yanhong  Li</span>, <span class="hlFld-ContribAuthor ">Pengcheng  Diao</span>, <span class="hlFld-ContribAuthor ">Fang  Yang</span>, <span class="hlFld-ContribAuthor ">Shengquan  Zheng</span>, <span class="hlFld-ContribAuthor ">Mengjin  Hu</span>, <span class="hlFld-ContribAuthor ">Wenwei  You</span>, <span class="hlFld-ContribAuthor ">Peiliang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112847. <a href="https://doi.org/10.1016/j.ejmech.2020.112847" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112847%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Btriazolothiadiazine%252Bderivatives%252Bas%252Bhighly%252Bpotent%252Btubulin%252Bpolymerization%252Binhibitors%25253A%252BStructure-activity%252Brelationship%25252C%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Bstudy%26aulast%3DMa%26aufirst%3DWeifeng%26date%3D2020%26volume%3D208%26spage%3D112847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haijun  Gu</span>, <span class="hlFld-ContribAuthor ">Yangrui  Peng</span>, <span class="hlFld-ContribAuthor ">Yihua  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">An Emerging Therapeutic Approach by Targeting Myoferlin (MYOF) for Malignant Tumors. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (17)
                                     , 1509-1515. <a href="https://doi.org/10.2174/1568026620666200618123436" title="DOI URL">https://doi.org/10.2174/1568026620666200618123436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200618123436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200618123436%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DAn%252BEmerging%252BTherapeutic%252BApproach%252Bby%252BTargeting%252BMyoferlin%252B%252528MYOF%252529%252Bfor%252BMalignant%252BTumors%26aulast%3DGu%26aufirst%3DHaijun%26date%3D2020%26volume%3D20%26issue%3D17%26spage%3D1509%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomas  Opsomer</span>, <span class="hlFld-ContribAuthor ">Wim  Dehaen</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14854-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14854-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14854-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14854-1%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C4-Triazoles%26aulast%3DOpsomer%26aufirst%3DTomas%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yimin  Dong</span>, <span class="hlFld-ContribAuthor ">Honglei  Kang</span>, <span class="hlFld-ContribAuthor ">Huiyong  Liu</span>, <span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Qian  Guo</span>, <span class="hlFld-ContribAuthor ">Chao  Song</span>, <span class="hlFld-ContribAuthor ">Yunlong  Sun</span>, <span class="hlFld-ContribAuthor ">Ya  Zhang</span>, <span class="hlFld-ContribAuthor ">Honghua  Zhang</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Hanfeng  Guan</span>, <span class="hlFld-ContribAuthor ">Zhong  Fang</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Myoferlin, a Membrane Protein with Emerging Oncogenic Roles. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2019,</strong> <em>2019 </em>, 1-9. <a href="https://doi.org/10.1155/2019/7365913" title="DOI URL">https://doi.org/10.1155/2019/7365913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2019/7365913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2019%2F7365913%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DMyoferlin%25252C%252Ba%252BMembrane%252BProtein%252Bwith%252BEmerging%252BOncogenic%252BRoles%26aulast%3DDong%26aufirst%3DYimin%26date%3D2019%26volume%3D2019%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">Bolun  Zhou</span>, <span class="hlFld-ContribAuthor ">Chenxuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhengqing  Ba</span>, <span class="hlFld-ContribAuthor ">Hongjuan  Xu</span>, <span class="hlFld-ContribAuthor ">Xuejun  Yan</span>, <span class="hlFld-ContribAuthor ">Weidong  Liu</span>, <span class="hlFld-ContribAuthor ">Bin  Zhu</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Caiping  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular and Molecular Medicine</span><span> <strong>2019,</strong> <em>23 </em>
                                    (11)
                                     , 7180-7189. <a href="https://doi.org/10.1111/jcmm.14648" title="DOI URL">https://doi.org/10.1111/jcmm.14648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcmm.14648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcmm.14648%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520and%2520Molecular%2520Medicine%26atitle%3DMyoferlin%25252C%252Ba%252Bmultifunctional%252Bprotein%252Bin%252Bnormal%252Bcells%25252C%252Bhas%252Bnovel%252Band%252Bkey%252Broles%252Bin%252Bvarious%252Bcancers%26aulast%3DZhu%26aufirst%3DWei%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D11%26spage%3D7180%26epage%3D7189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peulen</span>, <span class="hlFld-ContribAuthor ">Rademaker</span>, <span class="hlFld-ContribAuthor ">Anania</span>, <span class="hlFld-ContribAuthor ">Turtoi</span>, <span class="hlFld-ContribAuthor ">Bellahcène</span>, <span class="hlFld-ContribAuthor ">Castronovo</span>. </span><span class="cited-content_cbyCitation_article-title">Ferlin Overview: From Membrane to Cancer Biology. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2019,</strong> <em>8 </em>
                                    (9)
                                     , 954. <a href="https://doi.org/10.3390/cells8090954" title="DOI URL">https://doi.org/10.3390/cells8090954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells8090954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells8090954%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DFerlin%252BOverview%25253A%252BFrom%252BMembrane%252Bto%252BCancer%252BBiology%26aulast%3DPeulen%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D9%26spage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Several representative on-market drugs for pancreatic cancer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of the hit compound <b>2a</b>, reported compound <b>2b</b>, and the optimization section that led to compound <b>6y</b> (rings A and B, as well as R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> are highlighted as cited in the text).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0018.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes of 1,2,3-Triazole Derivatives of Compounds <b>6a</b>–<b>z</b><sup>a</sup><sup>,</sup><sup>b</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>R<sup>1</sup> = aryl(CH<sub>2</sub>)<i><sub>n</sub></i>(O)<i><sub>x</sub></i>(CH<sub>2</sub>)<i><sub>m</sub></i> (<i>m</i>, <i>n</i>, <i>x</i> = 0–2); R<sup>2</sup> = MeO, EtO, CF<sub>3</sub>O, CHF<sub>2</sub>O; R<sup>3</sup> = Me, Et, <i>i</i>-Pr, cyclopropyl.</p><p class="last"><span class="fn-label"><sup>b</sup></span>Reagents and conditions: (a) HATU, DIPEA, dimethylformamide (DMF), room temperature (rt); (b) methyl 3-hydrazinylbenzoate, acetic acid, 80 °C; (c) LiOH·H<sub>2</sub>O, CH<sub>3</sub>OH/H<sub>2</sub>O; (d) amines, EDC·HCl, hydroxybenzotriazole (HOBt), DMF, 0 °C to rt; (e) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes of 1,2,3-Triazole Derivatives of Compounds <b>7a</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HATU, DIPEA, DMF, rt; (b) 4-methoxyphenylhydrazine hydrochloride, acetic acid, 80 °C; (c) LiOH·H<sub>2</sub>O, CH<sub>3</sub>OH/H<sub>2</sub>O; (d) 4-phenyl-1-butylamine, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl), HOBt, DMF, 0 °C to rt.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route of 1,2,3-Triazole Derivative of Compound <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(TFA)<sub>2</sub>, 1,3-bis(diphenylphosphino)-propane, ethyl potassium oxalate; (b) LiOH·H<sub>2</sub>O, CH<sub>3</sub>OH/H<sub>2</sub>O; (c) 4-phenyl-1-butylamine, EDC·HCl, HOBt, DMF, 0 °C to rt.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of compound <b>6y</b> on the migration of pancreatic cancer cells. Compound <b>6y</b> concentration-dependently inhibited the migration of PANC1, MiaPaCa2, and Capan2 cells in the transwell migration assay. Significance between groups was analyzed by one-way analysis of variance (ANOVA) using IBM SPSS software. **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0016.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. SPR sensorgrams for the binding between the MYOF-C2D protein and each of the three representative compounds. The corresponding calculated <i>K</i><sub>D</sub> values (at the bottom of each sensorgram) are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0017.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. STD-NMR spectrum of <b>6y</b> bound to the MYOF-C2D protein. The STD-NMR spectrum (black) is superimposed with the one-dimensional (1D) spectrum (blue). MYOF-C2D and <b>6y</b> concentrations were set to 6 and 145 μM, respectively. The solvent accessibility of the <b>6y</b> protons, deduced from the STD signals, is indicated with spheres colored in red (buried) to yellow (solvent-exposed).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0013.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antimigration effect of compound <b>6y</b> was positively correlated with the expression of MYOF in PANC1 cells. (a) MYOF expression in MYOF-knockout and MYOF-rescued cells. (b) MYOF knockout inhibited cell migration, whereas compound <b>6y</b> showed little effect on MYOF-knockout cells. Moreover, compound <b>6y</b> restored its antimigration activities in the MYOF-rescued cells. (c) Statistics of cell migration with or without <b>6y</b> in MYOF-knockout and MYOF-rescued cells. Significance between groups was analyzed by one-way ANOVA using IBM SPSS software. ***, <i>p</i> < 0.001; NS stands for nonsignificant (<i>p</i> > 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>6y</b> suppressed pancreatic cancer lung metastasis in vivo. (a) PANC1-luc cells were injected intravenously into female nude mice. DMSO, <b>6y</b>, or <b>1d</b> (gemcitabine) was injected intraperitoneally on day 0. Lung metastasis was monitored by bioluminescence in an in vivo imaging system. (b) Quantification of bioluminescence. (c) Overall survival rate of mice in different treatment groups. <i>n</i> = 8 mice/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>6y</b> exhibited no significant toxic effect in mice. (a) Body weights observed in mice treated with DMSO or compound <b>1d</b> or <b>6y</b> (25 or 50 mg/(kg day)). (b) Hematoxylin–eosin staining of the heart, lung, liver, spleen, and kidney from animals treated with DMSO, <b>1d</b>, or <b>6y</b> (25 or 50 mg/(kg day)).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/medium/jm-2019-00059y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Underlying mechanism of compound <b>6y</b> on pancreatic cancer cell metastasis. (a) <b>6y</b> increased expressions of the epithelial marker E-cadherin and downregulated the mesenchymal marker fibronectin. (b) <b>6y</b> suppressed the secretions of MMP1 and MMP2 in PANC1 cells. (c) <b>6y</b> depressed the phosphorylation of VEGFR induced by VEGF. (d) Time-dependent phospho-EGFR and EGFR expressions after EGF stimulation with or without <b>6y</b> exposure. (e) Compound <b>6y</b> inhibited the metastasis of cancer cells probably by selectively regulating multiple metastasis-related proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00059/20190516/images/large/jm-2019-00059y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00059&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahib, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleshman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matrisian, L. M.</span></span> <span> </span><span class="NLM_article-title">Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2913</span>– <span class="NLM_lpage">2921</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-0155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1158%2F0008-5472.CAN-14-0155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=24840647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=2913-2921&author=L.+Rahibauthor=B.+D.+Smithauthor=R.+Aizenbergauthor=A.+B.+Rosenzweigauthor=J.+M.+Fleshmanauthor=L.+M.+Matrisian&title=Projecting+cancer+incidence+and+deaths+to+2030%3A+the+unexpected+burden+of+thyroid%2C+liver%2C+and+pancreas+cancers+in+the+United+States&doi=10.1158%2F0008-5472.CAN-14-0155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States</span></div><div class="casAuthors">Rahib, Lola; Smith, Benjamin D.; Aizenberg, Rhonda; Rosenzweig, Allison B.; Fleshman, Julie M.; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2913-2921</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the av. annual percentage changes in incidence and death rates.  Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, resp.  Lung cancer is projected to remain the top cancer killer throughout this time period.  However, pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, resp.  Advances in screening, prevention, and treatment can change cancer incidence and/or death rates, but it will require a concerted effort by the research and healthcare communities now to effect a substantial change for the future.  Cancer Res; 74(11); 2913-21. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHGt66quENkbVg90H21EOLACvtfcHk0lhj2lLef0uwcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D&md5=893d688f1ccba88ee094b743f7e4f152</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0155%26sid%3Dliteratum%253Aachs%26aulast%3DRahib%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DAizenberg%26aufirst%3DR.%26aulast%3DRosenzweig%26aufirst%3DA.%2BB.%26aulast%3DFleshman%26aufirst%3DJ.%2BM.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DProjecting%2520cancer%2520incidence%2520and%2520deaths%2520to%25202030%253A%2520the%2520unexpected%2520burden%2520of%2520thyroid%252C%2520liver%252C%2520and%2520pancreas%2520cancers%2520in%2520the%2520United%2520States%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D2913%26epage%3D2921%26doi%3D10.1158%2F0008-5472.CAN-14-0155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2018</span>. <i>CA—Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.3322/caac.21442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.3322%2Fcaac.21442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=29313949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A280%3ADC%252BC1MzoslGisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2018&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2018&doi=10.3322%2Fcaac.21442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2018</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data, available through 2014, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries.  Mortality data, available through 2015, were collected by the National Center for Health Statistics.  In 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the United States.  Over the past decade of data, the cancer incidence rate (2005-2014) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2006-2015) declined by about 1.5% annually in both men and women.  The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak.  Of the 10 leading causes of death, only cancer declined from 2014 to 2015.  In 2015, the cancer death rate was 14% higher in non-Hispanic blacks (NHBs) than non-Hispanic whites (NHWs) overall (death rate ratio [DRR], 1.14; 95% confidence interval [95% CI], 1.13-1.15), but the racial disparity was much larger for individuals aged <65 years (DRR, 1.31; 95% CI, 1.29-1.32) compared with those aged ≥65 years (DRR, 1.07; 95% CI, 1.06-1.09) and varied substantially by state.  For example, the cancer death rate was lower in NHBs than NHWs in Massachusetts for all ages and in New York for individuals aged ≥65 years, whereas for those aged <65 years, it was 3 times higher in NHBs in the District of Columbia (DRR, 2.89; 95% CI, 2.16-3.91) and about 50% higher in Wisconsin (DRR, 1.78; 95% CI, 1.56-2.02), Kansas (DRR, 1.51; 95% CI, 1.25-1.81), Louisiana (DRR, 1.49; 95% CI, 1.38-1.60), Illinois (DRR, 1.48; 95% CI, 1.39-1.57), and California (DRR, 1.45; 95% CI, 1.38-1.54).  Larger racial inequalities in young and middle-aged adults probably partly reflect less access to high-quality health care.  CA Cancer J Clin 2018;68:7-30. © 2018 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8-MQOcW2xELJzI8owOhpDfW6udTcc2eZO_NxfmiPAxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzoslGisQ%253D%253D&md5=0a85e5c9a2bffba9aa3950a140939b14</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21442%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202018%26jtitle%3DCA%25E2%2580%2594Cancer%2520J.%2520Clin.%26date%3D2018%26volume%3D68%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciliberto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correale, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caraglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tassone, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliaferri, P.</span></span> <span> </span><span class="NLM_article-title">Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">603</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2012.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.ejca.2012.08.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=593-603&author=D.+Cilibertoauthor=C.+Bottaauthor=P.+Correaleauthor=M.+Rossiauthor=M.+Caragliaauthor=P.+Tassoneauthor=P.+Tagliaferri&title=Role+of+gemcitabine-based+combination+therapy+in+the+management+of+advanced+pancreatic+cancer%3A+a+meta-analysis+of+randomised+trials&doi=10.1016%2Fj.ejca.2012.08.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2012.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2012.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DCiliberto%26aufirst%3DD.%26aulast%3DBotta%26aufirst%3DC.%26aulast%3DCorreale%26aufirst%3DP.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DCaraglia%26aufirst%3DM.%26aulast%3DTassone%26aufirst%3DP.%26aulast%3DTagliaferri%26aufirst%3DP.%26atitle%3DRole%2520of%2520gemcitabine-based%2520combination%2520therapy%2520in%2520the%2520management%2520of%2520advanced%2520pancreatic%2520cancer%253A%2520a%2520meta-analysis%2520of%2520randomised%2520trials%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D593%26epage%3D603%26doi%3D10.1016%2Fj.ejca.2012.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qian, B. Z.</span></span> <span> </span><span class="NLM_article-title">Inflammation fires up cancer metastasis</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2017.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.semcancer.2017.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=28838845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=170-176&author=B.+Z.+Qian&title=Inflammation+fires+up+cancer+metastasis&doi=10.1016%2Fj.semcancer.2017.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation fires up cancer metastasis</span></div><div class="casAuthors">Qian, Bin-Zhi</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">170-176</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Metastatic disease is the major challenge of cancer that accounts for over 90% of total cancer lethality.  Mounting clin. and preclin. data now indicate that inflammation, a potent immune and repair response, is indispensable for metastasis.  In this review we describe our current understanding of how major inflammatory cells contribute to metastatic cascade with a focus on the primary tumor.  We also discuss exciting new directions for future research and novel therapeutic approaches to tackle metastatic disease through targeting inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwDh7cWa-HSbVg90H21EOLACvtfcHk0liVdeNGRtTSJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeisL7E&md5=3e25238fa825b25d60941cce27ad0fac</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2017.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2017.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DB.%2BZ.%26atitle%3DInflammation%2520fires%2520up%2520cancer%2520metastasis%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D47%26spage%3D170%26epage%3D176%26doi%3D10.1016%2Fj.semcancer.2017.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swinney, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, J.</span></span> <span> </span><span class="NLM_article-title">How were new medicines discovered?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1038/nrd3480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fnrd3480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=21701501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F&doi=10.1038%2Fnrd3480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">How were new medicines discovered?</span></div><div class="casAuthors">Swinney, David C.; Anthony, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">507-519</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Preclin. strategies that are used to identify potential drug candidates include target-based screening, phenotypic screening, modification of natural substances and biol.-based approaches.  To investigate whether some strategies have been more successful than others in the discovery of new drugs, we analyzed the discovery strategies and the mol. mechanism of action (MMOA) for new mol. entities and new biologics that were approved by the US Food and Drug Administration between 1999 and 2008.  Out of the 259 agents that were approved, 75 were first-in-class drugs with new MMOAs, and out of these, 50 (67%) were small mols. and 25 (33%) were biologics.  The results also show that the contribution of phenotypic screening to the discovery of first-in-class small-mol. drugs exceeded that of target-based approaches - with 28 and 17 of these drugs coming from the two approaches, resp. - in an era in which the major focus was on target-based approaches.  We postulate that a target-centric approach for first-in-class drugs, without consideration of an optimal MMOA, may contribute to the current high attrition rates and low productivity in pharmaceutical research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE8Ah1iNz76bVg90H21EOLACvtfcHk0lgSEjrfMozHRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D&md5=7503620f8fbadb0a829f6ea2029936a2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3480%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519%26doi%3D10.1038%2Fnrd3480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, D.</span></span> <span> </span><span class="NLM_article-title">Phenotypic screening in cancer drug discovery - past, present and future</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1038/nrd4366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fnrd4366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=25033736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFygsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=588-602&author=J.+G.+Moffatauthor=J.+Rudolphauthor=D.+Bailey&title=Phenotypic+screening+in+cancer+drug+discovery+-+past%2C+present+and+future&doi=10.1038%2Fnrd4366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Phenotypic screening in cancer drug discovery - past, present and future</span></div><div class="casAuthors">Moffat, John G.; Rudolph, Joachim; Bailey, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">588-602</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There has been a resurgence of interest in the use of phenotypic screens in drug discovery as an alternative to target-focused approaches.  Given that oncol. is currently the most active therapeutic area, and also one in which target-focused approaches have been particularly prominent in the past two decades, we investigated the contribution of phenotypic assays to oncol. drug discovery by analyzing the origins of all new small-mol. cancer drugs approved by the US Food and Drug Administration (FDA) over the past 15 years and those currently in clin. development.  Although the majority of these drugs originated from target-based discovery, we identified a significant no. whose discovery depended on phenotypic screening approaches.  We postulate that the contribution of phenotypic screening to cancer drug discovery has been hampered by a reliance on 'classical' nonspecific drug effects such as cytotoxicity and mitotic arrest, exacerbated by a paucity of mechanistically defined cellular models for therapeutically translatable cancer phenotypes.  However, tech. and biol. advances that enable such mechanistically informed phenotypic models have the potential to empower phenotypic drug discovery in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTWtoTIgWqvbVg90H21EOLACvtfcHk0lgSEjrfMozHRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFygsr7L&md5=0e8efed90e5bc4b47f959b83a6ab5b96</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd4366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4366%26sid%3Dliteratum%253Aachs%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DRudolph%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DD.%26atitle%3DPhenotypic%2520screening%2520in%2520cancer%2520drug%2520discovery%2520-%2520past%252C%2520present%2520and%2520future%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D588%26epage%3D602%26doi%3D10.1038%2Fnrd4366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blomme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanza, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Tullio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Simaeys, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doumont, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Valentin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokobori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gofflot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peulen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellahcene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Goff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouithys-Mickalad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouret, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifrange, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pauw, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronovo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turtoi, A.</span></span> <span> </span><span class="NLM_article-title">Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2116</span>– <span class="NLM_lpage">2130</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fonc.2016.369" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=2116-2130&author=A.+Blommeauthor=B.+Costanzaauthor=P.+de+Tullioauthor=M.+Thiryauthor=G.+Van+Simaeysauthor=S.+Boutryauthor=G.+Doumontauthor=E.+Di+Valentinauthor=T.+Hiranoauthor=T.+Yokoboriauthor=S.+Gofflotauthor=O.+Peulenauthor=A.+Bellahceneauthor=F.+Shererauthor=C.+Le+Goffauthor=E.+Cavalierauthor=A.+Mouithys-Mickaladauthor=F.+Jouretauthor=P.+G.+Cusumanoauthor=E.+Lifrangeauthor=R.+N.+Mullerauthor=S.+Goldmanauthor=P.+Delvenneauthor=E.+De+Pauwauthor=M.+Nishiyamaauthor=V.+Castronovoauthor=A.+Turtoi&title=Myoferlin+regulates+cellular+lipid+metabolism+and+promotes+metastases+in+triple-negative+breast+cancer&doi=10.1038%2Fonc.2016.369"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.369%26sid%3Dliteratum%253Aachs%26aulast%3DBlomme%26aufirst%3DA.%26aulast%3DCostanza%26aufirst%3DB.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DThiry%26aufirst%3DM.%26aulast%3DVan%2BSimaeys%26aufirst%3DG.%26aulast%3DBoutry%26aufirst%3DS.%26aulast%3DDoumont%26aufirst%3DG.%26aulast%3DDi%2BValentin%26aufirst%3DE.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DYokobori%26aufirst%3DT.%26aulast%3DGofflot%26aufirst%3DS.%26aulast%3DPeulen%26aufirst%3DO.%26aulast%3DBellahcene%26aufirst%3DA.%26aulast%3DSherer%26aufirst%3DF.%26aulast%3DLe%2BGoff%26aufirst%3DC.%26aulast%3DCavalier%26aufirst%3DE.%26aulast%3DMouithys-Mickalad%26aufirst%3DA.%26aulast%3DJouret%26aufirst%3DF.%26aulast%3DCusumano%26aufirst%3DP.%2BG.%26aulast%3DLifrange%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DR.%2BN.%26aulast%3DGoldman%26aufirst%3DS.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DDe%2BPauw%26aufirst%3DE.%26aulast%3DNishiyama%26aufirst%3DM.%26aulast%3DCastronovo%26aufirst%3DV.%26aulast%3DTurtoi%26aufirst%3DA.%26atitle%3DMyoferlin%2520regulates%2520cellular%2520lipid%2520metabolism%2520and%2520promotes%2520metastases%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D2116%26epage%3D2130%26doi%3D10.1038%2Fonc.2016.369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rademaker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequiere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brohee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nokin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovinfosse, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gofflot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanza, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herfs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiffer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettendorff, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deroanne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hustinx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellahcene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronovo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peulen, O.</span></span> <span> </span><span class="NLM_article-title">Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">4398</span>– <span class="NLM_lpage">4412</span>, <span class="refDoi"> DOI: 10.1038/s41388-018-0287-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fs41388-018-0287-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=4398-4412&author=G.+Rademakerauthor=V.+Hennequiereauthor=L.+Broheeauthor=M.+J.+Nokinauthor=P.+Lovinfosseauthor=F.+Durieuxauthor=S.+Gofflotauthor=J.+Bellierauthor=B.+Costanzaauthor=M.+Herfsauthor=R.+Peifferauthor=L.+Bettendorffauthor=C.+Deroanneauthor=M.+Thiryauthor=P.+Delvenneauthor=R.+Hustinxauthor=A.+Bellahceneauthor=V.+Castronovoauthor=O.+Peulen&title=Myoferlin+controls+mitochondrial+structure+and+activity+in+pancreatic+ductal+adenocarcinoma%2C+and+affects+tumor+aggressiveness&doi=10.1038%2Fs41388-018-0287-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fs41388-018-0287-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-018-0287-z%26sid%3Dliteratum%253Aachs%26aulast%3DRademaker%26aufirst%3DG.%26aulast%3DHennequiere%26aufirst%3DV.%26aulast%3DBrohee%26aufirst%3DL.%26aulast%3DNokin%26aufirst%3DM.%2BJ.%26aulast%3DLovinfosse%26aufirst%3DP.%26aulast%3DDurieux%26aufirst%3DF.%26aulast%3DGofflot%26aufirst%3DS.%26aulast%3DBellier%26aufirst%3DJ.%26aulast%3DCostanza%26aufirst%3DB.%26aulast%3DHerfs%26aufirst%3DM.%26aulast%3DPeiffer%26aufirst%3DR.%26aulast%3DBettendorff%26aufirst%3DL.%26aulast%3DDeroanne%26aufirst%3DC.%26aulast%3DThiry%26aufirst%3DM.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DHustinx%26aufirst%3DR.%26aulast%3DBellahcene%26aufirst%3DA.%26aulast%3DCastronovo%26aufirst%3DV.%26aulast%3DPeulen%26aufirst%3DO.%26atitle%3DMyoferlin%2520controls%2520mitochondrial%2520structure%2520and%2520activity%2520in%2520pancreatic%2520ductal%2520adenocarcinoma%252C%2520and%2520affects%2520tumor%2520aggressiveness%26jtitle%3DOncogene%26date%3D2018%26volume%3D37%26spage%3D4398%26epage%3D4412%26doi%3D10.1038%2Fs41388-018-0287-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turtoi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musmeci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somja, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevilacqua, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pauw, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronovo, V.</span></span> <span> </span><span class="NLM_article-title">Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4302</span>– <span class="NLM_lpage">4313</span>, <span class="refDoi"> DOI: 10.1021/pr200527z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr200527z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=4302-4313&author=A.+Turtoiauthor=D.+Musmeciauthor=Y.+Wangauthor=B.+Dumontauthor=J.+Somjaauthor=G.+Bevilacquaauthor=E.+De+Pauwauthor=P.+Delvenneauthor=V.+Castronovo&title=Identification+of+novel+accessible+proteins+bearing+diagnostic+and+therapeutic+potential+in+human+pancreatic+ductal+adenocarcinoma&doi=10.1021%2Fpr200527z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Accessible Proteins Bearing Diagnostic and Therapeutic Potential in Human Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Turtoi, Andrei; Musmeci, Davide; Wang, Ying-Hong; Dumont, Bruno; Somja, Joan; Bevilacqua, Generoso; De Pauw, Edwin; Delvenne, Philippe; Castronovo, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4302-4313</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pancreas ductal adenocarcinoma (PDAC) remains a deadly malignancy with poor early diagnostic and no effective therapy.  Although several proteomic studies have performed comparative anal. between normal and malignant tissues, there is a lack of clear characterization of proteins that could be of clin. value.  Systemically reachable ("potentially accessible") proteins, suitable for imaging technologies and targeted therapies represent a major group of interest.  The current study explores potentially accessible proteins overexpressed in PDAC, employing innovative proteomics technologies.  In the discovery phase, potentially accessible proteins from fresh human normal and PDAC tissues were ex vivo biotinylated, isolated and identified using 2D-nano-HPLC-MS/MS method.  The anal. revealed 422 up-regulated proteins in the tumor, of which 83 (including protein isoforms) were evaluated as potentially accessible.  Eleven selected candidates were further confirmed as up-regulated using Western blot and multiple reaction monitoring protein quantification.  Of these, transforming growth factor beta-induced (TGFBI), latent transforming growth factor beta binding 2 (LTBP2), and asporin (ASPN) were further investigated by employing large scale immunohistochem.-based validations.  They were significantly expressed in a large group of clin. PDAC samples compared to corresponding normal and inflammatory tissues.  In conclusion, TGFBI, LTBP2, and ASPN are novel, overexpressed, and potentially accessible proteins in human PDAC.  They bear the potential to be of clin. value for diagnostic and therapeutic applications and merit further studies using in vivo models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbexSrePaqALVg90H21EOLACvtfcHk0lj0PteAU0xOUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSrs7g%253D&md5=f5144c8d407f0e9bb04a545bd0407855</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fpr200527z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr200527z%26sid%3Dliteratum%253Aachs%26aulast%3DTurtoi%26aufirst%3DA.%26aulast%3DMusmeci%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDumont%26aufirst%3DB.%26aulast%3DSomja%26aufirst%3DJ.%26aulast%3DBevilacqua%26aufirst%3DG.%26aulast%3DDe%2BPauw%26aufirst%3DE.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DCastronovo%26aufirst%3DV.%26atitle%3DIdentification%2520of%2520novel%2520accessible%2520proteins%2520bearing%2520diagnostic%2520and%2520therapeutic%2520potential%2520in%2520human%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2011%26volume%3D10%26spage%3D4302%26epage%3D4313%26doi%3D10.1021%2Fpr200527z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tognon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernatchez, P.</span></span> <span> </span><span class="NLM_article-title">Expression of myoferlin in human and murine carcinoma tumors: role in membrane repair, cell proliferation, and tumorigenesis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">1900</span>– <span class="NLM_lpage">1909</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2013.01.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.ajpath.2013.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=23499551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlGgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2013&pages=1900-1909&author=C.+Leungauthor=C.+Yuauthor=M.+I.+Linauthor=C.+Tognonauthor=P.+Bernatchez&title=Expression+of+myoferlin+in+human+and+murine+carcinoma+tumors%3A+role+in+membrane+repair%2C+cell+proliferation%2C+and+tumorigenesis&doi=10.1016%2Fj.ajpath.2013.01.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Myoferlin in Human and Murine Carcinoma Tumors</span></div><div class="casAuthors">Leung, Cleo; Yu, Carol; Lin, Michelle I.; Tognon, Cristina; Bernatchez, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1900-1909</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer cells are often characterized by high proliferation rates, a consequence of increased mitotic signaling coupled with unchecked cellular growth.  We recently demonstrated that vascular endothelial cells unexpectedly express ferlins, a family of muscle-specific proteins capable of regulating the fusion of lipid patches to the plasma membrane, and that these highly regulated membrane fusion events are essential to endothelial cell proliferation and homeostasis.  Here, we show that human and mouse breast cancer cell lines also express myoferlin at various levels, and that the processes of transformation, epithelial-mesenchymal transition, and metastasis do not appear to have any effect on myoferlin expression in vitro.  In vivo, we obsd. that solid mouse and human carcinoma tissues also express high levels of myoferlin protein.  Loss-of-function studies performed in mice revealed that myoferlin gene knockdown can attenuate cancer cell proliferation in vitro and decrease tumor burden, and that accelerated tumor cell growth appears to rely on intact myoferlin-dependent membrane repair and signaling under exponential growth conditions.  To our knowledge, these data provide the first evidence of myoferlin expression in solid human and mouse tumors.  We have thus identified a novel membrane repair process that likely helps sustain the high growth rates characteristic of tumors, and we suggest that interfering with normal myoferlin expression and/or membrane repair and remodeling may provide therapeutically relevant antiproliferative effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3kCV3cIdhPrVg90H21EOLACvtfcHk0lj0PteAU0xOUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlGgsrk%253D&md5=4201cee24dadd49ee15d2cc52e684aa8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2013.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2013.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DM.%2BI.%26aulast%3DTognon%26aufirst%3DC.%26aulast%3DBernatchez%26aufirst%3DP.%26atitle%3DExpression%2520of%2520myoferlin%2520in%2520human%2520and%2520murine%2520carcinoma%2520tumors%253A%2520role%2520in%2520membrane%2520repair%252C%2520cell%2520proliferation%252C%2520and%2520tumorigenesis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2013%26volume%3D182%26spage%3D1900%26epage%3D1909%26doi%3D10.1016%2Fj.ajpath.2013.01.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sachen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singletary, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alizadeh, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kattah, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lossos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellins, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, R.</span></span> <span> </span><span class="NLM_article-title">Self-antigen recognition by follicular lymphoma B-cell receptors</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">4182</span>– <span class="NLM_lpage">4190</span>, <span class="refDoi"> DOI: 10.1182/blood-2012-05-427534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1182%2Fblood-2012-05-427534" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=4182-4190&author=K.+L.+Sachenauthor=M.+J.+Strohmanauthor=J.+Singletaryauthor=A.+A.+Alizadehauthor=N.+H.+Kattahauthor=C.+Lossosauthor=E.+D.+Mellinsauthor=S.+Levyauthor=R.+Levy&title=Self-antigen+recognition+by+follicular+lymphoma+B-cell+receptors&doi=10.1182%2Fblood-2012-05-427534"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-05-427534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-05-427534%26sid%3Dliteratum%253Aachs%26aulast%3DSachen%26aufirst%3DK.%2BL.%26aulast%3DStrohman%26aufirst%3DM.%2BJ.%26aulast%3DSingletary%26aufirst%3DJ.%26aulast%3DAlizadeh%26aufirst%3DA.%2BA.%26aulast%3DKattah%26aufirst%3DN.%2BH.%26aulast%3DLossos%26aufirst%3DC.%26aulast%3DMellins%26aufirst%3DE.%2BD.%26aulast%3DLevy%26aufirst%3DS.%26aulast%3DLevy%26aufirst%3DR.%26atitle%3DSelf-antigen%2520recognition%2520by%2520follicular%2520lymphoma%2520B-cell%2520receptors%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D4182%26epage%3D4190%26doi%3D10.1182%2Fblood-2012-05-427534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turtoi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellahcene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilles, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequiere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pauw, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifrange, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronovo, V.</span></span> <span> </span><span class="NLM_article-title">Myoferlin is a key regulator of EGFR activity in breast cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">5438</span>– <span class="NLM_lpage">5448</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-1142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1158%2F0008-5472.CAN-13-1142" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=5438-5448&author=A.+Turtoiauthor=A.+Blommeauthor=A.+Bellahceneauthor=C.+Gillesauthor=V.+Hennequiereauthor=P.+Peixotoauthor=E.+Bianchiauthor=A.+Noelauthor=E.+De+Pauwauthor=E.+Lifrangeauthor=P.+Delvenneauthor=V.+Castronovo&title=Myoferlin+is+a+key+regulator+of+EGFR+activity+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-13-1142"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-1142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-1142%26sid%3Dliteratum%253Aachs%26aulast%3DTurtoi%26aufirst%3DA.%26aulast%3DBlomme%26aufirst%3DA.%26aulast%3DBellahcene%26aufirst%3DA.%26aulast%3DGilles%26aufirst%3DC.%26aulast%3DHennequiere%26aufirst%3DV.%26aulast%3DPeixoto%26aufirst%3DP.%26aulast%3DBianchi%26aufirst%3DE.%26aulast%3DNoel%26aufirst%3DA.%26aulast%3DDe%2BPauw%26aufirst%3DE.%26aulast%3DLifrange%26aufirst%3DE.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DCastronovo%26aufirst%3DV.%26atitle%3DMyoferlin%2520is%2520a%2520key%2520regulator%2520of%2520EGFR%2520activity%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D5438%26epage%3D5448%26doi%3D10.1158%2F0008-5472.CAN-13-1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernatchez, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acevedo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Hernando, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalouni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdjument-Bromage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sessa, W. C.</span></span> <span> </span><span class="NLM_article-title">Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">30745</span>– <span class="NLM_lpage">30753</span>, <span class="refDoi"> DOI: 10.1074/jbc.M704798200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1074%2Fjbc.M704798200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=30745-30753&author=P.+N.+Bernatchezauthor=L.+Acevedoauthor=C.+Fernandez-Hernandoauthor=T.+Murataauthor=C.+Chalouniauthor=J.+Kimauthor=H.+Erdjument-Bromageauthor=V.+Shahauthor=J.+P.+Grattonauthor=E.+M.+McNallyauthor=P.+Tempstauthor=W.+C.+Sessa&title=Myoferlin+regulates+vascular+endothelial+growth+factor+receptor-2+stability+and+function&doi=10.1074%2Fjbc.M704798200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M704798200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M704798200%26sid%3Dliteratum%253Aachs%26aulast%3DBernatchez%26aufirst%3DP.%2BN.%26aulast%3DAcevedo%26aufirst%3DL.%26aulast%3DFernandez-Hernando%26aufirst%3DC.%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DChalouni%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DShah%26aufirst%3DV.%26aulast%3DGratton%26aufirst%3DJ.%2BP.%26aulast%3DMcNally%26aufirst%3DE.%2BM.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DSessa%26aufirst%3DW.%2BC.%26atitle%3DMyoferlin%2520regulates%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520stability%2520and%2520function%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D30745%26epage%3D30753%26doi%3D10.1074%2Fjbc.M704798200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kniss, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, A.</span></span> <span> </span><span class="NLM_article-title">Mechanistic modeling of the effects of myoferlin on tumor cell invasion</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">20078</span>– <span class="NLM_lpage">20083</span>, <span class="refDoi"> DOI: 10.1073/pnas.1116327108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1073%2Fpnas.1116327108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=20078-20083&author=M.+C.+Eisenbergauthor=Y.+Kimauthor=R.+Liauthor=W.+E.+Ackermanauthor=D.+A.+Knissauthor=A.+Friedman&title=Mechanistic+modeling+of+the+effects+of+myoferlin+on+tumor+cell+invasion&doi=10.1073%2Fpnas.1116327108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1116327108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1116327108%26sid%3Dliteratum%253Aachs%26aulast%3DEisenberg%26aufirst%3DM.%2BC.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DAckerman%26aufirst%3DW.%2BE.%26aulast%3DKniss%26aufirst%3DD.%2BA.%26aulast%3DFriedman%26aufirst%3DA.%26atitle%3DMechanistic%2520modeling%2520of%2520the%2520effects%2520of%2520myoferlin%2520on%2520tumor%2520cell%2520invasion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D20078%26epage%3D20083%26doi%3D10.1073%2Fpnas.1116327108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span> <span> </span><span class="NLM_article-title">A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">3726</span> <span class="refDoi"> DOI: 10.1038/s41467-018-06179-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fs41467-018-06179-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=30213946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A280%3ADC%252BB3c3os1OrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&author=T.+Zhangauthor=J.+Liauthor=Y.+Heauthor=F.+Yangauthor=Y.+Haoauthor=W.+Jinauthor=J.+Wuauthor=Z.+Sunauthor=Y.+Liauthor=Y.+Chenauthor=Z.+Yiauthor=M.+Liu&title=A+small+molecule+targeting+myoferlin+exerts+promising+anti-tumor+effects+on+breast+cancer&doi=10.1038%2Fs41467-018-06179-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer</span></div><div class="casAuthors">Zhang Tao; Li Jingjie; He Yuan; Yang Feifei; Hao Yun; Jin Wangrui; Wu Jing; Li Yunqi; Chen Yihua; Yi Zhengfang; Liu Mingyao; Zhang Tao; Li Jingjie; Sun Zhenliang; Yi Zhengfang; Liu Mingyao</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3726</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Breast cancer is one of the most lethal cancers in women when it reaches the metastatic stage.  Here, we screen a library of small molecules for inhibitors of breast cancer cell invasion, and use structure/activity relationship studies to develop a series of small molecules with improved activity.  We find WJ460 as one of the lead compounds exerting anti-metastatic activity in the nanomolar range in breast cancer cells.  Proteomic and biochemical studies identify myoferlin (MYOF) as the direct target of WJ460.  In parallel, loss of MYOF or pharmacological inhibition of MYOF by WJ460 reduces breast cancer extravasation into the lung parenchyma in an experimental metastasis mouse model, which reveals an essential role of MYOF in breast cancer progression.  Our findings suggest that MYOF can be explored as a molecular target in breast cancer metastasis and that targeting MYOF by WJ460 may be a promising therapeutic strategy in MYOF-driven cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWjR92U2Rfrae0F5ixvZgXfW6udTcc2eaxXVRuNZNa87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3os1OrtQ%253D%253D&md5=11d72646d0e09ec8c11826ec126e4766</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06179-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06179-0%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DHao%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DM.%26atitle%3DA%2520small%2520molecule%2520targeting%2520myoferlin%2520exerts%2520promising%2520anti-tumor%2520effects%2520on%2520breast%2520cancer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26doi%3D10.1038%2Fs41467-018-06179-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volakis, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghadiali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kniss, D. A.</span></span> <span> </span><span class="NLM_article-title">Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion</span>. <i>PloS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e39766</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0039766</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1371%2Fjournal.pone.0039766" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=R.+Liauthor=W.+E.+Ackermanauthor=C.+Mihaiauthor=L.+I.+Volakisauthor=S.+Ghadialiauthor=D.+A.+Kniss&title=Myoferlin+depletion+in+breast+cancer+cells+promotes+mesenchymal+to+epithelial+shape+change+and+stalls+invasion&doi=10.1371%2Fjournal.pone.0039766"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0039766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0039766%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DAckerman%26aufirst%3DW.%2BE.%26aulast%3DMihai%26aufirst%3DC.%26aulast%3DVolakis%26aufirst%3DL.%2BI.%26aulast%3DGhadiali%26aufirst%3DS.%26aulast%3DKniss%26aufirst%3DD.%2BA.%26atitle%3DMyoferlin%2520depletion%2520in%2520breast%2520cancer%2520cells%2520promotes%2520mesenchymal%2520to%2520epithelial%2520shape%2520change%2520and%2520stalls%2520invasion%26jtitle%3DPloS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0039766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fahmy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arafa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellahcene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turtoi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronovo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peulen, O.</span></span> <span> </span><span class="NLM_article-title">Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">652</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1002/ijc.29820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1002%2Fijc.29820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=26311411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVGms77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=652-663&author=K.+Fahmyauthor=A.+Gonzalezauthor=M.+Arafaauthor=P.+Peixotoauthor=A.+Bellahceneauthor=A.+Turtoiauthor=P.+Delvenneauthor=M.+Thiryauthor=V.+Castronovoauthor=O.+Peulen&title=Myoferlin+plays+a+key+role+in+VEGFA+secretion+and+impacts+tumor-associated+angiogenesis+in+human+pancreas+cancer&doi=10.1002%2Fijc.29820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer</span></div><div class="casAuthors">Fahmy, Karim; Gonzalez, Arnaud; Arafa, Mohammad; Peixoto, Paul; Bellahcene, Akeila; Turtoi, Andrei; Delvenne, Philippe; Thiry, Marc; Castronovo, Vincent; Peulen, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">652-663</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma is one of the most deadly forms of cancers with no satisfactory treatment to date.  Recent studies have identified myoferlin, a ferlin family member, in human pancreas adenocarcinoma where its expression was assocd. to a bad prognosis.  However, the function of myoferlin in pancreas adenocarcinoma has not been reported.  In other cell types, myoferlin is involved in several key plasma membrane processes such as fusion, repair, endocytosis and tyrosine kinase receptor activity.  In this study, we showed that myoferlin silencing in BxPC-3 human pancreatic cancer cells resulted in the inhibition of cell proliferation in vitro and in a significant redn. of the tumor vol. in chick chorioallantoic membrane assay.  In addn. to be smaller, the tumors formed by the myoferlin-silenced cells showed a marked absence of functional blood vessels.  We further demonstrated that this effect was due, at least in part, to an inhibition of VEGFA secretion by BxPC-3 myoferlin-silenced cells.  Using immunofluorescence and electron microscopy, we linked the decreased VEGFA secretion to an impairment of VEGFA exocytosis.  The clin. relevance of our results was further strengthened by a significant correlation between myoferlin expression in a series of human pancreatic malignant lesions and their angiogenic status evaluated by the detn. of the blood vessel d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq30594mcCpQ7Vg90H21EOLACvtfcHk0lgcp3PQmUXaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVGms77L&md5=b8aa0ed2bb02b753e64e219d97713540</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fijc.29820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29820%26sid%3Dliteratum%253Aachs%26aulast%3DFahmy%26aufirst%3DK.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DArafa%26aufirst%3DM.%26aulast%3DPeixoto%26aufirst%3DP.%26aulast%3DBellahcene%26aufirst%3DA.%26aulast%3DTurtoi%26aufirst%3DA.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DThiry%26aufirst%3DM.%26aulast%3DCastronovo%26aufirst%3DV.%26aulast%3DPeulen%26aufirst%3DO.%26atitle%3DMyoferlin%2520plays%2520a%2520key%2520role%2520in%2520VEGFA%2520secretion%2520and%2520impacts%2520tumor-associated%2520angiogenesis%2520in%2520human%2520pancreas%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2016%26volume%3D138%26spage%3D652%26epage%3D663%26doi%3D10.1002%2Fijc.29820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. C.</span></span> <span> </span><span class="NLM_article-title">Prognostic role of myoferlin expression in patients with clear cell renal cell carcinoma</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">89033</span>– <span class="NLM_lpage">89039</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.21645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.18632%2Foncotarget.21645" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=89033-89039&author=D.+H.+Songauthor=G.+H.+Koauthor=J.+H.+Leeauthor=J.+S.+Leeauthor=J.+W.+Yangauthor=M.+H.+Kimauthor=H.+J.+Anauthor=M.+H.+Kangauthor=K.+N.+Jeonauthor=D.+C.+Kim&title=Prognostic+role+of+myoferlin+expression+in+patients+with+clear+cell+renal+cell+carcinoma&doi=10.18632%2Foncotarget.21645"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.21645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.21645%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DD.%2BH.%26aulast%3DKo%26aufirst%3DG.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DYang%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DM.%2BH.%26aulast%3DAn%26aufirst%3DH.%2BJ.%26aulast%3DKang%26aufirst%3DM.%2BH.%26aulast%3DJeon%26aufirst%3DK.%2BN.%26aulast%3DKim%26aufirst%3DD.%2BC.%26atitle%3DPrognostic%2520role%2520of%2520myoferlin%2520expression%2520in%2520patients%2520with%2520clear%2520cell%2520renal%2520cell%2520carcinoma%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D89033%26epage%3D89039%26doi%3D10.18632%2Foncotarget.21645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span> <span> </span><span class="NLM_article-title">Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1743</span>– <span class="NLM_lpage">1754</span>, <span class="refDoi"> DOI: 10.1111/jcmm.13455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1111%2Fjcmm.13455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=29164766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsVykt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=1743-1754&author=W.+Zhangauthor=P.+Zhouauthor=A.+Mengauthor=R.+Zhangauthor=Y.+Zhou&title=Down-regulating+Myoferlin+inhibits+the+vasculogenic+mimicry+of+melanoma+via+decreasing+MMP-2+and+inducing+mesenchymal-to-epithelial+transition&doi=10.1111%2Fjcmm.13455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition</span></div><div class="casAuthors">Zhang, Wenxue; Zhou, Ping; Meng, Ai; Zhang, Rongxin; Zhou, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1743-1754</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Vasculogenic mimicry (VM) constitutes a novel approach for tumor blood supply and contributes to tumor metastasis and poor prognosis in patients with melanoma.  Myoferlin (MYOF), a type II membrane protein involved in membrane regeneration and repair, is elevated in several malignant tumors, esp. in advanced melanomas.  This study aims to investigate the role and mechanism of MYOF in the regulation of VM.  VM structures were found in 14 of 52 tested melanoma samples, and high MYOF expression correlated with VM structures.  According to Kaplan-Meier survival curves, VM channels and elevated MYOF expression both correlated with poor prognosis in melanoma patients.  Down-regulation of MYOF by siRNA severely impaired the capability of A375 cells to form VM structures in vitro.  Further studies demonstrated MYOF knockdown inhibited cell migration and invasion, which is required for VM formation, via decreasing MMP-2 expression as evidenced by Western blotting, RT-RCP and ELISA results.  SB-3CT, a specific inhibitor of MMP-2, showed similar inhibiting effects with siMYOF, further supporting that MYOF down-regulation inhibits MMP-2 expression to affect VM formation.  Moreover, MYOF knockdown suppress VM formation by A375 cells by inducing mesenchymal-to-epithelial transition (MET).  After down-regulating MYOF, focal adhesions were enlarged and A375 cells developed into a clear epithelial morphol.  Such cells acquired the expression of E-cadherin at adherens junctions along with a loss of mesenchymal markers, such as Vimentin and Twist1.  In conclusion, MYOF plays an important role in VM and knockdown of MYOF suppresses VM formation via decreasing MMP-2 and inducing MET in A375 melanoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkXnMfe0o0M7Vg90H21EOLACvtfcHk0lgcp3PQmUXaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsVykt7Y%253D&md5=604bcb98525fdf101cc5e945c6f93883</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.13455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.13455%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DMeng%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DDown-regulating%2520Myoferlin%2520inhibits%2520the%2520vasculogenic%2520mimicry%2520of%2520melanoma%2520via%2520decreasing%2520MMP-2%2520and%2520inducing%2520mesenchymal-to-epithelial%2520transition%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2018%26volume%3D22%26spage%3D1743%26epage%3D1754%26doi%3D10.1111%2Fjcmm.13455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Z.</span></span> <span> </span><span class="NLM_article-title">A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling</span>. <i>Sci. China: Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1007/s11427-016-0369-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1007%2Fs11427-016-0369-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=28194552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVaru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=202-214&author=Y.+Liuauthor=Y.+Heauthor=F.+Yangauthor=X.+Congauthor=J.+Wangauthor=S.+Pengauthor=D.+Gaoauthor=W.+Wangauthor=L.+Lanauthor=X.+Yingauthor=M.+Liuauthor=Y.+Chenauthor=Z.+Yi&title=A+novel+synthetic+small+molecule+YF-452+inhibits+tumor+growth+through+antiangiogenesis+by+suppressing+VEGF+receptor+2+signaling&doi=10.1007%2Fs11427-016-0369-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling</span></div><div class="casAuthors">Liu, Yongrui; He, Yuan; Yang, Feifei; Cong, Xiaonan; Wang, Jinhua; Peng, Shihong; Gao, Dan; Wang, Weifang; Lan, Liping; Ying, Xuexiang; Liu, Mingyao; Chen, Yihua; Yi, Zhengfang</div><div class="citationInfo"><span class="NLM_cas:title">Science China: Life Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-214</span>CODEN:
                <span class="NLM_cas:coden">SCLSCJ</span>;
        ISSN:<span class="NLM_cas:issn">1674-7305</span>.
    
            (<span class="NLM_cas:orgname">Science China Press</span>)
        </div><div class="casAbstract">Tumor angiogenesis is characterized by abnormal vessel morphol., endowing tumor with highly hypoxia and unresponsive toward treatment.  To date, mounting angiogenic factors have been discovered as therapeutic targets in antiangiogenic drug development.  Among them, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors exerts potent antiangiogenic activity in tumor therapy.  Therefore, it may provide a valid strategy for cancer treatment through targeting the tumor angiogenesis via VEGFR2 pathway.  In this study, we established a high-profile compds. library and certificated a novel compd. named N-(N-pyrrolidylacetyl)-9-(4-bromobenzyl)-1,3,4,9-tetrahydro-β-carboline (YF-452), which remarkably inhibited the migration, invasion and tube-like structure formation of human umbilical vein endothelial cells (HUVECs) with little toxicity invitro.  Rat thoracic aorta ring assay indicated that YF-452 significantly blocked the formation of microvascular exvivo.  In addn., YF-452 inhibited angiogenesis in chick chorioallantoic membrane (CAM) and mouse corneal micropocket assays.  Moreover, YF-452 remarkably suppressed tumor growth in xenografts mice model.  Furthermore, investigation of mol. mechanism revealed that YF-452 inhibited VEGF-induced phosphorylation of VEGFR2 kinase and the downstream protein kinases including extracellular signal regulated kinase (ERK), focal adhesion kinase (FAK) and Src.  These results indicate that YF-452 inhibits angiogenesis and may be a potential antiangiogenic drug candidate for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrny_aLxFOISrVg90H21EOLACvtfcHk0lh19ga1xvbofQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVaru74%253D&md5=298f917f77ced4f69f7efdb47a9d257c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs11427-016-0369-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11427-016-0369-6%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DCong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DYing%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYi%26aufirst%3DZ.%26atitle%3DA%2520novel%2520synthetic%2520small%2520molecule%2520YF-452%2520inhibits%2520tumor%2520growth%2520through%2520antiangiogenesis%2520by%2520suppressing%2520VEGF%2520receptor%25202%2520signaling%26jtitle%3DSci.%2520China%253A%2520Life%2520Sci.%26date%3D2017%26volume%3D60%26spage%3D202%26epage%3D214%26doi%3D10.1007%2Fs11427-016-0369-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Optimization of 2-(3-(arylalkyl amino carbonyl)phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.ejmech.2014.04.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2014&pages=340-351&author=J.+Wuauthor=L.+Yuauthor=F.+Yangauthor=J.+Liauthor=P.+Wangauthor=W.+Zhouauthor=L.+Qinauthor=Y.+Liauthor=J.+Luoauthor=Z.+Yiauthor=M.+Liuauthor=Y.+Chen&title=Optimization+of+2-%283-%28arylalkyl+amino+carbonyl%29phenyl%29-3-%282-methoxyphenyl%29-4-thiazolidinone+derivatives+as+potent+antitumor+growth+and+metastasis+agents&doi=10.1016%2Fj.ejmech.2014.04.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DYi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DOptimization%2520of%25202-%25283-%2528arylalkyl%2520amino%2520carbonyl%2529phenyl%2529-3-%25282-methoxyphenyl%2529-4-thiazolidinone%2520derivatives%2520as%2520potent%2520antitumor%2520growth%2520and%2520metastasis%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D80%26spage%3D340%26epage%3D351%26doi%3D10.1016%2Fj.ejmech.2014.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seng, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span> <span> </span><span class="NLM_article-title">Rapid synthesis of 1,3,5-substituted 1,2,4-triazoles from carboxylic acids, amidines, and hydrazines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1177</span>– <span class="NLM_lpage">1179</span>, <span class="refDoi"> DOI: 10.1021/jo1023393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo1023393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=1177-1179&author=G.+M.+Castanedoauthor=P.+S.+Sengauthor=N.+Blaquiereauthor=S.+Trappauthor=S.+T.+Staben&title=Rapid+synthesis+of+1%2C3%2C5-substituted+1%2C2%2C4-triazoles+from+carboxylic+acids%2C+amidines%2C+and+hydrazines&doi=10.1021%2Fjo1023393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Synthesis of 1,3,5-Substituted 1,2,4-Triazoles from Carboxylic Acids, Amidines, and Hydrazines</span></div><div class="casAuthors">Castanedo, Georgette M.; Seng, Pamela S.; Blaquiere, Nicole; Trapp, Sean; Staben, Steven T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1177-1179</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general method for the synthesis of 1,3,5-trisubstituted 1,2,4-triazoles has been developed from reaction of carboxylic acids, primary amidines, and monosubstituted hydrazines.  This highly regioselective and one-pot process provides rapid access to highly diverse triazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxnKwy9kVqdrVg90H21EOLACvtfcHk0lh19ga1xvbofQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVehtw%253D%253D&md5=4ed7e87d6f25f096287e41185367da7d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo1023393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo1023393%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DSeng%26aufirst%3DP.%2BS.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DTrapp%26aufirst%3DS.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26atitle%3DRapid%2520synthesis%2520of%25201%252C3%252C5-substituted%25201%252C2%252C4-triazoles%2520from%2520carboxylic%2520acids%252C%2520amidines%252C%2520and%2520hydrazines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2011%26volume%3D76%26spage%3D1177%26epage%3D1179%26doi%3D10.1021%2Fjo1023393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Synthesis of aromatic esters via Pd-catalyzed decarboxylative coupling of potassium oxalate monoesters with aryl bromides and chlorides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">5738</span>– <span class="NLM_lpage">5739</span>, <span class="refDoi"> DOI: 10.1021/ja900984x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja900984x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFKktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=5738-5739&author=R.+Shangauthor=Y.+Fuauthor=J.+B.+Liauthor=S.+L.+Zhangauthor=Q.+X.+Guoauthor=L.+Liu&title=Synthesis+of+aromatic+esters+via+Pd-catalyzed+decarboxylative+coupling+of+potassium+oxalate+monoesters+with+aryl+bromides+and+chlorides&doi=10.1021%2Fja900984x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Aromatic Esters via Pd-Catalyzed Decarboxylative Coupling of Potassium Oxalate Monoesters with Aryl Bromides and Chlorides</span></div><div class="casAuthors">Shang, Rui; Fu, Yao; Li, Jia-Bin; Zhang, Song-Lin; Guo, Qing-Xiang; Liu, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5738-5739</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pd-catalyzed decarboxylative cross-coupling of aryl iodides, bromides, and chlorides with potassium oxalate monoesters has been discovered.  This reaction is potentially useful for lab.-scale synthesis of aryl and alkenyl esters.  Bulky, electron-rich bidentate phosphine ligands are preferred in the reaction, whereas Cu is not needed for decarboxylation.  Theor. calcns. suggest a five-coordinate Pd(II) transition state for decarboxylation with an energy barrier of ∼30 kcal/mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolyycA3l3rPbVg90H21EOLACvtfcHk0lgkcUTdf6wNSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFKktb4%253D&md5=055f5268f66859ba37718ff4b83ff991</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fja900984x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja900984x%26sid%3Dliteratum%253Aachs%26aulast%3DShang%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%2BB.%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DGuo%26aufirst%3DQ.%2BX.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DSynthesis%2520of%2520aromatic%2520esters%2520via%2520Pd-catalyzed%2520decarboxylative%2520coupling%2520of%2520potassium%2520oxalate%2520monoesters%2520with%2520aryl%2520bromides%2520and%2520chlorides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D5738%26epage%3D5739%26doi%3D10.1021%2Fja900984x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angulo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, P. M.</span></span> <span> </span><span class="NLM_article-title">STD-NMR: application to transient interactions between biomolecules-a quantitative approach</span>. <i>Eur. Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1357</span>– <span class="NLM_lpage">1369</span>, <span class="refDoi"> DOI: 10.1007/s00249-011-0749-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1007%2Fs00249-011-0749-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=21947507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeisbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=1357-1369&author=J.+Anguloauthor=P.+M.+Nieto&title=STD-NMR%3A+application+to+transient+interactions+between+biomolecules-a+quantitative+approach&doi=10.1007%2Fs00249-011-0749-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">STD-NMR: application to transient interactions between biomolecules-a quantitative approach</span></div><div class="casAuthors">Angulo, Jesus; Nieto, Pedro M.</div><div class="citationInfo"><span class="NLM_cas:title">European Biophysics Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1357-1369</span>CODEN:
                <span class="NLM_cas:coden">EBJOE8</span>;
        ISSN:<span class="NLM_cas:issn">0175-7571</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Satn. transfer difference NMR (STD NMR) spectroscopy is one of the most powerful NMR techniques for detection and characterization of transient (fast) receptor-ligand interactions in soln.  By observing the signals of a small mol. (ligand) with spectroscopic properties suitable for high-resoln. studies, irresp. of receptor size, STD NMR enables quant. structural and affinity information to be obtained about the mol. recognition process under study.  Approx. one decade after its introduction, the technique has reached maturity, and is highly robust and useful.  The objective of this article is to review the current status of this powerful technique, with particular emphasis on quant. applications, within the framework of the (bio-)chem. of mol. recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpviA2KOCTF8bVg90H21EOLACvtfcHk0lgkcUTdf6wNSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeisbjI&md5=e1a08ce79d780175dd5d6b96e661f68e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs00249-011-0749-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00249-011-0749-5%26sid%3Dliteratum%253Aachs%26aulast%3DAngulo%26aufirst%3DJ.%26aulast%3DNieto%26aufirst%3DP.%2BM.%26atitle%3DSTD-NMR%253A%2520application%2520to%2520transient%2520interactions%2520between%2520biomolecules-a%2520quantitative%2520approach%26jtitle%3DEur.%2520Biophys.%2520J.%26date%3D2011%26volume%3D40%26spage%3D1357%26epage%3D1369%26doi%3D10.1007%2Fs00249-011-0749-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, A.</span></span> <span> </span><span class="NLM_article-title">The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects</span>. <i>Am. Fam. Physician</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=17708140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A280%3ADC%252BD2svovFGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=391-396&author=T.+Lynchauthor=A.+Price&title=The+effect+of+cytochrome+P450+metabolism+on+drug+response%2C+interactions%2C+and+adverse+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects</span></div><div class="casAuthors">Lynch Tom; Price Amy</div><div class="citationInfo"><span class="NLM_cas:title">American family physician</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">391-6</span>
        ISSN:<span class="NLM_cas:issn">0002-838X</span>.
    </div><div class="casAbstract">Cytochrome P450 enzymes are essential for the metabolism of many medications.  Although this class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most significant enzymes being CYP3A4 and CYP2D6.  Genetic variability (polymorphism) in these enzymes may influence a patient's response to commonly prescribed drug classes, including beta blockers and antidepressants.  Cytochrome P450 enzymes can be inhibited or induced by drugs, resulting in clinically significant drug-drug interactions that can cause unanticipated adverse reactions or therapeutic failures.  Interactions with warfarin, antidepressants, antiepileptic drugs, and statins often involve the cytochrome P450 enzymes.  Knowledge of the most important drugs metabolized by cytochrome P450 enzymes, as well as the most potent inhibiting and inducing drugs, can help minimize the possibility of adverse drug reactions and interactions.  Although genotype tests can determine if a patient has a specific enzyme polymorphism, it has not been determined if routine use of these tests will improve outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQE6VB-Pf2cThe4jJGKT5N0fW6udTcc2eZGWshwR4TRbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svovFGhtQ%253D%253D&md5=68832276c56c8fb5f2818fc25bcc637f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DPrice%26aufirst%3DA.%26atitle%3DThe%2520effect%2520of%2520cytochrome%2520P450%2520metabolism%2520on%2520drug%2520response%252C%2520interactions%252C%2520and%2520adverse%2520effects%26jtitle%3DAm.%2520Fam.%2520Physician%26date%3D2007%26volume%3D76%26spage%3D391%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jolly, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somarelli, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biddle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanash, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bapat, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangarajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, H.</span></span> <span> </span><span class="NLM_article-title">Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2018.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.pharmthera.2018.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=30268772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGisLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2019&pages=161-184&author=M.+K.+Jollyauthor=J.+A.+Somarelliauthor=M.+Shethauthor=A.+Biddleauthor=S.+C.+Tripathiauthor=A.+J.+Armstrongauthor=S.+M.+Hanashauthor=S.+A.+Bapatauthor=A.+Rangarajanauthor=H.+Levine&title=Hybrid+epithelial%2Fmesenchymal+phenotypes+promote+metastasis+and+therapy+resistance+across+carcinomas&doi=10.1016%2Fj.pharmthera.2018.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas</span></div><div class="casAuthors">Jolly, Mohit Kumar; Somarelli, Jason A.; Sheth, Maya; Biddle, Adrian; Tripathi, Satyendra C.; Armstrong, Andrew J.; Hanash, Samir M.; Bapat, Sharmila A.; Rangarajan, Annapoorni; Levine, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">161-184</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Cancer metastasis and therapy resistance are the major unsolved clin. challenges, and account for nearly all cancer-related deaths.  Both metastasis and therapy resistance are fueled by epithelial plasticity, the reversible phenotypic transitions between epithelial and mesenchymal phenotypes, including epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET).  EMT and MET have been largely considered as binary processes, where cells detach from the primary tumor as individual units with many, if not all, traits of a mesenchymal cell (EMT) and then convert back to being epithelial (MET).  However, recent studies have demonstrated that cells can metastasize in ways alternative to traditional EMT paradigm; for example, they can detach as clusters, and/or occupy one or more stable hybrid epithelial/mesenchymal (E/M) phenotypes that can be the end point of a transition.  Such hybrid E/M cells can integrate various epithelial and mesenchymal traits and markers, facilitating collective cell migration.  Furthermore, these hybrid E/M cells may possess higher tumor-initiation and metastatic potential as compared to cells on either end of the EMT spectrum.  Here, we review in silico, in vitro, in vivo and clin. evidence for the existence of one or more hybrid E/M phenotype(s) in multiple carcinomas, and discuss their implications in tumor-initiation, tumor relapse, therapy resistance, and metastasis.  Together, these studies drive the emerging notion that cells in a hybrid E/M phenotype may occupy 'metastatic sweet spot' in multiple subtypes of carcinomas, and pathways linked to this (these) hybrid E/M state(s) may be relevant as prognostic biomarkers as well as a promising therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocsdQxD5n7iLVg90H21EOLACvtfcHk0lgCbAZzTt3qlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGisLbJ&md5=4837c77f0c3eb157f352490d8641e592</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2018.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2018.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DJolly%26aufirst%3DM.%2BK.%26aulast%3DSomarelli%26aufirst%3DJ.%2BA.%26aulast%3DSheth%26aufirst%3DM.%26aulast%3DBiddle%26aufirst%3DA.%26aulast%3DTripathi%26aufirst%3DS.%2BC.%26aulast%3DArmstrong%26aufirst%3DA.%2BJ.%26aulast%3DHanash%26aufirst%3DS.%2BM.%26aulast%3DBapat%26aufirst%3DS.%2BA.%26aulast%3DRangarajan%26aufirst%3DA.%26aulast%3DLevine%26aufirst%3DH.%26atitle%3DHybrid%2520epithelial%252Fmesenchymal%2520phenotypes%2520promote%2520metastasis%2520and%2520therapy%2520resistance%2520across%2520carcinomas%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D194%26spage%3D161%26epage%3D184%26doi%3D10.1016%2Fj.pharmthera.2018.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, K.</span></span> <span> </span><span class="NLM_article-title">Proteolytic interstitial cell migration: a five-step process</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1007/s10555-008-9174-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1007%2Fs10555-008-9174-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=19153672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A280%3ADC%252BD1M3hslSnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=129-135&author=P.+Friedlauthor=K.+Wolf&title=Proteolytic+interstitial+cell+migration%3A+a+five-step+process&doi=10.1007%2Fs10555-008-9174-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic interstitial cell migration: a five-step process</span></div><div class="casAuthors">Friedl Peter; Wolf Katarina</div><div class="citationInfo"><span class="NLM_cas:title">Cancer metastasis reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">129-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cell migration is a multi-step process that leads to the actin-driven translocation of cells on or through tissue substrate.  Basic steps involved in cell migration have been defined for two-dimensional haptokinetic migration which, however, does not provide physical constraints imposed by three-dimensional interstitial tissues.  We here describe the process of pericellular proteolysis that leads to extracellular matrix (ECM) degradation and realignment during cell movement and integrate it into established steps of cell migration.  After actin-driven leading edge protrusion (step I) and anterior formation of integrin-mediated focal interactions to the substrate (step II), ECM breakdown is focalized towards physical ECM barriers several micrometer rearward of the leading edge (step III).  Actomyosin-mediated cell contraction (step IV) then leads to rear-end retraction and forward sliding of cell body and nucleus so that a small tube-like matrix defect bordered by realigned ECM fibers becomes apparent (step V).  Pericellular proteolysis is thus integral to the migration cycle and serves to widen ECM gaps and thereby lowers physical stress upon the cell body, which ultimately leads to aligned higher-oder ECM patterns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgWNHWmc0hKL7NkxioyDXTfW6udTcc2eaIMqKe3u_Bl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3hslSnsQ%253D%253D&md5=27340e9b034a83d270057d54201c996c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9174-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9174-3%26sid%3Dliteratum%253Aachs%26aulast%3DFriedl%26aufirst%3DP.%26aulast%3DWolf%26aufirst%3DK.%26atitle%3DProteolytic%2520interstitial%2520cell%2520migration%253A%2520a%2520five-step%2520process%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2009%26volume%3D28%26spage%3D129%26epage%3D135%26doi%3D10.1007%2Fs10555-008-9174-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, F.</span></span> <span> </span><span class="NLM_article-title">Emerging protein kinase inhibitors for treating pancreatic cancer</span>. <i>Expert Opin. Emerging Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1080/14728214.2017.1293648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1080%2F14728214.2017.1293648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=28253828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFWntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=77-86&author=J.+Furuseauthor=F.+Nagashima&title=Emerging+protein+kinase+inhibitors+for+treating+pancreatic+cancer&doi=10.1080%2F14728214.2017.1293648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging protein kinase inhibitors for treating pancreatic cancer</span></div><div class="casAuthors">Furuse, Junji; Nagashima, Fumio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-86</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Pancreatic cancer, the incidence and mortality of which are increasing around the world, has the most dismal prognosis among the commonly encountered cancers.  Systemic chemotherapy plays an important role in the treatment of patients with pancreatic cancer, and development of more effective chemotherapies is being sought.: This review article provides a summary about protein kinase inhibitors that have been investigated for the treatment of pancreatic cancer, not only existing agents targeting RAS, EGFR, VEGFR, MEK, etc., but also various compds. targeting, including the MAPK, PI3 K/Akt/mTOR, and JAK/STAT signaling pathways, trials of which are currently ongoing.  To date, none has shown sufficient efficacy as to merit becoming established as a std. treatment agent for pancreatic cancer.: As the toxicities of protein kinase inhibitors usually differ from those of cytotoxic agents, it could be of value to use these agents in combination with gemcitabine plus nab-paclitaxel.  It may be reasonable to identify a suitable disease and/or predictive markers for new compds. in proof of concept trials.  It is an urgent need to conduct phase III trials, on the basis of the results obtained, in subpopulations with biomarkers to predict the efficacy of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8KLcqtCPuhbVg90H21EOLACvtfcHk0lgCbAZzTt3qlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFWntL0%253D&md5=e421eee1b9489287ee1fd63f177e619c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F14728214.2017.1293648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728214.2017.1293648%26sid%3Dliteratum%253Aachs%26aulast%3DFuruse%26aufirst%3DJ.%26aulast%3DNagashima%26aufirst%3DF.%26atitle%3DEmerging%2520protein%2520kinase%2520inhibitors%2520for%2520treating%2520pancreatic%2520cancer%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2017%26volume%3D22%26spage%3D77%26epage%3D86%26doi%3D10.1080%2F14728214.2017.1293648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Y.</span></span> <span> </span><span class="NLM_article-title">Drug target identification using network analysis: Taking active components in Sini decoction as an example</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">24245</span> <span class="refDoi"> DOI: 10.1038/srep24245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1038%2Fsrep24245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=27095146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A280%3ADC%252BC28bhslWqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=S.+Chenauthor=H.+Jiangauthor=Y.+Caoauthor=Y.+Wangauthor=Z.+Huauthor=Z.+Zhuauthor=Y.+Chai&title=Drug+target+identification+using+network+analysis%3A+Taking+active+components+in+Sini+decoction+as+an+example&doi=10.1038%2Fsrep24245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Drug target identification using network analysis: Taking active components in Sini decoction as an example</span></div><div class="casAuthors">Chen Si; Jiang Hailong; Cao Yan; Wang Yun; Zhu Zhenyu; Chai Yifeng; Hu Ziheng</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24245</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Identifying the molecular targets for the beneficial effects of active small-molecule compounds simultaneously is an important and currently unmet challenge.  In this study, we firstly proposed network analysis by integrating data from network pharmacology and metabolomics to identify targets of active components in sini decoction (SND) simultaneously against heart failure.  To begin with, 48 potential active components in SND against heart failure were predicted by serum pharmacochemistry, text mining and similarity match.  Then, we employed network pharmacology including text mining and molecular docking to identify the potential targets of these components.  The key enriched processes, pathways and related diseases of these target proteins were analyzed by STRING database.  At last, network analysis was conducted to identify most possible targets of components in SND.  Among the 25 targets predicted by network analysis, tumor necrosis factor α (TNF-α) was firstly experimentally validated in molecular and cellular level.  Results indicated that hypaconitine, mesaconitine, higenamine and quercetin in SND can directly bind to TNF-α, reduce the TNF-α-mediated cytotoxicity on L929 cells and exert anti-myocardial cell apoptosis effects.  We envisage that network analysis will also be useful in target identification of a bioactive compound.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyH-6lz7TqEaNc3HjJRoFAfW6udTcc2eaiaDZw6y4tw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bhslWqsA%253D%253D&md5=804323e4a9c8e68ae8f2c9fa804fd926</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep24245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep24245%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DChai%26aufirst%3DY.%26atitle%3DDrug%2520target%2520identification%2520using%2520network%2520analysis%253A%2520Taking%2520active%2520components%2520in%2520Sini%2520decoction%2520as%2520an%2520example%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fsrep24245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2017.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=10.1016%2Fj.toxlet.2017.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=28941798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKit7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2017&pages=74-83&author=S.+Tangauthor=A.+Chenauthor=X.+Zhouauthor=L.+Zengauthor=M.+Liuauthor=X.+Wang&title=Assessment+of+the+inhibition+risk+of+shikonin+on+cytochrome+P450+via+cocktail+inhibition+assay&doi=10.1016%2Fj.toxlet.2017.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay</span></div><div class="casAuthors">Tang, Shuowen; Chen, Ang; Zhou, Xiaojing; Zeng, Li; Liu, Mingyao; Wang, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-83</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Shikonin is a naphthoquinone pigment extd. from roots of Lithospermum erythrorhizon Sieb. et Zucc. (Boraginaceae), and possesses various pharmaceutical activities, such as anti-inflammation and anti-cancer effects.  In addn., shikonin as a natural red colorant for food garnishment and cosmetics ingredient is widely used in the world.  However, the inhibition risk of shikonin on cytochrome P 450 (CYP) remains unclear.  The aim of this study was to investigate the potential inhibition of shikonin against CYP1A2, CYP2B1/6, CYP2C9/11, CYP2D1/6, CYP2E1 and CYP3A2/4 activities in human and rat liver microsomes through cocktail approach in vitro.  The results demonstrated that shikonin exhibited no time-dependent inhibition of CYP activities.  In human liver microsomes, shikonin was not only a mixed inhibitor of CYP1A2, CYP2B6, CYP2C9, CYP2D6 and CYP3A4, but also a competitive inhibitor of CYP2E1, with Ki values no more than 7.72 μM.  In rat liver microsomes, shikonin also exhibited the mixed inhibition on CYP1A2, CYP2B1, CYP2C11, CYP2D1, and the competitive inhibition on CYP2E1.  Interestingly, shikonin presented an atypical kinetic inhibition of CYP3A2-mediated midazolam 1-hydroxylation in rats.  In conclusion, the relatively low Ki values of shikonin would have a high risk potential to cause the possible toxicity, esp. drug-drug or food-drug interactions based on the potent inhibition of CYP enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_H8DW4pWptLVg90H21EOLACvtfcHk0lg4bwB5Mw6rxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKit7zI&md5=4a91fcb7abfccbb9030ea01c62a8d8cd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2017.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2017.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DAssessment%2520of%2520the%2520inhibition%2520risk%2520of%2520shikonin%2520on%2520cytochrome%2520P450%2520via%2520cocktail%2520inhibition%2520assay%26jtitle%3DToxicol.%2520Lett.%26date%3D2017%26volume%3D281%26spage%3D74%26epage%3D83%26doi%3D10.1016%2Fj.toxlet.2017.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i74"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00059">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_85354"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00059">10.1021/acs.jmedchem.9b00059</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Physicochemical properties of representative compounds (Table S1); antiviability effects of compound <b>6y</b> against PANC1 cell lines in different concentration for 18 h (Figure S1); <b>1g</b> inhibited the migration of MYOF-knockout cells (Figure S2); inhibitory effects against CYP450 isozymes in pooled human liver microsomes for compounds <b>2a</b>, <b>6k</b>, <b>6y</b>, and <b>7a</b> (Figure S3); effects of different concentrations of compound <b>6y</b> on the expressions of E-cadherin and fibronectin, secretions of MMP1 and MMP2, expressions as well as phosphorylations of EGFR and VEGFR2 in MYOF-knockout PANC1 cells (Figure S4); compound <b>6y</b> exhibited selectivity for MYOF over other metastasis-associated proteins (Figure S5); compound <b>6y</b> did not affect the expressions of myosin IIA and dynein (Figure S6); <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS (ESI), and HPLC spectra of target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_001.pdf">jm9b00059_si_001.pdf (13.63 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00059/suppl_file/jm9b00059_si_002.csv">jm9b00059_si_002.csv (3.34 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00059&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00059%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-10%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00059" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                10MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a83e09cd324eb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
